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—MORE CONFIDENCE IN A N T I T H R O M B O T IC  TH E R A P Y
New Guidelines for 
Antithrombotic Therapy 
In Surgical Cases
The American College of Chest Physi­
cians and the National Heart, Lung and 
Blood Institute recently issued new 
guidelines for antithrombotic therapy.1 
There were four Grade A recom­
mendations for the use of warfarin 
(Coumadin®) in surgical cases. In each 
of these four (and other Grade A and B 
recommendations for Coumadin®) a PT 
ratio of 1.2-1.5 (rabbit brain) was 
emphasized for clinical efficacy and 
reduced side-effects risk.
an
INDICATIONS: Elective hip surgery/ 
surgery for fractured 
hips.
"  • ■ ■ patients undergoing elective hip surgery 
should be pretreated prophylactically with 
adjusted-dose heparin or moderate-dose war­
farin sodium . .
. patients undergoing surgery for fractured 
hips should be treated prophylactically with 
moderate-dose warfarin.
INDICATION: Prophylaxis of venous 
thromboembolism.
"It is strongly recommended that the 
therapeutic range for prophylaxis . . .  in high- 
risk medical or surgical patients should be 
equivalent to an INR o f 2.0-3.0 (corresponding 
rabbit brain thromboplastin ratio 1.2-1.5)."
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(warfarin sodium)
for Antithrombotic Therapy
O F  V A L U E  I N  Y O U R  P R A C T I C E
CONDITION: Bioprosthetic heart valves.
. . all patients with bioprosthetic heart valves 
in the mitral position be treated for the first 
three months after valve insertion with less 
intense warfarin . . ."
ff
CONDITION: Prophylaxis of venous 
thromboembolism.
"It is recommended that anticoagulant therapy 
should be continued for three months using 
oral anticoagulants to prolong prothrombin 
tim e. . ."
1. Chest 1966;89(2);1S-106S
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QUILL ON SCALPEL
This section provides a medium through which Canadian 
surgeons can declare themselves, briefly and informally, on 
the day-to-day affairs of surgery.
Substitutes for Homologous Blood Transfusion
One cornerstone of surgical treatment, 
the use of homologous blood, is being 
challenged for very good reasons. The 
transmission of infectious diseases, espe­
cially acquired immune deficiency syn­
drome (AIDS) and hepatitis, and the evi­
dence that homologous blood transfu­
sions can induce immunosuppression1 
have stimulated the search for alternative 
therapies. Non-A, non-B hepatitis, for 
which vaccination is not available, is the 
commonest life-threatening infection 
transmitted by blood transfusion.2 A 
high prevalence (8% to 17%) of post­
transfusion hepatitis has been reported 
from Sweden, Spain, Italy, the United 
States and Israel. Lower percentages (2% 
to 5%) are reported from Australia, Fin­
land, West Germany and Canada.2
The transmission of the human 
immunodeficiency virus (HIV) is rela­
tively low by sexual contact (1% per 
exposure),3 even lower by contaminated 
needlestick (less than 1% per exposure), 
but is highly efficient in single-donor 
blood products. Studies4 of recipients of 
blood from donors in whom AIDS later 
developed have never identified a
recipient who did not acquire the infec­
tion after a transfusion from an infected 
donor.
At least four strategies to avoid trans­
fusion of homologous blood are availa­
ble to us — hemodilution, predonation, 
normovolemic hemodilution and cell 
saving.
Hemodilution with acceptance of a 
lower hematocrit (0.25 to 0.30) is one of 
the simplest measures, the consequences 
of which are reviewed by Landow in this 
issue (pages 321 to 325). Patients should 
not have any pulmonary defect that might 
impair oxygenation of blood and must 
have the capacity to increase cardiac out­
put to ensure oxygen delivery.
Autologous blood donation is safe and 
deserves wider clinical application. Mann 
and associates5 found no dangerous 
complications in 342 “ high-risk” 
patients, including those with severe heart 
disease, the elderly, children and pregnant 
women. Absolute contraindications to 
autologous blood predeposit are bactere­
mia, severe coronary artery disease and 
anemia. The number of donations, given 
at intervals of 2 to 7 days, is calculated.
assuming that the target preoperative 
hematocrit level is 0.35 and that the aver­
age hematocrit drop per donation (usually 
350 ml) in adults is approximately 0.02. 
The red cells are stored preferably in 
citrate-phosphate-dextrose-adenine 
(CPDA), which provides 5 to 6 weeks’ 
storage life with a post-transfusion red 
cell survival of about 80%. Patients 
whose blood needs may be large (more 
than 4 units) can give units that are frozen 
some months before entering a predeposit 
program.
Normovolemic hemodilution is a third 
option. When a substantial blood loss at 
operation is anticipated, 1500 to 2000 ml 
of blood are withdrawn, before or after 
induction of anesthesia, into standard col­
lection bags and as CPD blood at room 
temperature. The amount of blood with­
drawn is replaced simultaneously by 
isovolemic infusion of colloids (human 
albumin 5%) or Ringer’s lactate solution 
in a volume three times that of the blood 
withdrawn, to maintain normovolemia. 
The autologous blood ideally is reinfused 
when hemostasis is established. The units 
are reinfused without a filter to ensure
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maximum retransfusion of platelets.
Autotransfusion (cell saving) is the 
final technique. Devices are available for 
aspirating shed blood into a plastic bag 
through a filter with transfusion by 
gravity or external pressure. Air embolism 
is a risk of systems that aspirate blood 
from the operative field into a reservoir 
with immediate transfusion. More studies 
are required to determine the precise 
requirements of cell washing and the 
potential risks of infusing clotting factors 
and tumour cells, but the equipment used 
for blood retrieval in open-heart surgery 
is being widely used in clean abdominal
and thoracic noncardiac surgery to save 
blood.
All these techniques are extremely 
effective and can eliminate completely the 
need for homologous blood transfusion 
in the majority of patients on whom it is 
currently being used.
L loyd D. MacLean , m d , frcsc 
Coeditor.
Surgeon-in-chief,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ 
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Postresection Empyema
Empyema complicating pulmonary resec­
tion is relatively uncommon today. Sur­
gical residents and young graduate 
surgeons are unlikely to have encounte­
red the problem often. Furthermore, 
most young surgeons have never perfor­
med a thoracoplasty or seen one perfor­
med. In this issue of the Journal are two 
articles describing the management of 
postresection empyema. They will be of 
considerable interest to readers. The arti­
cle by Bayes and colleagues from Mon­
treal (pages 329 to 331) describes their 
experience with what can be termed the 
“ modern” treatment of postresection 
empyema — the Clagett technique of 
open-window thoracostomy followed by 
closure of the thoracostomy after sterili­
zation of the empyema cavity. The second 
article by Gregoire and colleagues from 
Quebec City (pages 343 to 345) describes 
what can be referred to as the “ old- 
fashioned” treatment for postpneumo­
nectomy empyema — a six-rib single- 
stage thoracoplasty.
Although these articles appear to pre­
sent competing techniques for the mana­
gement of postresection empyema, they 
are actually complementary and both can 
be part of a comprehensive treatment 
scheme.
Historically, open-window thoracos­
tom y was originally described by 
Eloesser1 in 1935 for the management of 
tuberculous empyema. The procedure 
involves the creation of a U-shaped skin 
flap and resection of a 5-cm rib segment, 
after which the edge of the cutaneous flap 
is sutured to the pleura. Clagett and 
Geraci2 modified this procedure by ope­
ning the post-thoracotomy incision and 
suturing the “ superficial fascia” to the 
periosteum of the resected rib, leaving a 
good-sized window in the thoracic wall. 
This facilitates irrigation of the empyema 
space and avoids the use of a tube, resul­
ting in much greater comfort for the pa­
tient. Clagett and Geraci2 also intro­
duced the concept that a pleural space 
infected after pneumonectomy can be 
sterilized by irrigation with an antiseptic 
solution (such as half-strength Dakin’s 
solution) through an open thoracostomy 
window and that in 6 to 8 weeks the pleu­
ral cavity can be filled with a saline solu­
tion containing 250 mg/dl of neomycin 
and the thoracostomy window closed.
It is important to emphasize that 
empyema occurring after pneumonec­
tomy is an extremely serious complication 
with a very high morbidity and mortality. 
In the Quebec series of 46 patients with 
nontuberculous, postpneumonectomy 
empyema, definitive treatment by single- 
stage thoracoplasty was attempted in only 
17 (37%) patients. For a variety of rea­
sons, the remaining patients were not con­
sidered candidates for definitive treatment 
and it can be assumed that many of them 
died early after operation as a result of 
their empyema. In the Montreal series, 
103 patients had empyema but only 41 
underwent open-window thoracostomy. 
This group included 28 patients with 
postpneumonectomy empyema. Although 
Bayes and associates were not specific, 
it is likely that there were others with 
postpneumonectomy empyema who did 
not undergo definitive therapy and died 
as a consequence of this complication. 
Although both articles address primarily 
the issue of treatment, perhaps more 
emphasis should have been placed on 
the prevention of this catastrophic com­
plication. As Bayes and colleagues point 
out, the published incidence of postre­
section empyema varies between 2% and 
10%. However, in the current practice 
of thoracic surgery, a rate of 10% is 
totally unacceptable and 2% should be 
the goal. Such a low incidence of post­
resection emDyema can be achieved by the
careful selection and preparation of 
patients for surgery and by meticulous 
surgical technique.
It is also important to emphasize that 
postresection empyemas vary in their 
associated morbidity and mortality. An 
empyema that occurs as a complication 
of pneumonectomy is far more serious 
than one following lobectomy. Further­
more, an empyema that is complicated by 
a bronchopleural fistula is more serious 
and difficult to manage than one not 
complicated by such a fistula. Fistulas 
themselves can be subdivided into major 
and minor depending on the size of 
the bronchial opening. Therefore, a com­
parison of different techniques for the 
management of postresection empyemas 
must take into account the different 
types.
The experience of the Montreal group 
with the Clagett two-stage procedure sug­
gests that this technique may be success­
ful in managing patients without a bron­
chopleural fistula or in patients with small 
fistulas that close spontaneously. Of their 
17 patients who had a postpneumonec­
tomy empyema and a bronchopleural 
fistula, closure of the thoracostomy win­
dow was attempted in only 11 and in only 
4 (36%) of these was primary closure suc­
cessful. Therefore, success was achieved 
in less than 25% of the 17 patients. Of 
the 11 patients who had postpneumonec­
tomy empyema without a bronchopleural 
fistula, 7 had attempted closure of the 
thoracostomy window with success in 6, 
an overall success rate of 55%.
The series reported from Quebec 
presents a technique that is well known 
to thoracic surgeons who trained during 
the era when surgery for pulmonary 
tuberculosis was common — a space- 
reducing thoracoplasty. The authors uti­
lized a tailoring six-rib (second to seventh 
ribs inclusive) thoracoplasty in 17
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patients, with a successful outcome in 15 
(88%). Of the 17 patients, 7 had a 
bronchopleural fistula, but in only 2 was 
the fistula considered sufficiently major 
to require specific treatment. Although 
the results appear superior to those 
reported by the Montreal group it must 
be emphasized that the treated group was 
highly selected and only 17 patients from 
the entire group of 41 were treated by 
thoracoplasty.
The lessons we can learn from these 
two articles are fourfold.
• Postpneumonectomy empyema, par­
ticularly that associated with a major 
bronchopleural fistula, is a very serious 
complication and is better prevented than 
treated.
• Once the complication occurs, sep­
sis must first be controlled and aspiration 
avoided. These can be achieved by open- 
window thoracostomy; adjuvant treat­
ment involves the appropriate use of 
antibiotics and careful attention to 
nutrition.
• In the absence of a bronchial fistula 
or when the fistula closes spontaneously, 
the Clagett procedure of irrigation of the 
empyema cavity followed by closure of 
the thoracostomy window may be success­
ful. If the Clagett procedure fails, the 
window can be reopened and a space- 
reducing thoracoplasty, as advocated by 
the Quebec group, can be carried out in 
“ good risk” patients. The thoracoplasty 
must be meticulously performed follow­
ing the principles they advocate. If the 
bronchial fistula is minor (less than 2 mm 
in diameter), closure of the fistula is likely 
to result from the thoracoplasty alone. If 
the fistula is major, then it will have to 
be closed by some type of muscle flap.
• In patients who have evidence of 
recurrent neoplasm or who cannot toler­
ate a thoracoplasty, the open-window 
thoracostomy can be maintained in the 
long term.
N.M. Sheiner, md, frcsc 
Member,
Editorial Board.
Chief of Cardiovascular and 
Thoracic Surgery,
Sir Mortimer B. Davis-Jewish 
General Hospital,
3755 Cote Ste-Catherine,
Montreal, PQ 
H3T 1E2
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Lower Extremity Amputation in Elderly Patients
The increasing longevity of the popula­
tion combined with improved techniques 
of peripheral vascular surgery is produc­
ing a growing number of geriatric lower 
extremity amputees. Fortunately, better 
prostheses and rehabilitation return a 
majority to a reasonably independent life 
in their own homes. Surprisingly, their 
life expectancy is similar to that for their 
age.
The surgeon should know what results 
to expect from lower extremity amputa­
tion at each of the conventional levels. 
The article in this issue (pages 374 to 376) 
by Lexier and colleagues provides this 
information.
In general, the greater the length of 
limb preserved, the better the functional 
result. By “ length” we do not necessar­
ily mean the physical length of the stump, 
but the number of joints that are saved 
and can function in an appropriate 
prosthesis. For example a mid-tarsal 
(Chopart) amputation may preserve nor­
mal ankle function but the stump is so 
short that a conventional shoe or boot 
falls off, and a prosthesis that eliminates 
ankle movement is required. In other 
words, the potential advantage of saving 
the ankle joint is lost and, functionally, 
not only is there no difference between 
this and a below-knee amputation, but 
prosthetic fitting is more difficult. 
Finally, it is often said that a longer stump 
provides a longer lever arm, facilitating 
control of the prosthesis. This is not true; 
it is a mistake to preserve a long stump 
if there is inadequate muscle or skin cover
of the end of the bone. The ideal stump 
should be long enough to suspend its 
prosthesis, have its bone end covered by 
muscle under correct tension (i.e., not so 
tight that the muscles pull away from the 
bone and not so loose that a floppy mass 
of soft tissue impedes prosthetic fitting) 
and be surrounded by healthy skin with 
the incision line so located that it won’t 
adhere to bone.
From time to time surgical fashion has 
emphasized “ end-bearing” stumps such 
as the Symes at the ankle and the Gritti- 
Stokes, Callender and knee disarticula­
tion at the knee. Advocates of these 
procedures believed that as the patient 
could take his full weight at the end of 
the stump, prosthetic fitting was more 
comfortable and its control improved. 
Our experience1 suggests that most 
patients cannot tolerate unlimited weight­
bearing on the end of the stump, so suc­
cessful fitting depends on the use of old 
fashioned (and no longer appropriate) 
lace-up corsets that distribute weight 
throughout the stump. Thus, contrary to 
the conclusion of Lexier and colleagues 
we see little advantage in saving such a 
long stump, particularly in older patients 
such as theirs. The long stump makes it 
harder to don the prosthesis: it’s difficult 
for an elderly patient to stand on one leg 
and bend over far enough to get the 
socket opening off the end of the stump. 
This difficulty is compounded because 
most elderly patients have poor vision and 
weak hand grasp.
There is another problem with a long
stump: a conventional artificial joint can­
not be used because its axis of flexion lies 
distal to the anatomical axis. Less satis­
factory alternatives, such as outside 
hinges or four-bar linkages, must be used.
Many factors influence the outcome of 
lower extremity amputation in the elderly 
besides surgical technique. They include 
number of functional joints that can be 
saved and the general vigour of the 
patient. Having in mind the great 
improvements in current prosthetic tech­
nology, we believe that if a transmetatar­
sal amputation does not survive, the next 
appropriate level is below the knee, and 
if this amputation fails the next should 
be above the knee at the junction of its 
middle and distal thirds, leaving room to 
accomodate an artificial knee so that its 
axis of flexion is at the correct anatomi­
cal level.
W.R. Harris, md, frcsc
Department of Surgery,
University of Toronto,
Combined Division of Orthopedic Surgery, 
Toronto General Hospital and Mount Sinai
Hospital,
1-234 Eaton Wing,
Toronto General Hospital,
Toronto, Ont.
M5G 2C4
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BOOK REVIEWS
BIOLOGIC & BIOPROSTHETIC VALVES. 
Proceedings of the Third International 
Symposium. Edited by Endre Bodnar and 
Magdi Vacoub. 885 pp. Illust. Yorke Med­
ical Books, New York, 1986. $125. (US). 
ISBN 09-14316-49-4.
The growing popularity during the last decade 
of biologic tissue for heart-valve prostheses has 
stimulated interest for the continued assessment 
of clinical results, and the need for discussing 
problems and sharing experience has resulted 
in the organization on a regular basis of inter­
national meetings of practitioners involved in 
treating heart-valve diseases. After the Munich 
and Rome meetings held in 1979 and 1982, 
whose presentations have also been published, 
this book presents the proceedings of the third 
international symposium, held in London in 
1985, and includes more than 90 papers on 
different aspects of valve replacement with 
bioprostheses presented by experienced groups 
world-wide.
Clinical results with the use of aortic 
homografts, and traditional porcine and 
pericardial valve bioprostheses, are reviewed 
extensively in the first 27 chapters of the book. 
More than one-third of the book is devoted to 
valve-related morbidity, which has become a 
major concern now that improved surgical 
techniques have decreased the operative death 
rate substantially. The main and unresolved 
problem of tissue heart valves is that of long­
term durability. This is particularly true in chil­
dren in whom an early degenerative process has 
generally been found, as it has also been the 
experience of the various groups who reported 
their results at the symposium. A consensus has 
now developed that, because of the early and 
severe calcification of tissue valves in children, 
the use of mechanical valve prostheses is gener­
ally preferable, although the results reported 
with fresh aortic homografts do not appear to 
be as dismal as those with bioprostheses.
Since the last symposium in 1982, most 
reporting groups have gained experience with 
reoperation due to a variety of valve-related 
complications, primary tissue failure being the 
leading cause among patients with biopros­
theses. This problem is discussed in eight 
chapters of the book. The pathophysiology, 
mechanisms and techniques of prevention of 
calcification and degeneration of biologic 
valves are addressed by experts in the field. The 
major drawback of degeneration, however, is 
counterbalanced by a much lower incidence of 
other valve complications such as thromboem­
bolism, bleeding related to anticoagulation and 
infection, which are presented in the next eight 
chapters.
The hydrodynamics of bioprostheses and 
their postoperative hemodynamic performance 
are discussed by various groups. The role of 
noninvasive evaluation of valve prostheses is
apt to become predominant in the postopera­
tive assessment of their hemodynamic perfor­
mance. As further experience is gained, Dop­
pler echo studies will progressively become the 
standard technique for postoperative valve 
evaluation.
Finally, a long section is devoted to new con­
cepts and ideas, including the use of the Kan­
garoo aortic valve, the unicusp pericardial 
valve, and a number of new designs and 
modifications of various bioprostheses. In the 
last section, clinical results with bioprostheses 
and mechanical valves are compared. From the 
general discussion that follows, it is concluded 
that one should be eclectic in choosing the right 
prosthesis, and that both mechanical and bio­
logic valve prostheses have advantages and 
drawbacks.
This book presents the state of the art in 
regard to the use, limitations, complications, 
hemodynamic performance and long-term 
results of the various types of biologic valves 
available today. It addresses a very specific 
group of physicians interested in this highly 
specialized area of cardiology. This symposium 
represents a world-wide experience that will be 
of value to all those involved in the treatment 
of patients with heart-valve disease — cardiac 
surgeons, cardiologists and internists alike. 
This well-edited text is an up-to-date reference 
tool and should be readily available to clini­
cians so that they can make their own decisions 
in regard to choice of valve devices and their 
long-term follow-up. Residents in cardiac sur­
gery and cardiology will also benefit from this 
comprehensive review of the problem of 
cardiac valve replacement with tissue valves 
and can use this text as a practical reference 
guide.
L. Conrad Pelletier, md, frcsc, facs
Professor and chairman,
Department of Surgery,
Universite de Montreal and
The Montreal Heart Institute,
CP 6128,
Succursale A,
Montreal, PQ 
H3C 3J7
CORRECTIVE OSTEOTOMIES OF THE 
LOWER EXTREMITY AFTER  
TRAUMA. Edited by G. Hierholzer and 
K.H. Muller. 407 pp. Illust. Springer- 
Verlag New York Inc., New York, 1985. 
$75. (US). ISBN 0-387-15879-0.
This book is based on proceedings of a sym­
posium held to commemorate the 65th birth­
day of Dr. Jorg Rehn. It is divided into a num­
ber of sections — basic principles, surgical
techniques and results surrounding four ana­
tomical sites of osteotomy, a major section on 
post-traumatic deformity in the growing child 
and a short epilogue.
Inevitably, the book has the advantages and 
disadvantages of a multiauthor format. A wide 
spectrum of opinions is represented, but the 
style and quality are uneven. The book does 
not read easily, having been translated from 
German, but it has many redeeming qualities.
The excellent illustrations, meticulous 
descriptions of preoperative planning, surgi­
cal technique and results make it a useful refer­
ence. While it need not be in the library of every 
practising orthopedic surgeon, I would strongly 
recommend it to those who are interested in 
lower extremity reconstructive surgery and in 
the management of the traumatized patient. In 
addition, it would be a useful reference text for 
orthopedic trainees.
R .Y . M cM u r tr y , m d , fr csc , FACS 
Director,
Regional Trauma Unit,
Sunnybrook Medical Centre,
2075 Bay view Ave.,
Toronto, Ont.
M4N 3M5
INFLAMMATORY BOWEL DISEASE: EX­
PERIENCE AND CONTROVERSY. 
Edited by Burton I. Korelitz and Norman 
Sohn. 297 pp. Illust. Grune &  Stratton, 
Inc., Orlando, Fla.; Academic Press 
Canada, Don Mills, Ont., 1985. $46.50. 
ISBN 0-8089-1693-9.
Based on the third postgraduate course in 
inflammatory bowel disease held at the Lenox 
Hill Hospital in New York, this short text 
reflects the views and opinions of the group 
at this hospital and those of a few guest 
contributors. In particular, the use of 
6-mercaptopurine (6-MP) in the management 
of Crohn’s disease is strongly supported.
Because it cannot be regarded as a compre­
hensive review of inflammatory bowel disease, 
the book is not a reference work. It highlights 
certain issues, some controversial, others not. 
It is written in a light style and may be read 
in two to three evenings.
The book is divided into seven sections, each 
with four to seven chapters, some of which are 
very short. The first section provides an over­
view and points to population groups that have 
particular problems in inflammatory bowel dis­
ease, such as children. This excellent chapter 
highlights nutritional disturbances and growth 
retardation, so important in these individuals.
continued on page 337
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Equivalence in Treatments
To the editors.—I disagree with Blair and 
colleagues who in their article “ Ticarcil- 
lin/clavulanic acid (Timentin) compared 
to metronidazole/netilmicin in prevent­
ing postoperative infection after elective 
colorectal surgery” (Can J Surg 1987; 30: 
120-122) conclude that these two combi­
nations are equally effective in prevent­
ing septic complications after elective 
colorectal surgery. They reported that 
there were no significant differences in 
postoperative infections between the two 
treatment groups.
There were 46 patients in each group. 
Three patients (6.5%) in the ticarcil- 
lin/clavulanic acid group and five patients 
(10.9%) in the metronidazole/netilmicin 
group had wound infections. The differ­
ence of 4.4% (which represents a 40% 
reduction in infection rate) may be clini­
cally important in view of the large abso­
lute number of patients who undergo 
colorectal surgery. If one calculates the 
95% confidence interval on the observed 
difference, the true difference could be as 
great as 16%.
The power of the study to detect a true 
difference of 4.4% was only 11%. To be 
reasonably confident (say power 90%) of 
detecting this difference, one would need 
to study 850 patients in each group. The 
Toronto study was therefore much too 
small for any conclusions to be drawn.
The authors have confused statistical 
nonsignificance with equivalence. To 
demonstrate equivalence, I would suggest 
the following steps.
• In planning the experiment, decide 
on the smallest absolute difference that 
is clinically important.
• Calculate the sample size to detect 
this difference with appropriate alpha and 
beta errors. (When determining equiva­
lence a power of 95% would be 
appropriate.)
• If the observed difference is not 
statistically significant, one may then con­
clude equivalence.
Some authors and editors are aware of 
type I errors but seem to be less vigilant 
in guarding against type II errors. The 
quality of most journals would be 
enhanced and ethical concerns would be 
addressed if investigators were required
to specify in the method section (a) what 
difference they considered clinically 
important and (b) the power of their 
study to detect this difference. As 
Altman1 has pointed out, “ The purpose 
of power calculations is to maximize the 
chances of finding a real and important 
effect if it is there, and to enable us to 
be reasonably sure that a negative find­
ing is strong grounds for believing that 
there is no important difference.”
The message is clear but often ignored 
or forgotten: the absence of proof is not 
proof of absence.
J.F. GATELY, MB, B CHIR, FRCS(Edin), 
FRCS, FRCSC
Department of Surgery,
McMaster University Medical Centre,
1200 Main St. W,
Hamilton, Ont.
L8N 3Z5
Reference
1. Altman DG: Statistics and ethics in medical research: III 
How large a sample? Br Med J 1980; 281: 1336-1338
Use of the Huber-Point Needle 
in the Port-A-Cath System
To the editors.—We would like to com­
ment on the letter entitled “ The need to 
use the Huber-point needle in the Port- 
A-Cath implantable device” (Can J  Surg 
1987; 30: 75, 99) and the article “ Implant­
able device for venous access” (Can J 
Surg 1987; 30: 127-129) by Leclerc and 
Loutfi. Although we agree that the Port- 
A-Cath (PAC) system is efficient and safe 
and provides easy accessibility in patients 
receiving chemotherapy, we do not 
believe that the authors should advocate 
the use of Yale hypodermic needles in 
place of the recommended Huber-point 
needle. At our institution we have 
implanted over 100 PACs mainly for the 
administration of chemotherapy and we 
have always used Huber-point needles. 
Although the authors report on an 
interesting observation of the possible 
safety of standard needles, their use in 
place of the Huber-point needle puts 
patients at risk of significant local toxic­
ity should drug leakage occur. We have
had two episodes of severe extravasation 
reactions after Adriamycin administra­
tion even with the use of the recom­
mended needle. One of these patients 
required excision of sloughed skin and 
skin grafting. In our opinion, the 
increased risk using standard needles with 
the PAC for the administration of 
chemotherapy is not justified either for 
patient safety or for medicolegal reasons.
Ia n  G. K e r r , m d , f r c p c
Medical Oncology,
Toronto-Bayview Regional Cancer Centre, 
Sunnybrook Medical Centre,
University of Toronto,
Toronto, Ont.
S h e r if  S . H a n n a , m d , f r c s c , f a c s
General Surgery,
Sunnybrook Medical Centre,
University of Toronto,
Toronto, Ont.
McGoey-Evans Total Hip 
Prosthesis
To the editors.— As the Evans of the 
McGoey-Evans total hip arthroplasty 
(Can J  Surg 1987; 30: 81-85) I have a 
vested interest in the journal article.
It may have been an oversight on our 
part, but I thought one of the reviewers 
might have realized that Paul McGoey 
died June 3, 1984.
Personally, I am very glad the article 
was published, because it really is a 
memorial to Paul. It was his idea. He did 
most of the work, and being as skilled as 
he was, did the first procedure, I believe, 
in February 1964 with a scrub nurse as 
his only assistant. This indicates the facil­
ity with which the procedure could be 
done in the hands of a skilled surgeon.
The original criteria for the operation 
were very simple and threefold; to relieve 
pain and to allow the patient to sit and 
walk. These objectives were fulfilled in 
patients who had the operation. The arti­
cle indicates the problems we had.
I remember once during a presentation 
Paul was asked by a member of the 
audience if there were any complications. 
He said “ sure” and described the com­
plications of all hip surgery. The fact that
VOLUME 30, NO. 5, SEPTEMBER 1987 /  THE CANADIAN JOURNAL OF SURGERY 317
he admitted that he had experienced every 
one of them confirms his forthright ap­
proach to surgery, to his patients, to 
teaching and to writing during all his 
years in practice.
One of the reviewers was apparently 
critical of our paper. Possibly he is one 
of the junior surgeons now reaping the 
benefits of the older researchers who 
really did the bulk of the work on total 
joint arthroplasty. It does not come over­
night and some of the pioneers really 
deserve some credit.
In teaching the present-day residents 
and fellows, I constantly remind them 
that bones did heal before the “AO” peo­
ple arrived on the scene and that there 
have been many skilled surgeons through­
out the world who were not born in Swit­
zerland.
I asked Doctor Brian McGoey, Paul’s 
son, if he had seen the March 1987 issue 
of Canadian Journal o f  Surgery. He said 
yes, he had read Bob Harris’s note about 
the cost of arthroscopic surgery but did 
not turn through and see the article 
about his father. I suppose this is a bit 
ironic.
In any case, I am glad the article was 
published; it really is a tribute to Paul.
John G. Evans, md, frcsc
Ste. 800,
55 Queen St. E,
Toronto, Ont.
M5C 1R6
Management of Urinary Stress 
Incontinence
To the editors.—The editorial in the May 
1987 issue of the Journal by Taguchi 
(pages 150-151) and the article by Boyd 
(pages 157-159) on stress urinary incon­
tinence in women are both timely and per­
tinent. With the ever-increasing life expec­
tancy of women in this country, the 
management of urinary incontinence is of 
paramount importance to many health­
care workers.
The advent of modern urodynamic 
techniques of investigation has provided 
clinicians with safe, reliable and reprodu­
cible methods of differentiating inconti­
nence problems in women. Incontinence 
is not necessarily a simple anatomical 
weakness of the sphincter. The patient’s 
history may be suggestive but is not diag­
nostic and no longer the sole basis for sur­
gical treatment. Urodynamics is not con­
fined to one test — cystometrography, a 
urethral pressure profile (static or 
dynamic), a uroflow study, video­
cystourethrography or pelvic electro­
myography. It is a series of tests that 
provide the clinician with a picture of nor­
mal versus abnormal voiding mechan­
isms. Certainly, both Taguchi and Boyd 
would agree that the woman with a dis­
organized uroflow pattern preoperatively,
showing decreased peak flow rate, 
prolonged voiding time, increased 
residual urine and delayed time to peak 
flow will do poorly after any incontinence 
procedure.
When surgery for stress urinary incon­
tinence is indicated, it should no longer 
be a battle whether a M arshall- 
Marchetti-Krantz operation is a better 
choice than a Burch procedure. [The 
reader should be aware that the former 
operation was devised by a urologist 
(Marshall) and two gynecologists (Mar- 
chetti and Krantz).] There is no single 
operation, whether vaginal or retropubic, 
or the two combined, that will cure all 
cases of genuine stress urinary inconti­
nence. Each case must be treated 
individually, and surgery should not only 
be based on the position of the urethro- 
vesical junction but also take into con­
sideration degrees of genital prolapse, 
cystocele, rectocele and enterocele as well 
as the patient’s age, parity, weight, 
general habitus, sexual function, smok­
ing habits, occupation and degree of 
physical activity. The adage “ do a vagi­
nal procedure first and when that fails go 
from above” is antiquated and plays no 
role in modern medicine.
Today, many disciplines (nursing, 
family practice, urology, gynecology, 
neurology, geriatrics, rehabilitation medi­
cine, pediatrics, psychology) are involved 
in the care of the incontinent woman. 
Although surgery plays a role in some 
cases, the majority of women can be 
helped with conservative treatment. This 
may involve neuropharmacologic mani­
pulation of the lower urinary tract, exer­
cises, mechanical aids, biofeedback and 
relaxation therapy. It is only through 
ongoing dialogue, not monologue, be­
tween the various health-care workers 
that improved care for incontinent 
women will be provided.
Harold P. Drutz, md, frcsc, facog, 
facs
Director of Gynecological Urology 
and Urodynamic Investigative Units, 
Mount Sinai Hospital and Baycrest 
Geriatric Centre,
Toronto, Ont.
M5G 1X5
To the editors.—The article on stress 
incontinence of urine by Boyd (Can J 
Surg 1987; 30: 157-159), which purports 
to review the state of the art of stress uri­
nary incontinence contains many inac­
curacies. Some of these are noted by 
Taguchi in his editorial (Can J Surg 1987; 
30: 150-151) and his criticisms are ap­
propriate. There has been an explosion of 
information and ideas regarding alterna­
tive surgical procedures for urinary stress 
incontinence. Various techniques of 
endoscopic needle suspension have 
become widely used in the United States 
and Canada. These offer similar results
and substantially less morbidity. For a 
“ state-of-the-art” article not to mention 
these procedures is unacceptable. 
Individuals operating on patients with 
stress incontinence must be competent in 
performing cystoscopy and both en­
doscopic and conventional procedures.
L. Klotz, md, frcsc
Division of Urology,
Sunnybrook Medicai Centre,
University of Toronto,
2075 Bayview Ave.,
Toronto, Ont.
M4N 3M5
To the editors.—Although I enjoyed the 
article “ Stress incontinence of urine” by 
Boyd (Can J Surg 1987; 30: 157-159), I 
do take issue with some statements at the 
end of his paper.
I have been using the Marshall- 
Marchetti-Krantz procedure for over 30 
years and the results have been excellent 
with no serious complications.
Parnell and colleagues, in their 1982 
review1 of 151 patients, reported 14 
patients with clinical osteitis pubis, only 
5 of whom had radiologic changes. Years 
ago, when retropubic prostatectomy first 
came into vogue, the incidence of ostei­
tis pubis was quite high. But I have not 
seen a case in the past 25 years, probably 
due to routine prophylactic use of anti­
biotics. It has not occurred in the 
Marshall-Marchetti procedures I have 
done.
I never found it necessary to open the 
bladder suprapubically except to free it 
in those patients who had undergone 
retropubic surgery previously. I have 
always used 0 chromic catgut for sutures, 
finding them to be more than sufficient 
in maintaining suspension of the bladder 
and urethra. If one uses Prolene or other 
nonabsorbable sutures, then entering the 
bladder is a serious complication. 1 have 
removed many nonabsorbable sutures 
from the urinary bladders of women 
operated on previously by gynecologists. 
Chromic catgut is absorbed and causes no 
problems.
As far as endangering the ureteral 
orifices, one would have to work very 
hard to obstruct them, if the Marshall- 
Marchetti-Krantz procedure is correctly 
carried out.
Philip G. Klotz, md, frcsc, facs
Associate professor of surgery,
Ste. 455,
Mount Sinai Hospital,
University of Toronto,
600 University Ave.,
Toronto, Ont.
M5G 1X5
Reference
1, Parnell JP ii , Marshall v f , Vaughan ED jr : 
Primary management of urinary stress incontinence by the 
Marshali-Marchetti-Krantz vesicourethropexy. J Urol 
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What's new in surgery is the subject of this column. The short items are designed to let readers know 
who's doing what and why. Surgeons are interested in what other surgeons are doing in 
research, education, practice and administration. Surgery is a vibrant specialty, and, as 
its practitioners, you must be the source as well as the readers of this column.
Surgical Research:
Who’s Doing It and Who’s Paying?
The feeling is that the numbers of surgi­
cal researchers have reached an all-time 
low, says Jean Couture, FRCSC, former 
president of the Royal College of Physi­
cians and Surgeons of Canada. He is a 
member of the committee appointed by 
the Association of the Departments of 
Surgery Chairmen who will shortly 
launch a survey to find out who is doing 
research in the surgical specialties, what 
facilities are available within the medical 
schools and who is providing the funds.
Couture, David Mulder, FRCSC, sur­
geon in chief at the Montreal General 
Hospital, and John Duff, FRCSC, pro­
fessor and chairman of the Department 
of Surgery at the University of Western 
Ontario, who make up the committee, 
have drawn up a questionnaire and hope 
to get the go ahead from other members 
of their association this month.
Mulder, who spoke briefly to CJS, out­
lined the rationale and the time frame for 
the survey: “ We as surgical chairmen feel 
that research has fallen off dramatically, 
but we don’t have the empirical data.” 
He said that the 14-item questionnaire 
had been translated and had been re­
viewed by experts in epidemiology.
The questions were designed to elicit 
information on “ level of grants provided 
externally and internally, the level of 
faculty funding, physical plant and labo­
ratory facilities available to surgical 
researchers, ways that surgical trainees are 
involved in research, and the productivity 
of different departments,” he said. 
“ When we have the responses, we will 
decide whether we need to find someone 
to conduct personal visits to the depart­
ments, which was the approach in the last
Contributions to this column are welcome. 
Please send your material to: Mrs. Amy 
Chouinard, Canadian Journal o f Surgery, 
PO Box 8650, Ottawa, Ont. K1G 0G8.
study — undertaken in the late 1960s by 
Dr. Robert Macbeth.
“ The Royal College has identified 
research as an important part of training 
and we are trying to find ways and means 
for surgical departments to mount suc­
cessful research programs.”
Couture noted that the concern is for 
all the surgical disciplines not only gene­
ral or orthopedic surgery, although these 
two disciplines may be the most affected 
by the low level of funding. He said, “ We 
have contacted all surgical specialties and 
there seems to be interest in joining us to 
exert pressure that would bring about 
more funding and better organization and 
facilities for surgical research.
“ Our plan is to hold a 1-day conference 
in spring 1988 with representatives from 
all the surgical disciplines to discuss the 
results of the questionnaire and to draft 
plans to improve the level of research in 
surgery. The second objective of the mee­
ting will be to consider the establishment 
of a conjoint council on surgical research.
“ This would be similar to an organi­
zation in the United States. About 3 years 
ago, the Americans undertook a survey 
similar to the one we are doing and, as 
a result, they formed a conjoint council 
that has been very effective in getting trai­
ning grants from the NIH [National Ins­
titutes of Health].
“The Americans found that research in 
surgery was lower than in other health 
disciplines and that research teams incor­
porating PhDs had better chances of 
obtaining funds than did teams with only 
MDs. They also found that some topics 
were more attractive than others: trauma, 
gastrointestinal surgery and transplanta­
tion were singled out in their report as 
being able to attract funds easily. Fol­
lowing the publication of their findings, 
they obtained training grants for sur­
geons, and we are hoping we can get the
same from MRC [Medical Research 
Council].”
Robert Maudsley, FRCSC, coordina­
tor of the Royal College’s research com­
mittee, spoke briefly with CJS about resi­
dents’ exposure to research: “ A few years 
ago the credentials committee looked at 
the training requirements for all the 
specialties and found that most allowed 
residents to do research for 6 or 12 
months and receive credit for the work.
“ In practice, not a great number of 
residents do so, and many who ask for 
credit for a year’s research actually have 
done the work before or during medical 
school — some time distinct from the 
specialty training.
“ In the surgical disciplines in particu­
lar, the residents are concerned that they 
have to develop and maintain their clini­
cal skills and they feel hard pressed to 
undertake research in time set aside for 
their training.”
Henry Dinsdale, FRCPC, professor 
and head, Department of Medicine, 
Queen’s University, is chairman of the 
Royal College research committee; he 
accompanied the accreditation team sur­
veying residency training programs at the 
University of Alberta in April, and this 
was the first time someone on the team 
had gone specifically to look at research 
facilities. One of his aims was to deter­
mine whether adequate information could 
be gathered by questionnaire and normal 
survey procedures.
He told CJS, “ The programs were 
evaluated in the usual fashion by the sur­
vey team, but as a result of my report 
there may be some modifications or addi­
tions to the way in which future surveys 
are carried out by the College....I had the 
opportunity of meeting with heads of 
basic science and clinical departments and 
with a number of residents who were 
either engaged in research training or 
planning to do so next year. One item for 
discussion was the pros and cons of man­
datory years of research. Some programs 
at Alberta such as urology and general 
surgery require a year of research, 
whereas for others such as neurosurgery
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a year of research is optional. There was 
also a review of salary funding for 
individuals wishing to do research train­
ing and considerable and increasing 
interest at the university in the relation­
ship between basic science and clinical 
departments in providing research years 
and supervision.”
The research committee and, later, the 
Council for the Royal College were elated 
to review his findings and consider recom­
mendations.
One step taken by the Royal College to 
increase interest in research was to revive 
a program in which it provides $1500 to 
university departments to defray some of 
the costs for a visiting professorship in 
research. For 1987, the money will go to 
the universities of British Columbia (Dr. 
D. Bichet, FRCPC, Montreal), Saskatch­
ewan (Dr. M.L. Flalperin, FRCPC, To­
ronto), Toronto (Dr. R. Cotton, Boston) 
and Western Ontario (Dr. R. Kelch, Ann 
Arbor). The visiting professors were 
chosen on the basis of stature, back­
ground and ability to excite students 
about a career in research.
However, the problem is not a lack of 
interest on the part of surgeons. Just a 
year ago, a group of orthopedic surgeons 
and basic scientists conducted a survey of 
research and submitted their findings to 
the MRC. Although the focus was ortho­
pedic research, the information was 
applicable to surgeons and clinicians in 
general, according to Derek Cooke, 
FRCSC, who chaired the task force. 
Cooke summarized the report for CJS: 
“ We reviewed information from each 
university centre about what was being 
done in orthopedic research and where 
the researchers were getting their funding. 
We emphasized in our examination 
money coming from the Medical 
Research Council, but we found that 
much of the money was coming from out­
side MRC through the efforts of sur­
geons, local groups and industry.
“ We looked at the problems of getting 
money from MRC and found that we as 
surgeons weren’t very professional at 
preparing grant applications. It wasn’t 
that we didn’t have good questions to ask; 
we just didn’t have know-how in making 
a scientific case for the work to be done.
“ However, more important, we lacked 
peer review in the MRC. When applica­
tions for funding in the musculoskeletal 
system were submitted, they went to a 
variety of committees and the people who 
were doing the reviews often didn’t have 
expertise in orthopedics or this system. 
Being reviewed by experts in a relevant 
field is crucial.”
One surprise, said Cooke, was “ that 
research was going on in every centre 
across Canada. We had expected sur­
geons to be less active than they turned 
out to be; they are generating their own 
funds — sometimes from their own
pockets. Some centres are stronger than 
others. Where we found strength — Mon­
treal, London, Toronto, Winnipeg and 
here in Kingston — we also found links 
between surgeons and basic scientists, 
particularly PhDs, for example, in 
engineering.
“ Clinicians don’t have the epidemio­
logic skills needed to design appropriate 
methods but they do have an interest in 
doing research. They need training — at 
least 2 years — to get the expertise to do 
research, and they need input from other 
disciplines. Also, the incentives — in sim­
ple terms money — are not adequate for 
surgeons to do basic research. They can 
generate their income much more easily 
by seeing patients.”
According to Cooke, the attitude 
among other researchers that surgeons are 
doers not thinkers can be a deterrent to 
cooperative research. Yet, he said, sur­
geons have a unique contribution to make 
because they directly examine damaged 
and diseased tissue, bone and organs.
Do You Want Routine Testing 
for HIV Antibodies?
“ How many physicians in this room 
have had an accident in the operating 
room and hit themselves with a needle?” 
asked John Lamont, FACOG, FRCSC, 
and most members of the audience raised 
their hand.
Lamont, speaking in a session on AIDS 
at the annual meeting of the Society of 
Obstetricians and Gynaecologists of 
Canada in June, said that there had been 
102 occasions “ just from one major 
teaching hospital reported over the last 
year, and 16 were experts who should 
have known better.” Yet had any one of 
them been treating a patient with human 
immunodeficiency virus, the contact 
could have been deadly.
Such accidents have prompted a new 
anxiety, he said — “ the worried well who 
develop psychosomatic symptoms” . He 
noted that the New England Journal o f  
Medicine had recently carried an article 
in “ Sounding Board” that recommended 
all sexually active adults have voluntary 
testing. According to Lamont, the facili­
ties are not in place to handle such mass 
screening and many of the groups for 
whom testing has been recommended — 
the soon-to-be-married, immigrants and 
patients admitted to hospital — are not 
high-risk groups. In an interview with 
CJS later, he commented that the ethical 
questions are just beginning to be posed:
What rights do physicians have to 
demand testing? What dangers do sur­
geons and their teams have to accept in 
their moral obligation to provide care for 
a patient? Without refusing treatment, 
how can one ensure against life- 
threatening accidents in the operating 
room and elsewhere in and out of 
hospital?
The anxiety about AIDS stems at least 
partly from the lengthy incubation of the 
disease: the maximum is as yet unknown, 
according to the next speaker at the con­
ference, and the average asymptomatic 
period is 5 years. Kate Hankins, FRCPC, 
assistant professor at McGill and epidemi­
ologic consultant on sexually transmitted 
diseases, went on to say that the long 
incubation means that most of the new 
cases are among men 30 to 39 years old 
and “ what we are reporting is the tip of 
the iceberg” .
What was clear from this exchange was 
the uncertainty. It surfaced again last 
month at the annual meeting of the Cana­
dian Medical Association in a debate on 
whether physicians should be required to 
report patients who test positive for the 
HIV antibody and to trace their sexual 
contacts.
In June the surgeon general of the 
United States, C. Everett Koop, called for 
routine antibody testing for all patients 
who were to undergo major surgery. 
Others have encouraged routine testing on 
admission to hospital, and still others, cit­
ing the emotional and social trauma 
associated with a false-positive result and 
recent evidence of false-positive rates as 
high as 8%, have recommended treating 
body fluids from all patients as if they 
were infected.
The debate is on; what do readers of 
this column think?
Two Alma Maters in US 
Honour C. Barber Mueller
CJS coeditor C. Barber Mueller, 
FRCSC, recently received an honorary 
doctorate of humane letters from Black­
burn University, Carlinville, Illinois, 
where he earned his first degree. More 
recently he added the 1987 alumni 
achievement award from Washington 
University School of Medicine, St. Louis, 
where he graduated in 1942. Mueller is 
professor emeritus at McMaster Univer­
sity and is vice-president elect of the 
American College of Surgeons.
AMY Chouinard
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Perioperative Hemodilution
Perioperative hemodilution is one way of 
minimizing the morbidity and mortality 
associated with blood transfusion. A 
review of the literature indicates that, for 
many patients, substitution of crystalloid 
solutions for surgical blood loss is safe 
and physiologically advantageous as long 
as euvolemia is maintained. Increased 
stroke volume is the principal mechanism 
responsible for augmented tissue oxygen 
delivery. Based on this review the surgi­
cal population can be divided into three 
groups: most patients under 60 years of 
age (group 1); those with important 
cardiac disease (group 2); and the elderly 
(group 3). Patients in group 1 can safely 
undergo hemodilution to a hematocrit of 
0.25; patients in the other groups should 
probably not be subjected to hemodilu­
tion. Implementation of this proposal 
could diminish the risk and expense of 
many surgical procedures.
L'hemodilution peroperatoire represente 
une facon de minimiser la morbidite et la 
mortalite associees aux transfusions san­
guines. Une revue de la litterature sug- 
gere que, pour plusieurs patients, les 
pertes sanguines durant les interventions 
chirurgicales peuvent etre compensees 
par des solutions de cristalloides; le pro- 
cede est securitaire et physiologiquement 
avantageux aussi longtemps que I'euvo- 
lemie est maintenue, L'augmentation du 
volume systolique est le principal meca- 
nisme responsable de I'amelioration de 
I'apport d'oxygene aux tissus. A partir 
de cette revue on a pu diviser la popula­
tion en trois groupes: la plupart des 
patients de moins de 60 ans (le groupe 
1); ceux qui ont une maladie cardiaque 
importante (le groupe 2); et les person- 
nes agees (le groupe 3). Les patients du 
groupe 1 peuvent, en toute innocuite, 
etre soumis a l'hemodilution jusqu'a ce 
que I'hematocrite atteigne 0.25; les
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patients faisant partie des autres groupes 
ne doivent probablement pas subir 
d'hemodilution. L'application de ces 
recommandations peut diminuer le risque 
et le cout de plusieurs interventions chi­
rurgicales.
Intimidated by the link between blood 
products and potentially lethal infections 
(e.g., AIDS and hepatitis), some patients 
are refusing transfusions of any blood but 
their own, if needed during major surgi­
cal procedures. This problem will likely 
be of increasing importance to physicians. 
The purpose of this paper is to examine 
the literature on hemodilution and pro­
pose recommendations for future clinical 
trials based on this research.
Background
The decline of paid donor blood clinics 
in the United States in the 1970s stimu­
lated intense research into alternatives to 
blood transfusion. These studies were 
based upon two well-known physiologi­
cal principles — the amount of blood deli­
vered to the tissues (cardiac output) is a 
product of heart rate and the volume of 
blood pumped each beat (stroke volume), 
and the amount of oxygen delivered to the 
tissues is a product of cardiac output, 
hemoglobin saturation and hematocrit. 
Despite decreasing hematocrit, euvolemic 
hemodilution attempts to improve oxygen 
delivery to the tissues by augmenting 
cardiac output.
Hemodilution and Tissue Oxygenation
The amount of oxygen available to the 
body is governed by the equation: oxy­
gen available = cardiac output X oxy­
gen saturation x hemoglobin X 1.34.1 
Although oxygen utilization as a whole 
is low, there is great variation between tis­
sues — from 5% by the skin to 55% by 
the coronary circulation.1 Thus, the 
myocardium, being a tissue with a high 
oxygen extraction, is particularly vulner­
able to a reduction of its available oxygen.
Euvolemic hemodilution causes major 
physiological changes. By far the most 
important compensatory mechanism for
decreased hematocrit during hemodilu­
tion is increased stroke volume.2-5 Heart 
rate usually remains constant. Transport 
of oxygen to tissues actually increases as 
hematocrit decreases to 0.20 to 0.25 when 
oxygen delivery starts to decrease.6 On 
the other hand, cardiac output increases 
steadily as the blood is diluted. The rise 
in cardiac output depends more upon 
decreased blood viscosity than upon any 
reduction in either oxygen-carrying capac­
ity or mixed venous oxygen tension.7
Augmented oxygen delivery can be 
analysed in terms of pressure-volume 
loops. Laboratory studies in dogs have 
shown that decreasing the hematocrit 
from 0.40 to 0.20 slightly increases end- 
diastolic volume, does not significantly 
alter end-diastolic pressure nor diastolic 
compliance, but decreases end-systolic 
volume, thus explaining the increased 
stroke volume.8 The decrease in end- 
systolic volume that accompanies a 
decreased hematocrit occurs because the 
systolic function curve shifts to the left, 
secondary to a decreased afterload.9"11 
In other words, without changing the 
cross-sectional area of the blood vessels, 
decreased viscosity lowers systemic vas­
cular resistance.11 (Studies have shown 
that these effects are seen even when the 
animals are prevented from changing the 
contractile state of their heart by /3- 
adrenergic blockade.8)
Blood Rheology
The Poiseuille-Hagen law describes 
laminar flow in noncollapsible tubes as 
follows:
Q = P, -  P2(3.14)R4 
8 VL
where P, = inlet pressure, P2 = outlet 
pressure, R = radius of tube, L = tube 
length and V = viscosity. Viscosity can 
be defined as a measure of internal fric­
tion in a laminar flow system.12 If the 
pressure and radius from one end of a 
tube to the other remain constant, 
hemodilution, by lowering blood vis­
cosity, will increase flow. For anatomic
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reasons, this effect is most noticeable in 
the postcapillary venules and capil­
laries,13 and is clinically manifested as 
improved homogeneity of capillary blood 
flow.
However, capillaries and post-capillary 
venules rather than being straight tubes 
are composed of right angles and T pieces 
that generate turbulence. This causes loss 
of inertial energy and calculated overes­
timation of true flow.14 Moreover, blood 
rheology (the science of physics applied 
to blood flow) must be considered. Nor­
mal saline and Ringer’s lactate solution, 
two solutions commonly used in hospi­
tals for replacement of blood loss, show 
no change in viscosity as flow decreases. 
Such solutions are known as Newtonian 
fluids. On the other hand, blood with a 
hematocrit of 0.45 is characterized by a 
marked increase in viscosity with decreas­
ing flow velocity;13 although the effect is 
attenuated if this same blood is diluted 
to a hematocrit of 0.30, at a hematocrit 
of 0.15, blood essentially behaves as a 
Newtonian fluid.15 Why does blood 
change its behaviour at different erythro­
cyte concentrations?
As blood makes its way through the 
subdivisions of the circulatory system, its 
velocity diminishes; this change is 
associated with erythrocyte clumping 
(Rouleux formation), which in turn is
thought to be due to the formation of 
electrostatic bridges between the surface 
of the erythrocyte membrane and fibrino­
gen molecules.16 As more of these 
bridges are created, flow is impeded, 
necessitating more energy to maintain 
movement (increasing internal friction 
expressed as viscosity). Stated otherwise, 
erythrocytes suspended in saline 
(hematocrit = 0.40) show virtually no 
change in viscosity as flow rates dimin­
ish. Addition of fibrinogen causes a 
marked increase in viscosity most notice­
able in the microcirculation. Other fac­
tors that play a role include flow veloc­
ity, platelet concentration and function, 
leukocyte aggregation, osmolality and 
pH .17 In conclusion, areas most sensitive 
to oxygen deprivation are supplied by 
capillaries whose flow velocity clinically 
depends principally upon hematocrit.
Microcirculation
The microcirculation is where the 
advantages of hemodilution are most evi­
dent. Since the tendency for aggregation 
is diminished by hemodilution, erythro­
cytes are able to negotiate the narrowest 
of capillaries. This promotes homogenous 
perfusion of surrounding tissues and les­
sens the chance that cells will utilize 
anaerobic metabolism for their energy
needs. In the animal laboratory, investi­
gators,13 using multiwire, platinum, 
oxygen-tissue electrodes, measured actual 
tissue-oxygen tension in liver, pancreas, 
small intestine and kidney during hemodi­
lution in the rat and found no significant 
change as the hematocrit was decreased 
from 0.42 to 0.20. Other studies,18 using 
radioactive microsphere techniques in the 
dog, have shown that total oxygen deliv­
ery increases as hematocrit is reduced 
toward 0.25 to 0.30; more importantly, 
organ oxygen transport (i.e., the absolute 
amount of oxygen transported to the 
heart, liver, spleen, muscle and skin) 
progressively increased in a similar 
fashion, suggesting that hemodilution 
does not effect a redistribution of cardiac 
output (at least in animal studies). 
Sophisticated animal studies have con­
firmed that microcirculatory nutrient 
flow and oxygenation are enhanced, not 
retarded, by diluting the blood to “abnor­
mally low” hematocrits of 0.20 to 0.25.
Brain
Numerous laboratory and clinical 
studies19-25 have confirmed that hemo­
dilution, presumably by homogenizing 
microcirculatory flow, is beneficial in 
severe cerebral stenosis and ischemia. In 
one study,21 the size of hemispheric
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infarction resulting from clipping the dis­
tal internal carotid and proximal middle 
cerebral arteries was reduced by 60% in 
animals receiving two serial infusions of 
low molecular weight dextran, a sub­
stance known to cause disaggregation of 
erythrocytes. In contrast, a study using 
an experimental model of focal cerebral 
ischemia demonstrated that whole blood 
infusions, despite substantial elevations 
in cardiac output via the Frank-Starling 
effect, failed to improve cortical blood 
flow in the area of focal ischemia.26 
Once again, the clinical evidence supports 
the practice of lowering the hematocrit 
(while maintaining euvolemia) to augment 
homogenous distribution of flow to the 
microcirculation, rather than simply aug­
menting cardiac output (at constant 
hematocrit) and continuing maldistribu­
tion in the capillary bed.
Heart
Pressure loss across a stenosis is an 
important determinant of ischemia. To 
estimate this loss, the appropriate prin­
ciples of fluid mechanics have been 
adapted to the geometry of the nonuni­
form stenotic lumen encountered in prac­
tice and validated experimentally. The 
following expression provides a good 
approximation of the hemodynamic
behaviour of a typical high-grade human 
coronary stenosis:27 pressure drop across 
stenosis = loss due to viscosity + 3(loss 
due to inertial energy).2
Therefore, despite decreased viscosity, 
any increase in turbulence from hemodi- 
lution worsens the pressure drop and 
evokes distal arteriolar dilatation in the 
face of increasingly severe stenosis. This 
pressure loss in the stenosis is an impor­
tant determinant of ischemia. Imagine a 
vessel in skeletal muscle with a high-grade 
stenosis. Proximal to the stenosis, the 
blood pressure is 120/80 mm Hg with 
good flow. Once the stenosis is encoun­
tered, turbulence increases markedly, 
pressure falls to 80/40 mm Hg and flow 
rates decrease. The net effect is decreased 
velocity and increased viscosity. This may 
create a vicious circle wherein elevated 
blood viscosity further compromises 
blood flow and ischemia worsens. In spite 
of this, one study employing hemodilu- 
tion in patients with peripheral vascular 
disease showed a beneficial effect on the 
healing of trophic ulcers and rest pain,28 
suggesting that in some patien ts , 
improved homogeneity of flow in the 
microcirculation more than compensates 
for the decline in overall flow rate.
Stenosis in coronary vessels is differ­
ent from that in skeletal muscle for two 
important reasons:
• Since mechanical effects of ventric­
ular contraction impede systolic perfusion 
to a greater extent in the inner layers of 
the heart than the outer, the inner layers 
must receive a proportionately greater 
portion of their perfusion during diastole. 
Diastolic flow to the inner layers of the 
heart therefore exceeds that to the outer, 
and it appears that coronary vascular 
resistance is lower in the subendocardium 
than in the subepicardium.29 Conse­
quently, the subendocardial vessels are 
closer to maximum vasodilatation at rest. 
It therefore seems reasonable to assume 
that the capacity of subendocardial ves­
sels to dilate is much more limited 
than that of vessels in other parts of the 
heart, resulting in maximal suben­
docardial vasodilatation at all times and 
strict dependence on diastolic filling 
time.30
• Being collapsible tubes, the driving 
pressure for subendocardial coronary 
flow is determined not by the outlet pres­
sure minus the inlet pressure, but by the 
surrounding pressure at the point of col­
lapse minus the inlet pressure (aortic 
diastolic pressure). The surrounding pres­
sure is in turn determined by the com­
bined effects of extravascular compres­
sion of coronary vessels and intrinsic 
vasomotor tone. Not only may the sur­
rounding pressure be substantially higher
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than the measured right or left atrial pres­
sure, but in the presence of critical 
stenotic lesions, the inlet pressure may be 
considerably less than the aortic diastolic 
pressure!31 The uncertainties inherent in 
such a situation and our rudimentary 
knowledge of the factors affecting the 
coronary circulation obligate the clinician 
to question maneuvers that may exhaust 
the reserves of the myocardium at risk.
This, then, is a critical issue with 
respect to hemodilution in patients with 
coronary artery disease — can the suben­
docardium extract any more oxygen and 
can subendocardial vessels dilate any fur­
ther to provide the needed flow? Recall 
that increased stroke volume is the main 
compensation for a decreased hematocrit. 
Thus, inability to increase oxygen output 
will lead to ischemia and infarction 
should oxygen delivery be inadequate 
during hem odilution. Buckberg’s 
studies32'33 performed in the early 1970s 
with dogs illustrate this nicely ./Endo­
cardial flows are slightly more than 
epicardial flows initially. With hemodilu­
tion, flows in both layers increase but the 
ratio of endocardial to epicardial flow 
remains similar to the control. With artifi­
cially created coronary stenosis or valvu­
lar aortic stenosis in the presence of 
moderate hemodilution (hematocrit 0.30), 
the epicardium receives substantially 
more flow than the endocardium, and 
subendocardial ischemic changes appear 
within a few minutes on the electrocardi­
ogram. These ischemic changes also occur 
with extreme hemodilution (hematocrit 
0.15) in dogs with normal arteries and 
normal aortic valves. Subsequent studies 
have confirmed Buckberg’s work and 
shown that hearts with normal coronary 
arteries may be unable to compensate for 
severe hemodilution with sufficient coro­
nary dilation.32,34 In spite of these data, 
patients with severe coronary artery dis­
ease routinely undergo hemodilution to 
hematocrits of 0.20 at the start of cardi­
opulmonary bypass. Since the morbidity 
and mortality of coronary artery bypass 
surgery is low, it appears that by the very 
nature of the operation (to bypass 
obstructed coronary arteries and improve 
flow) and by the various methods used to 
minimize oxygen consumption (cardiople­
gia, hypothermia), the diseased heart is 
usually able to withstand a transient 
period of hemodilution. It must be 
emphasized, however, that in the absence 
of these events, hemodilution of the 
patient with important coronary artery 
disease is hazardous and cannot be 
recommended, despite the use of sophisti­
cated monitoring capable of detecting 
regional ischemia in real time (2 D Echo).
Hemodilution and the Elderly
Another question is whether patients 
over 60 years of age, even those without
substantial coronary artery disease, can 
compensate for moderate hemodilution 
by increased stroke volume. Studies in 
aged rats35 have shown a diminished 
intrinsic inotropic response to catechola­
mines when compared with that of young 
control rats.
In humans, the influence of age on 
cardiovascular performance, especially 
during exercise, has long been recognized 
and it has been suggested that cardiac 
function deteriorates with age. Decreases 
in cardiac output in patients over 60 years 
old have been noted at rest and during 
maximal exercise, whereas systolic blood 
pressure and total peripheral resistance 
are increased.36-38 A study of 39 healthy 
men and women, 70 to 83 years old, 
showed that 26% had a decreased ejec­
tion fraction with exercise and 35% 
exhibited minor regional abnormalities of 
wall motion.39 A recent report from 
Sweden showed that many elderly 
patients were not able to increase stroke 
volume in the presence of hemodilu­
tion.40 In other words, the vital organs 
of elderly patients might possibly become 
ischemic when subjected to this tech­
nique, in contrast to younger patients in 
whom hemodilution was clearly benefi­
cial to tissue oxygenation. To summarize, 
whether they have overt coronary artery 
disease or not, the elderly patient must be 
considered at risk in the presence of 
hemodilution.
Summary
Although intraoperative normovolemic 
hemodilution has been used in cardiac 
surgery for over 20 years, only recently 
has this technique been applied to other 
areas of surgery.
Based on data from the literature, the 
surgical population can be divided into 
three subsets. The first consists of healthy 
patients from under 2 to the age of 
around 50 to 60 years41 who most likely 
can tolerate euvolemic hemodilution 
down to hematocrits of around 0.25 with 
no untoward effects. Group 2 consists of 
patients with symptomatic heart disease 
or those suspected of having heart disease 
but who are asymptomatic, e.g. diabetics, 
sedentary patients, patients with claudi­
cation, left ventricular hypertrophy on the 
electrocardiogram and documented idi­
opathic hypertrophic subaortic stenosis. 
These patients probably should not 
undergo hemodilution unless shown to be 
free of important coronary artery atheros­
clerosis. Group 3 consists of the elderly, 
symptomatic or not, who probably 
should not undergo hemodilution at all.
For any patient who is to undergo 
hemodilution, the following guidelines 
seem prudent: since the heart is the prin­
cipal organ at risk, it should be monitored 
with sophisticated electrocardiography,
preferably with a print-out so that trac­
ings can be compared. Although some 
investigators believe that the epicardio- 
gram is sensitive for transmural ischemia 
but insensitive for mild subendocardial 
ischemia,42'43 the differential diagnosis 
of any marked ST-segment change must 
include inadequate oxygen delivery secon­
dary to hemodilution and be treated 
appropriately. If a pulmonary artery 
catheter is in place, filling pressures 
should be kept constant throughout the 
hemodilution process and the “ wedge” 
tracing examined frequently to detect the 
appearance of new “V” waves suggestive 
of an ischemic left ventricle.
Numerous studies have shown that 
euvolemic hemodilution in appropriately 
selected patients is physiologically advan­
tageous. What we need to do now is to 
document that the use of blood products 
can be substantially reduced if guidelines 
set forth in this article are followed. Once 
the results of these studies become avail­
able, transfusion-related morbidity may 
become rare.
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NOTICES
AIDS and Surgery
An international symposium on protec­
tive policy is planned for Dec. 1 and 2,
1987 at the Royal Lancaster Hotel in Lon­
don, England, for surgeons, anesthetists, 
senior theatre staff and administrators. 
For information contact Ms Pauline 
Sleight, BDI Conferences Ltd., 9/11 Ken­
sington High Street, London W8 5NP; 
telephone 01-938 2151.
Canadian AIDS Research 
Conference
This conference will be held Jan. 26-29,
1988 in Toronto, providing a forum in 
which delegates can learn about research 
aspects of AIDS. International experts 
will address such topics as: detection of 
AIDS, working with the virus, prepara­
tion of vaccines and the functioning of 
viral proteins. Further information can be 
obtained from the Conference Office, 
Suite 4, 1172 Pembina Highway, Winni­
peg, Manitoba R3T 2A4; telephone (204) 
474-1565 or 474-1617.
continued on page 362
Motion sickness 
seldom occurs 
in hospitals... 
so why use an 
antihistamine?
Anaesthesia 
Surgery 
Oncology 
General ward
Stemetir
prochlorperazine
an antiemetic that acts 
where it is needed
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THE ONLY THING 
COMPETITIVE ABOUT 
BECTON DICKINSON 
IS THE PRICE
AT EVERYTHING ELSE W E 
BEAT THE COMPETITION  
HANDS DOW N.
We can sharpen our pencil with the 
best of them.
Price is important! We know that! When 
you’re shopping around, you’ll find we’re as 
competitive as anyone.
But price isn’t everything. What 
really counts is value; knowing that when 
you place an order, you’ll be getting 
superior quality products backed by a com­
pany that’s in business for the long term.
That describes Becton Dickinson. 
We’ve been in business in Canada since 
1951 and we plan to do business here for 
many years to come. If we didn’t intend 
staying around, we wouldn't be undergoing 
a major expansion of our office, ware­
house and production facilities.
So while it’s nice for you to know 
that we’re just as price conscious 
as you are, it’s also good to 
know that we refuse to 
compromise on 
quality and
Product "  service,
quality puts us 
out ahead.
At Becton Dickinson, we base our 
success on a reputation for product 
quality, innovative design and unequalled 
quality control.
It’s these high standards that 
have made B-D* the world’s leading 
producer of disposable hypodermic 
syringes and needles. We’re also 
a world leader in evacuated blood col 
lection systems. Our BARD-PARKER* 
surgical blades have been the choice of 
leading surgeons around the world for 
over 75 years. In hospitals, clinics and 
physicians’ offices, TRU-TOUCH* brand vinyl 
medical gloves are providing the protection 
that health care professionals require.
That’s the Becton Dickinson differ­
ence. We stand behind our products after 
they’ve left our plant.
A winning nationwide distribution 
network.
When you deal with Becton Dickinson, you’re 
dealing with a sophisticated, integrated, 
manufacturing/distribution delivery system.
Our large and expanding warehouses 
in Mississauga and in Calgary provide fast, 
easy access to inventory.
Our network of established distribu­
tors work with us to ensure that you get 
the supplies you need promptly and efficiently.
For you it means no waiting for 
deliveries. For us it means satisfied customers 
who keep coming back.
We lead the field in technical 
support services.
You get more than 
quality health care 
products when
you buy from 
Becton Dickinson. 
Every product we sell 
is backed by highly experi­
enced support professionals.
Technical support specialists will help 
you with advice and assistance on the use 
of our products. Our own sales force, located 
in major centres across the country, backs 
the efforts of our distributors. Our personnel 
are always available to provide in-service 
training in the use of our products.
You’re assured of on-the-spot back­
up service. There are no overseas phone 
calls to track down a manufacturer. No frus­
trating, time-consuming wait to get an 
answer. At Becton Dickinson we're just a 
phone call away.
So if you’re buying from one of our 
competitors now, give us a call.
We thrive on competition.
‘ BARD-PARKER, B-D and TRU-TOUCH are registered 
trade marks of Becton Dickinson and Company 
reg. user Becton Dickinson Canada Inc.
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Clagett Open-Window Thoracostomy in Patients 
With Empyema Who Had and Had Not 
Undergone Pneumonectomy
Patients with empyema not responding 
to simple chest-tube drainage and antibi­
otic therapy have been managed by a 
"Clagett"-type procedure that consists 
of open-window thoracostomy, antibiotic 
irrigation and closure of the window. The 
results of such treatment were reviewed. 
Of the 103 patients with empyema 
treated between 1967 and 1983, 41 
underwent open-window thoracostomy. 
Twenty-eight (group 1) had empyema 
after pneumonectomy, 13 (group 2) 
did not; however, 9 of the 13 in 
group 2 had undergone lobectomy. The 
mean follow-up was 46 months for 
group 1 and 42 months for group 2. 
When surgical closure of the open-window 
thoracostomy was attempted, the suc­
cess rate in group 1 was 85%  for those 
without concomitant bronchopleural 
fistula, but only 3 6 %  in patients with a 
fistula. In group 2 the respective success 
rates were 50%  and 57% . Unsuccessful 
closure resulted in chronic fistulas in four 
patients in each of the two groups. Six 
deaths in group 1 and two in group 2 
were related to the original disease, but 
one was an operative death. These 
results demonstrate both the effective­
ness and limitations of open-window 
thoracostomy in the management of 
these difficult cases.
From the Department o f  Surgery, Montreal 
Chest Hospital Center and McGill Univer­
sity, Montreal, PQ
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Reprint requests to: Dr. Ray C-J. Chiu, 
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Les patients souffrant d'empyeme qui ne 
repondaient pas a un simple drainage 
thoracique et a une antibiotherapie ont 
ete soumis a une operation de type "Cia- 
gett” qui consiste a pratiquer une fene- 
tre de thoracostomie, a irriguer avec des 
antibiotiques. puis a refermer I'ouverture. 
On passe en revue les resultats de cette 
therapie. Sur 103 patients souffrant 
d'empyeme tra ils  entre 1967 et 1983, 
41 ont eu une fenetre de thoracostomie. 
Vingt-huit (le groupe 1) avaient un 
empyfeme consicutif a une pneumonec- 
tomie, 13 (le groupe 2) ne I'avaient 
pas; alors que 9 des 13 avaient subi 
une lobectomie. En moyenne, les exa- 
mens de surveillance s'etalaient sur 46 
mois pour le groupe 1 et sur 42 mois 
pour le groupe 2. Le taux de fermeture 
avec succ&s de la fenetre de thoracosto­
mie a ete de 8 5 %  chez les patients du 
groupe 1 qui n'avaient pas de fistule 
bronchopleurale concomitante, mais seu- 
lement de 3 6 %  chez les porteurs d’une 
fistule. Dans le groupe 2, les taux de 
succes respectifs ont et6 de 50% et 
5 7 % . Les echecs de fermeture ont 
resulte en des fistules chroniques pour 
quatre patients dans chacun des deux 
groupes. Six deces du groupe 1 et deux 
du groupe 2 sont attribuables a la mala- 
die sous-jacente, mais on a enregistre un 
deces operatoire. Ces resultats demon- 
trent, a la fois, I'efficacite et les limites 
de la fenetre de thoracostomie dans le 
traitement des cas difficiles.
Modern techniques of anesthesia allow 
major pulmonary resections, but post­
resection empyema has emerged as an 
important cause of morbidity, with pub­
lished incidences ranging from 2% to 
10%, most series reporting less than 
5%.' This complication often committed 
the patient to a series of major procedures 
each with its associated complications and 
high death rate.
In 1963, Clagett and Geraci2 from the 
Mayo Clinic proposed a definitive two- 
stage procedure, emerging from a previ­
ous single-stage palliative procedure 
described by Eloesser.3 Although the 
overall course of therapy is longer, the 
main advantage of the Clagett procedure 
is the lesser magnitude of each procedure 
compared with that of staged thoraco­
plasties. It is better tolerated by patients 
who are recovering from recent major 
surgery, are malnourished or are 
immunologically depleted from extensive 
inflammatory or neoplastic diseases.
There have been numerous reports of 
the management of empyema, with suc­
cess rates ranging from 4°7o to 66%.4-7 
This study is a retrospective analysis of 
all patients with surgically managed 
empyema seen at the Montreal Chest 
Hospital Center.
Patienls and Methods
Between 1967 and 1983, 103 patients 
were treated surgically for empyema, 41 
of whom were managed by the Clagett 
open-window thoracostomy. Clagett and 
Geraci2 originally described their proce­
dure for the treatment of post pneumo­
nectomy empyema and 28 (group 1) of the 
41 patients in our study had previously 
undergone pneumonectomy. However, 
the principles of the procedure could also 
be applied to selected cases of loculated 
empyema as in the remaining 13 patients 
(group 2) in the study. Carcinoma was the 
most common indication for pneumonec­
tomy with inflammatory and miscella­
neous diseases such as tuberculosis, 
bronchiectasis and emphysema being less 
frequent.
The preponderance of postpneumo­
nectomy empyemas in men over women 
(22 versus 6) reflects the increased inci­
dence of pulmonary resections, mainly 
for carcinoma, in men. The mean age was 
63 years (ranging from 45 to 77 years).
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The mean follow-up for group 1 patients 
was 46 months and was 42 months for 
group 2 patients.
The organisms implicated in the infec­
tions changed during the study. In the 
earlier years, cultures tended to be 
monobacterial, mainly staphylococcal or 
streptococcal. The infections in later years 
tended to be poly bacterial, often with 
mixed gram-negative aerobic organisms 
together with anaerobic organisms. There 
was one positive fungal culture.
Results
Group 1
Of the 28 patients in this group, 17 had 
a concomitant bronchopleural fistula — 
14 on the right side and 3 on the left 
(Table I). There was a similar preponder­
ance of right-sided empyemas that were 
not associated with bronchopleural fistula 
(8 of 11). The main reason for pneu­
monectomy was neoplastic disease, a 
trend that became more evident later in 
the study. Of the 17 patients with bron­
chopleural fistula, 4 of 11 (36%) in whom 
closure of the window was attempted had 
an apparently successful primary closure 
of the fistula, sterilization of the cavity 
and final closure of the open-window 
thoracostomy (Table II).
The method of management of the 
*" _*ichopleural fistula varied during the 
study period in the 11 patients who had 
attempted closure of the open-window 
thoracostomy. The fistula closed spon­
taneously in five patients, three had a sim­
ple operative closure consisting of dissec­
tion, reamputation and closure of the 
bronchial stump and three had reclosure 
of the bronchial stump with a muscle bun­
dle translocation. Of these 11 patients, 4 
remained well with no further evidence of 
leakage or infection. One patient had a 
recurrence of empyema 5 years later and 
underwent reopening, resterilization and 
successful reclosure of open-window 
thoracostomy (follow-up 11 years). Three 
patients had a breakdown of the bron­
chial stump. Two others had a recurrence 
of infection alone and in one patient an 
esophagopleural fistula developed; all 
three underwent reopening of the open- 
window thoracostomy. In six patients 
whose initial open-window thoracostomy 
was left open intentionally, two were left 
with a chronic open fistula and four died 
of their disease early after the procedure. 
The mean follow-up was 48 months.
Of the 11 patients in this group of 28 
who had no bronchopleural fistula, 7 had 
an attempted closure of the open-window 
thoracostomy after stabilization; in 6 it 
was successful. The remaining patient had 
an esophageal fistula that required 
reopening of the thoracostomy. Of the 
remaining four patients, one died in the
operating room during the procedure 
under local anesthesia, presumably of a 
myocardial infarction, two were left with 
a chronic chest-wall fistula and one died 
of his disease. The mean follow-up was 60 months.
The interval from the previous surgery 
to the appearance of the empyema ranged 
from 3 days to 6 years. The length of time 
for closure of the thoracostomy ranged 
from 6 weeks to 2 years, depending on the 
physical and nutritional status of the 
patient, the extent and status of the origi­
nal disease process and the time required 
to sterilize the empyema cavity.
Group 2
Nine of the 13 patients in this group 
had undergone lobectomy previously 
(Table III); the other 4 had not had any 
thoracic surgery. In patients who had 
undergone lobectomy, a bronchopleural
fistula was defined as air leak persisting 
for more than 14 days. Of the seven 
patients with empyema associated with a 
bronchopleural fistula (Table IV), three 
had a successful first-time closure of the 
fistula, three were left with a chronic 
fistula and one had spontaneous closure. 
Of those with no fistula, two had success­
ful closure of the thoracostomy, one a 
spontaneous closure, one was left with a 
chronic fistula and two died of their disease.
Discussion
The problem of intrathoracic infection 
has been recognized for many centuries. 
Hippocrates described a method of locat­
ing and draining an empyema and 
drainage remained a mainstay of manage­
ment. The fact that drainage of empyema 
was effective was further demonstrated by 
Everts Graham and the World War I
Table 1—Location of Empyema and Reason for Resection 
in 28 Group 1 Patients Who Had Empyema After Pneumonectomy
Location/reason Bronchopleural No bronchopleural
for resection fistula fistula
Right side 14 8
Left side 3 3
Carcinoma 14 5
Inflammatory condition 3 6
Table II—Results of Open-Window Thoracostomy in Group 1 Patients
Result
Bronchopleural No bronchopleural
fistula (n ~ 17) fistula (n-11)
Attempted closure
Successful 4 6
Successful reoperation 1 0
Failure
Breakdown 3 0
Reinfection 2 0
1Esophageal fistula 1
No attempted closure
Chronic fistula 2 2
Death from disease 4 1
Operative death 0 1
Table Ill-Previous Surgery in Group 2 Patients
Bronchopleural No bronchopleural
Procedure fistula fistula
Right upper lobectomy 3 3
Left lower lobectomy 1 0
Right middle lobectomy 1 1
No previous surgery 2 2
Table IV—Results in Group 2 Patients
Result
Bronchopleural No bronchopleural
fistula fistula
Successful closure 3 2
Recurrence 0 0
Chronic fistula (OWT) 3 1
Spontaneous closure 1 1
Early death 0 2
OWT -  open-window thoracostomy.
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Empyema Commission who, it was esti­
mated, reduced the death rate of parap­
neumonic empyemas from 75% to 15% 
with the use of tube thoracostomy. The 
advent of safe resectional lung surgery 
brought with it the new complications of 
postresection empyema. In 1963, Clagett 
and Geraci2 described a two-stage 
drainage and reconstruction procedure 
that replaced the former deforming 
thoracoplasties.
Bronchopleural fistula may occur at 
any time postoperatively.8 In our series, 
it ranged from 3 days to 6 years with two 
peaks in incidence: less than 1 month and 
more than 1 year. The early fistulas are 
usually a result of technical errors at the 
time of operation, such as inadequate 
suturing or, less commonly, misfired sta­
ple lines.9 Ischemia from over-zealous 
dissection may be manifest from 10 days 
to 3 weeks postoperatively. The late 
fistulas are usually a result of recurrent 
tumour or, less likely, from an indolent 
infection.
The treatment of the fistula depends on 
the time of presentation. If it presents 
within several days of the initial opera­
tion, early reoperation is advisable to gain 
control of the bronchial stump and effect 
a secure closure. If the onset is delayed 
beyond 10 to 14 days, it is probably bet­
ter to pursue a more conservative course, 
although in selected cases one may be able 
to secure the bronchial stump at this late 
date. The method of dealing with the 
fistula varies. In our series, 5 of 11 (45%) 
closed spontaneously. This has also been 
noted by others who reported spontane­
ous closure in 20% to 33%. This, of 
course, assumes that the margins of the 
fistula are free of tumour or active infec­
tion. The spontaneous closure may take 
from weeks to months, but in the 
moderate- to high-risk group it is well 
worth the wait in an effort to avoid major 
thoracostomy. It is unlikely, however, 
that the pleural cavity will be completely 
sterilized so long as the fistula is open.
At the time of closure of the 
thoracostomy, an antibiotic saline solu­
tion is instilled. This has traditionally 
been a 1% neomycin solution with the 
volumes ranging from 250 ml to more 
than 1000 ml, thus giving a dose ranging 
from 2.5 to 10 g of neomycin. Despite a 
thick empyema peel, this has been shown 
by Meakins and Allard10 to be absorbed 
in significant and toxic quantities with 
subsequent neuromuscular blockade 
requiring ventilatory support. Deafness, 
nephrotoxicity and lesions of the central 
nervous system have also been reported. 
As a result, it is both acceptable and 
advisable to use a 0.25% neomycin solu­
tion or to add a second antibiotic solu­
tion such as bacitracin.
The success rates with the Clagett 
procedure in treating intrathoracic infec­
tion have varied widely. When Clagett
first reported his results, he had a success­
ful outcome in all three patients, none of 
whom had a bronchopleural fistula. Since 
then, there have been reports with success 
rates ranging from 4% (with fistula) to 
14% (with no fistula)6 and as high as 
66% .5 These authors all noted a 
decreased rate of successful permanent 
closure in the presence of bronchopleural 
fistula. Our results confirm this observa­
tion in that the presence of a fistula 
reduced the chance of permanent closure 
from 85% (6 of 7 patients without a bron­
chopleural fistula) to 36% (4 of 11 
patients with such a fistula).
It appears now that the aggressive use 
of muscle flaps may improve results. Our 
early experience with muscle flaps (in two 
using intercostal muscle bundles and in 
one using latissimus dorsi) was less than 
encouraging in that two of these three 
patients had a recurrence of the fistula 
infection. Recently, Pairolero and 
colleagues11 from the Mayo Clinic 
reported on the use of transposed mus­
cle flaps in controlling the bronchopleural 
fistula in 11 patients. Good results were 
obtained in seven.
As mentioned, the original open- 
window thoracostomy was described for 
use in postpneumonectomy empyema. 
The same principles should be applicable, 
however, to a loculated empyema. Open 
drainage of an abscess cavity is a standard 
surgical procedure. Once the empyema is 
established and loculated in patients who 
have not undergone pneumonectomy, the 
remaining lung is firmly adherent to the 
chest wall and risk of collapse in the 
presence of an open-window thoraco­
stomy is no longer a concern. In our ser­
ies, 13 such patients were treated in this 
manner, including 7 who also had a 
proven bronchopleural fistula. The results 
in this group appear to be better in that 
there were no cases of recurrent infection 
or breakdown of the fistula after 
thoracostomy closure. Although the num­
ber is small, satisfactory results suggest 
that this is an acceptable option for 
patients in whom decortication is 
undesirable or unsuccessful.
Summary and Conclusions
Open-window thoracostomy, intro­
duced by Clagett and Geraci, was a major 
improvement in the management of post­
pneumonectomy empyema, particularly 
that associated with a bronchopleural 
fistula. Tolerated by acutely ill patients, 
the two major complicating factors, sep­
sis and aspiration of infected material into 
the contralateral lung, were rapidly con­
trolled. Although our results indicated a 
61% success rate in those in whom closure 
of the window was attempted, this is 
often associated with a prolonged period 
of disability and several subsequent oper­
ations. In addition, there remains a dis­
turbingly high failure rate.
What are the possibilities for improve­
ment? Prevention by more careful selec­
tion of patients for resection. Patients 
with cancer who have had major weight 
loss or show evident muscle weakness are 
unlikely to benefit from resection of their 
tumour, particularly if pneumonectomy 
is required. Resection should not be done 
unless the resection margin is visibly free 
of tumour. In the presence of gross medi­
astinal node involvement, node sampling 
for staging is preferred to radical medi­
astinal dissection which is unlikely to alter 
ultimate survival and may predispose to 
the formation of bronchial fistulae.
In managing the acute phase of an 
empyema, particularly that associated 
with a bronchopleural fistula, open- 
window thoracostomy remains the treat­
ment of choice. One should then pay par­
ticular attention to nutritional support. If 
the bronchial fistula is small and likely to 
close spontaneously, the Clagett proce­
dure should be followed through. If the 
fistula is large, it would be wise, when the 
patient is stable, to close the fistula by 
reamputation of the bronchus through an 
extrapleural transpericardial approach. If 
the empyema is likely to recur because of 
its size or difficulty in controlling infec­
tion, it would be wise to fill the space with 
a large pedicled muscle flap bearing an 
intact blood supply.
For certain postlobectomy and other 
localized empyemas where decortication 
is not feasible, open-window thoraco­
stomy appears to be an effective form of 
treatment and preferable to thoracoplasty 
particularly in the lower thorax.
References
1. A dler  RH , P laut  ME: Post-pneum onectom y 
empyema. Surgery 1972; 71: 210-214
2. CLAGETT OT, G eraci JE: a  procedure for management 
of postpneumonectomy empyema. J  Thorac Cardiovasc 
Surg 1963; 45: 141-145
3. ELOESSER L: Operation for tuberculous empyema. Surg 
Gynecol Obstet 1935; 60: 1096-1097
4. Stafford  EG, Clagett OT: Postpneumonectomy 
empyema. Neomycin instillation and definitive closure. 
J  Thorac Cardiovasc Surg 1972; 63: 771-775
5. GOLDSTRAW P: Treatment of postpneumonectomy 
empyema: the case for fenestration. Thorax 1979; 34: 
740-745
6. Virkkula L, EEROLA S: Treatment of postpneumonec­
tomy empyema. Scand J  Thorac Cardiovasc Surg 1974; 
8: 133-137
7. Shamji FM, G insberg RJ, Cooper  JD , et al: Open 
window thoracostomy in the management of postpneu­
monectomy empyema with or without bronchopleural 
fistula. J  Thorac Cardiovasc Surg 1983; 86: 812-822
8. Malave G, Foster ED, W ilson JA, et al: Bron­
chopleural fistula — present day study of an old problem. 
A review o f 52 cases. Ann Thorac Surg 1971; 11: 1-10
9. H akim M, M ilstein  BB: Role of automatic staplers in 
the aetiology o f bronchopleural fistula. Thorax 1985; 40: 
27-31
10. Meakins JL , A llard J: Neomycin absorption follow­
ing Clagett procedure for postpneumonectomy empyema. 
Ann Thorac Surg 1980; 29: 32-35
11. P a ir o l e r o  P C , A rnold  PG, P ie h l e r  JM : 
Intrathoracic transposition of extrathoracic skeletal mus­
cle. J  Thorac Cardiovasc Surg 1983; 86: 809-817
VOLUME 30, NO. 5, SEPTEMBER 1987 /  THE CANADIAN JOURNAL OF SURGERY 331
'COUMADIN
(Warfarin sodium) ANTICOAGULANT
IN D IC A TIO N S : T he  prophylaxis and/or trea tm en t o f veno us  th ro m b o s is  and its extension, p u lm onary  
em bo lism , a tria l fibrilla tion with em bo liza tion , and as an ad ju nc t in the  p rophylaxis of systemic em bo lism  
a fte r m yoca rd ia l infarction. S om e of th e  m ore  com m on c lin ic a l d iso rd e rs  w h ich  may be associa ted  w ith 
o r p red ispose  patients to the above ind ica tions are: Throm boph leb itis ; C ongestive heart fa ilure; Surg ical 
p ro ce d u re  o r  tra u m a  associated w ith  a h igh  risk  o f th rom boem bo lism ; M yocard ia l infarction; Cerebra l 
e m b o lism . It m ay a lso  be useful as an a d ju n c t in  th e  trea tm en t o f tra n s ie n t cereb ra l ischem ic a ttacks due 
to  in tra v a scu la r c lotting.
C O N T R A IN D IC A TIO N S : Any loca lized  o r gene ra l phys ica l c o n d itio n  o r pe rso na l c ircum stance in  w hich 
th e  haza rd  o f hem orrhage m igh t be grea ter th a n  the  po te n tia l c lin ic a l b ene fits  of an ticoagulation, such 
as: P reg nancy: CO UM AD IN 8 is co n tra ind ica te d  in p reg nancy  beca use  th e  d rug  passes th ro u g h  the 
p la ce n ta l b a rr ie r  a nd  may cause fatal h e m o rrhage  to th e  fe tu s  in  utero. A lso, there  have been reports 
o f b ir th  m a lfo rm a tions  in child ren born  to  m o th e rs  w ho have been trea ted  w ith  warfarin during  p reg nan­
cy. W om e n  o f ch ildbearing  po te n tia l w ho are  cand ida tes  fo r thera py s h o u ld  be carefully evaluated and 
th e  ind ica tions  critica lly  reviewed w ith  the  patient. If the  pa tien t becom es pregnant while taking th is  drug, 
sh e  shou ld  be apprised of the potential risks to  the  fetus, and the  poss ib ility  o f termination of the  pregnancy 
sh o u ld  be d iscu sse d  in light o f those  risks. H em o rrhag ic  te n d e n c ies  o r  blood dyscrasias. R ecent or 
co n te m p la te d  surgery of: 1. cen tra l nervo us system ; 2 . eye; 3. tra u m a tic  surge ry resu lting  in large 
o p e n  surfaces. Bleeding tend e n c ies  asso ciated  w ith  active u lceration  or overt b lee d in g  of: 
gastro in testin a l, genitourinary or respiratory tracts ; cerebrovascu lar hem orrhage; aneurysm s -  cerebral, 
d is s e c tin g  aorta ; pericarditis an d  perica rd ia l e ffus ions; bacteria l endo ca rd itis . Threatened abortion , 
e c la m p s ia  a nd  preeclam psia. Inadequate  laboratory  fa c ilities  or unsu perv ised  senility, a lcoho lism , 
psychosis, o r lack of patient cooperation. Spinal puncture and other d iagnostic or therapeutic procedures 
w ith  po tentia l fo r uncontrollable b leeding. M iscellaneous: m ajor regional, lum bar block anes thesia  and 
m a lig n a n t hypertension .
W A R N IN G S: The most serious risks are hem orrhage in any tissu e  or o rgan and, less frequently, necrosis 
and/or gang rene of skin and o the r tissues. R isk o f hem orrhage is related to  the  level of intensity and duration 
o f therapy. H em o rrhage  and necro s is  have in  som e cases been repo rted  to  resu lt in death or perm anent 
d isab ility . N ecros is  appears to be associated w ith  local th rom bosis  and usua lly  appears w ith in  a  few days 
o f th e  s ta rt o f therapy. In severe case s  of necrosis, trea tm en t th ro u g h  d e b r idem en t or am pu ta tion  of the  
affected tissue, limb, breast or pen is  has been reported. Careful d iagnosis is required to determ ine whether 
nec ro s is  is cau s e d  by an un d e rly in g  d isease. Therapy shou ld  be d isco n tinued  when w arfa rin  is the 
su sp e c te d  cause  o f developing necro s is  a nd  hepa rin  m ay be cons ide red . A lthough various ones have 
bee n  a ttem p ted , no treatment fo r  necros is  has been cons ide red  u n ifo rm ly  effective. See be low  for infor­
m a tio n  on pred isposing  cond itions. These a nd  o the r risks m ust be w e igh ed  against the risk  o f th rom ­
bo s is  o r em bo liza tion  in untreated cases. CO U M A D IN  is a potent d rug  w ith  a half-life of 2.5 days; therefore 
e ffec ts  m ay beco m e more pron ounced  as d a ily  m a in tenance dose s overlap. It cannot be em phasized  
to o  strong ly  th a t treatm ent o f each p atien t is a highly ind iv id u a lized  m atter. Dosage shou ld  be co n ­
tro lle d  by p e rio d ic  determ inations o f p ro th rom b in  tim e  o r o th e r su ita b le  coagulation tests. D ete rm ina­
t io n s  of w ho le  b lood clotting and b leed ing  tim es are not effective m easures fo r control of therapy. Heparin 
p ro longs the  one-stage prothrombin time. W hen heparin and C O U M AD IN  are administered concomitantly, 
re fe r to  C O N V E R S IO N  FROM HEPARIN TH E R A P Y  fo r recom m enda tions . C aution shou ld  be observed 
w h e n  C O U M A D IN  is administered in  any s itua tion  or in th e  presence o f any predisposing cond ition  where 
a d d e d  r isk  o f hem orrhage or necro s is  is present. A dm in is tra tion  o f an ticoagu lan ts  in the  fo llow ing  co n ­
d itio n s  w ill be  based upon c lin ic a l ju d g e m e n t in w h ich  risks o f thera py are w eighed aga inst the  risk of 
th ro m b o s is  o r embolization in un treated cases. The fo llow ing  m ay be associa ted  with these  increased 
risks: Lacta tion . Severe to m oderate  hepatic  or renal insuffic iency. Infectious diseases o r distur­
ban c es  of in tes tina l flora -  sprue , a n tib io tic  therapy. Traum a w h ich  m ay result in in te rna l b leeding. 
S u rg e ry  or traum a resulting in large exposed raw surfaces. Indw elling catheters. Severe to m oderate  
h yp e rte n s io n . Known or susp ected  d efic iency in pro tein  C: T h is  h e re d ita ry  or acqu ired  cond ition , 
w h ic h  sh o u ld  be  suspected if th e re  is  a h is to ry  o f recurren t ep iso des  of th rom boem bo lic  d isorders in  the 
p a tie n t o r in  th e  fam ily, has been associa ted  w ith  an incre ased risk  o f deve lop ing  necrosis fo llow ing  war­
fa rin  adm in istration . Tissue necrosis may occu r in the absence o f protein C deficiency. It has been reported 
th a t co n c u rre n t anticoagulation therapy w ith  hepa rin  fo r 5 to  7 days d u rin g  initiation o f the ra py  w ith  
C O U M A D IN  m ay minimize th e  inc idence of th is  reaction. W arfa rin  thera py shou ld be d iscontinued when 
it is su sp ec ted  to  be the cause of deve lop ing  necrosis, and  hepa rin  m ay be considered. M iscellaneous: 
po lyc y th e m ia  vera, vasculitis, severe d iabetes, severe a lle rg ic  and anap hy lac tic  disorders. Patients w ith  
co n g e s tive  h e a rt failure may beco m e m ore sens itive  to  C O U M A D IN , the re by  requ iring m ore  frequent 
la b o ra to ry  m on ito ring , and redu ced  doses. C oncu rren t use of an ticoagu lan ts  with s trep tok inase or 
u ro k in a se  is not recom m ended and m ay be hazardous. (P lease note recom m endations accom panying  
th e s e  prep a ra tions.)
P R E C A U TIO N S : Periodic determ in atio n  o f prothrom bin tim e  or o th e r suitable coagulation test is 
es s e n tia l. Num erous factors, a lone o r in com b in atio n , inclu ding trave l, changes in d ie t, environ­
m en t, physical state and m edication may influence response to anticoagulants. It is good practice  
to m onitor th e  response w ith additional prothrom bin tim e determ inations in the period im m ediately 
a fte r  d isc h arg e  from  the hosp ita l, and w hen ever o th e r m edica tio n s  are initiated, d iscontinued  or 
take n  haphazard ly . The fo llow ing  factors are listed fo r your reference; however, o th er factors may 
also  a ffec t th e  anticoagulant response.
T h e  fo llow ing  factors, a lone or in com b in atio n , may be resp onsib le  for INCREASED pro­
throm bin tim e response: ENDO G EN O U S FACTORS: cancer, co llagen disease, congestive heart failure, 
d ia rrh e a , e leva ted temperature, hepa tic  d isorders: (in fec tious  hepa titis , jaundice), poor nu tr it io n a l state, 
s tea to rrhea , v itam in  K defic iency. EX O G E N O U S  FACTORS: a lc o h o l,!  a llopurino l, am inosa licy lic  acid, 
am iodarone HCI, anabolic steroids, anesthetics, inhalation, antib iotics, bromelains, chloral hydra te,! chlor­
p ropam ide, chymotrypsin, cim etidine, clo fibrate, CO UM ADIN overdosage, dextran, dextrothyroxine. diazox- 
ide, d iflu n isa l, d iu re tics ,! d isu lfiram , e th a cryn ica c id , fenoprofen, g luca gon , hepatotoxic drugs, ibuprofen, 
in flue nza  v iru s  vaccine, m e fenam ic ac id , m ethy ldopa, m ethy lphen ida te , metronidazole, m iconazole, 
m o n o a m in e  ox idase inh ib ito rs , n a lid ix ic  ac id , nap roxen , n a rco tics , pro longed, pen tox ify lline , 
p h e n y lbu tazone , phenytoin, pyrazo lones, qu in id ine , qu in ine , ra n it id in e ,! salicylates, su lfinpyrazone, 
s u lfo n a m id e s , long-acting, su lindac, thy ro id  d rugs, to lbu tam ide , trim ethoprim /su lfam ethoxazole, o the r 
m ed ica tions affecting blood elem ents w hich may m odify hemostasis. A lso: dietary deficiencies, prolonged 
ho t weather, unre liab le pro th rom bin  tim e  de te rm ina tions.
T he follow ing factors, a lone or in com bination, may be responsible for DECREASED prothrom ­
bin tim e  response: ENDO GENOUS FACTORS: edem a, hered ita ry  coum arin  resistance, hyperlipem ia, 
h ypo thyro id ism . EXOGENOUS FACTORS: a d re noco rtica l ste ro ids, a lc o h o l,!  antacids, an tih is tam ines, 
b a rb itu ra tes , carbam azepine, ch lo ra l h yd ra te ,! ch lo rd iazepox ide , cholestyram ine , C O U M A D IN  unde r­
dosage, d iu re tic s ,! ethchlorvynol, g lu te th im ide , g rise o fu lv in , ha loperido l, meprobamate, oral contracep­
tives, para ldehyde , prim idone, ra n itid in e ,! rifam p in , v ita m in  C. A lso: d ie t h igh  in  vitam in K, un re liab le  PT 
d e te rm ina tion s . Because a pa tie n t m ay be exposed to  a  co m b ina tion  o f the  above factors, th e  net effect 
on  PT respo nse  may be unpredictable . M ore  frequent labo ra to ry  m on ito ring  is, therefore, advisable. 
C oum arins may also affect the  actions of o the r drugs. Hypoglycem ic agents (chlorpropamide, tolbutam ide 
and g lybu ride ) and anticonvulsants (phenyto in and phenobarb ita l) m ay accum ulate in the body as a result 
o f in te rfe re n ce  w ith  either th e ir  m etabo lism  or excre tion.
A D VE RSE REACTIONS: Potential adverse reactions may include: •  Hem orrhage from any tissue or o rgan. 
T h is  is a  consequence of th e  an ticoagu lan t effect. S ig n s  and  sym p tom s w ill vary acco rd ing  to  the  loca­
tio n  and d eg ree  or extent o f b lee d ing . There fore, th e  p o ss ib ility  o f hem orrhage shou ld be cons idered  
in  eva lu a ting  th e  condition o f any an ticoagu la ted  pa tie n t w ith  co m p la in ts  which do not ind ica te  an o b ­
vious d iagnosis. Bleeding during  anticoagulan t therapy does not always correlate with prothrom bin activity. 
(S ee S YM P TO M S AND TR EA TM E N T OF O VE RDO SAG E .) B le e d in g  w h ich  occurs w hen th e  pro th rom ­
b in  tim e  is  w ith in  the th e ra peu tic  range w arran ts d ia g n o s tic  inves tiga tion , since it m ay unm ask a
p rev ious ly  unsuspected  les ion , e.g. tumor, ulcer, etc. •  N ecrosis of skin and o the r tissues. (SEE W AR N ­
INGS). •  O the r adverse reactions are infrequent and consist of alopecia, urticaria , dermatitis, fever, nausea, 
d ia rrhea, abdom ina l cram ping, a syndrom e called "pu rp le  toes,”  cholestatic hepa tic  in jury, and hypersen­
s itiv ity  reactions. •  P riap ism  has been associated w ith  an ticoagu lan t adm in is tra tion , however, a causal 
re la tionsh ip  has not been established.
DOSA G E A N D  LABO RATORY CONTRO L: Adm in istration: A dm in is tra tion  and dosage m ust be 
ind iv idua lized . A djust the  dosage acco rd ing  to  results of th e  one-stage pro th rom b in  tim e (PT) w ith  
com m only used rabb it brain th rom boplastin. There is ample evidence that prolongation of the prothrombin 
tim e  1.2 to  1.5 tim e s contro l is su ffic ien t for p rophylaxis and trea tm ent o f venous throm boem bo lism , 
m in im iz in g  the  risk  of hem orrhage associated w ith  m ore pro longed PT values. W here  the  risk of th ro m ­
b oem bo lism  is grea t, such  as w ith  recurren t system ic em bo lism , a PT of 1.5 to  2.0  tim es control shou ld 
be m aintained. A  ratio greater than 2.0 appears to provide no additional therapeutic benefit in most patients 
and is associa ted  w ith  a h igh e r risk o f bleeding.
C lin ica l State
Table of R ecom m ended Therapeutic  PT R anges*
R abbit Brain PT Ratio**
P rophylax is  -  venous throm boem bo lism
H igh-risk  su rge ry  1.2 -1.4
H ip  su rge ry  1.3-1.5
Treatm ent-deep ve in  th rom bosis  or pu lm onary em bo lism  1.2-1.5
P revention o f system ic em bo lism  in patients w ith:
•  a tria l fib rilla tion ,
•  tissu e  hea rt valves, or
•  acu te  m yocard ia l infarc tion 1.2-1.5
R ecu rren t system ic em bo lism  1.5-2.0
'M o d if ie d  from  Chest, ACCP-NHLBI National C onference on A n tith rom bo tic  Therapy, vo lum e 89, 
n um b er 2, page 14S, 1986.
" F o r  the  th ree  th rom bop las tins  curren tly  used in N orth  A m erica , a PT w ith  rabb it brain th rom bo­
p las tin  o f 1.3 to 2 .0  is equ iva len t to  an International N orm a lized  Ratio  (INR) o f 2 .0  to  4.0. For other 
th ro m bop las tins  the  INR can be ca lcu lated as: INR = (observed PT).ISI T he  ISI (Inte rnational 
S ens itiv ity  Index) is ava ilab le  from  the  m anu facturers o f th rom bop lastin .
IN ITIA L DOSAGE: Is com m only started above antic ipated main tenance dosage levels. A  commonly-used 
reg im en is 10mg/day fo r 2 to  4 days, w ith  da ily  ad justm ents based on the  resu lts  o f PT determ inations. 
A  la rge  load ing  dose  (i.e., 30m g) may increase th e  inc idence of h e m o rrhag ic  and o the r com plications, 
does not o ffe r more rapid protection against th rom bi form a tion, and is not recom m ended . Lower doses 
are recom m ended for e lde rly  and/or deb ilita ted  patients and pa tien ts  w ith  increased sens itiv ity  (see 
PREC AUTIO NS). M aintenance: Most patients are sa tis factorily m a in ta ined at a dose o f 2 to 10mg daily. 
F lexib ility of dosage is provided by breaking scored tablets in  half. The in d iv idua l dose and interval should 
be gaug ed  by th e  p a tie n t’s p ro th rom bin  response. Duration of therapy: The du ra tion  o f therapy in each 
pa tie n t shou ld  be ind iv idua lized . In genera l, therapy shou ld  be con tinued  un til th e  dang er o f th rom bosis  
and e m bo lism  has passed. Treatm ent During D entis try and S urgery: M ana gem en t of patients who 
unde rgo  denta l and  surg ica l procedures requ ires close lia ison betw een a tten d ing  physicians, surgeons 
and dentis ts . In pa tien ts  w ho m ust be anticoagu la ted  prio r to, durin g , o r im m ed ia te ly  fo llow ing denta l or 
surg ica l procedures, ad justing  the  dosage to  m a in ta in  the  PT at the  low e nd  o f th e  thera peutic  range, 
may sa fe ly  a llow  fo r con tinued an ticoagu la tion . The operative s ite  shou ld  be su ffic ien tly  lim ited  and 
access ib le  to  perm it the  effective use of local procedures for hem ostasis. U nder these conditions, dental 
and surgical procedures may be performed w ithout undue risk of hemorrhage. Conversion from Heparin 
Therapy: S ince the  onse t of C O U M A D IN ’S effect is delayed, hepa rin  is p re fe rred  in itia lly  for rap id  an ti­
coagulation. Conversion to CO UM ADIN may begin concom itantly w ith  hepa rin  therapy or may be delayed 
3 to  6  days. As hepa rin  may affect the  PT, patients rece iv ing  both hepa rin  a nd  CO U M A D IN  shou ld  have 
b lood draw n for PT de te rm ina tion , at least: •  5 hours after the  last IV bo lus dose  of heparin , or •  4 hours 
a fte r cessa tion  of a co n tinuous  IV in fus ion of hepa rin , or •  24 hours after the  last subcutaneous heparin  
in jection. W hen C O U M A D IN  has produced the desired therapeutic  range or pro th rom bin activity, heparin 
may be d isco ntinued .
SYMPTOMS AND TREATMENT OF OVERDOSAGE: Sym ptoms: Suspected o r overt abnormal bleeding 
(i.e., appearance o f blood in  stools or urine, hem aturia, excessive m enstrual b leed ing , melena, petechiae, 
excessive bruis ing o r persistent oozing from superficial in juries) are early manifestations of anticoagulation 
beyond a safe and sa tis facto ry  level. Treatm ent: Excessive an ticoagu la tion , w ith  or w ithout bleeding, 
may be contro lled by discontinuing therapy and if necessary, by adm inistration of oral or parenteral vitam in 
K, 2 .5m g to 10mg. (P lease see recom m endations accom panying  v itam in K, prepara tions p rio r to use.) 
Use of vitam in K, reduces responses to subsequent CO UM ADIN therapy. Patients may return to a pretreat­
m ent th rom bo tic  s ta tus fo llow ing  the  rapid reversal o f a p ro longed PT. R esu m ption  o f CO UM AD IN  ad­
m inistration reverses the effect of vitam in K ,, and a therapeutic PT can again be obta ined by careful dosage 
ad ju stm ent. If rap id an ticoagu la tion  is ind icated, hepa rin  may be pre fe rab le  fo r in itia l therapy. If m inor 
b lee d ing  p rog resses to  m ajor b leeding, give 5 to  25m g (rarely up to  50m g) parentera l v itam in K ,. In 
em erg ency s itua tions  o f severe hem orrhage, c lo tting  factors can  be re tu rned to  norm al by adm in istering 
200 to  500m L of w ho le  blood o r fresh frozen p lasm a, or by g iv in g  com m erc ia l Factor IX com p lex. Packed 
red b lood ce lls  m ay a lso  be given if s ign ifican t blood loss has occu rred . In fus ions  of blood or p lasm a 
shou ld  be m onitored carefu lly to  avoid precip ita ting pu lm onary edem a in e lde rly  patients or patients with 
hea rt d isease.
DO SA G E FO RM S: C O U M A D IN  TABLETS are sing le -scored , and are im prin ted  as follows:
SIZE: 2m g 2.5m g 5m g 10mg
CODE: 0101 0201 0301 0401
CO LO R: lavender orange peach w hite
IMPRINT: 
S ide  1: C O U M AD IN CO UM AD IN C O U M AD IN C O UM ADIN
b isec ted  2 bisected 2 1/2 bisec ted  5 bisec ted  10
S ide 2: Du Pont Du Pont Du Pont Du Pont
S upp lied  in bo ttles o f 100.
in c re a s e d  and decreased proth rom bin tim e responses have been repo rted .
Reference:
1. O ’R e illy  RA, A gge le r PM: Stud ies on coum arin  an ticoagu lan t d rugs: in itia tion  o f warfarin therapy 
w ith o u t a load ing  dose. C ircu la tion  38:169-177, 1968.
P roduct m onograph availab le on request.
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Peritracheal Membranous Adipose Tissue for Early 
Revascularization of the Bronchial Anastomosis
The effect of a peritracheal wrap of 
membranous adipose tissue on revas­
cularization of the bronchial anastomosis 
after left lung autotransplantation was 
evaluated in four groups of dogs. The 
bronchial anastomosis was performed 
just distal to the carina in groups 1 (6 
dogs) and 2 (7 dogs) and as close to the 
lobar division as possible in groups 3 (14 
dogs) and 4 (7 dogs). Peritracheal mem­
branous adipose tissue was used in 
groups 1 and 3 only. The other two 
groups served as controls. Three dogs 
from group 2 had elastic Dacron fabric 
wrapped around the anastomotic site.
Revascularization of the distal bron­
chus through the wrap was demon­
strated in all dogs in groups 1 and 3. 7 
days after surgery by postmortem injec­
tion studies but not in control groups 2 
and 4, and serious bronchostenosis was 
also observed in the latter two groups. 
Histologic examination of the bronchial 
anastomosis revealed better structural 
preservation of the bronchus distal to the 
suture line with the adipose tissue wrap. 
The dogs with elastic Dacron fabric 
wraps showed poor structural integrity 
below the suture line (necrosis and cal­
cification).
Our results suggest that the level of 
bronchial anastomosis does not alter the 
healing process of the distal bronchus 
when a peritracheal membranous adipose 
tissue wrap is applied to the anastomotic 
site. They also indicate that the wrap is 
effective in restoring vascular flow 
across the suture line within 1 week of 
lung autotransplantation.
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Le role d'un pedicule de membrane adi- 
peux a localization peritracheal pour la 
revascularization prgcoce de I'anasto- 
mose bronchique apres une reimplanta­
tion pulmonaire gauche, a ete evalue 
dans quatre groupes de chiens. (.'anasto­
mose bronchique a ete effectuee a proxi- 
mite de la carene dans les groupes 1 (6 
chiens) et 2 (7 chiens) et le plus proche 
possible de la division lobaire dans les 
groupes 3 (14 chiens) et 4 (7 chiens). Le 
pedicule de membrane adipeux a localiza­
tion peritracheal a ete utilise dans les 
groupes 1 et 3 seulement. Les deux 
autres groupes ont servi de groupes 
temoins. Chez trois chiens du groupe 2 
une bande de Dacron elastique a 6te 
employee pour envelopper I'anastomose 
bronchique.
Sept jours apr6s la chirurgie, la revas­
cularization de la bronche avec I'aide du 
pedicule de membrane adipose a ete 
dgmontree dans les groupes 1 et 3 par 
des etudes radiographiques avec des 
injections de Microfil faites a post­
mortem. Le retablissement de la circula­
tion bronchique semblait considerable- 
ment plus abondant chez les chiens du 
groupe 3 dans lesquels I'anastomose 
avait §te performee pres de la division 
lobaire. Par contre, I'absence de vais- 
seaux bronchiques, a travers et au dela 
de I'anastomose, 7 jours apres I'auto- 
plastie pulmonaire a ete constatee chez 
les chiens temoins des groupes 2 et 4.
L'examen histologique a demontre que 
les structures essentielles de la bronche 
distale de la zone anastomotique, etaient 
bien plus prgservees dans les groupes 
d'animaux avec le pedicule de membrane 
adipeux a localization peritracheale, que 
dans les groupes d'animaux temoins. La 
conservation de la vitalite et de I'int6- 
grite structurale de la bronche, au niveau 
et au deld de la ligne de sutures, s'est 
montree extremement pauvre (necrose et 
calcification) chez les chiens avec une 
bande de Dacron entourant la zone anas­
tomotique.
La nettete des resultats obtenus dans 
ce travail experimental permet de con- 
clure que ('application d'un pedicule de 
membrane adipeux a localization peritra­
cheal sur I'anastomose bronchique, favo- 
rise effectivement le retablissement de la 
circulation bronchique dans les 7 jours 
qui suivent la reimplantation du poumon.
Poor healing o f the bronchial anastomo­
sis, which has been a serious obstacle to 
the success o f human lung transplanta­
tion,1 may occur as a result o f ischemia 
secondary to division o f the bronchial 
blood supply.
In an attempt to correct this problem, 
we have assessed a technique to enhance 
early revascularization o f the distal bron­
chus by using a peritracheal membranous 
adipose tissue graft fastened around the 
anastomosis.
Peritracheal membranous adipose tis­
sue is that part o f the mediastinal pleura 
overlying the aortic arch and the thora­
cic aorta. It is microscopically composed 
of membranous adipose tissue, numerous 
capillaries and small blood vessels, 
lymphatics and peripheral nerve fibres. 
The blood supply is from the thoracic 
aorta.
Material and Methods
Thirty-four adult mongrel dogs, each 
weighing 18 to 22 kg, were premedicated 
with atropine sulfate (0.04 m g/kg) and 
anesthetized with intravenous droperidol- 
fentanyl citrate (Innovar Vet, 0.1 ml/kg). 
General anesthesia was maintained with 
1% halothane in oxygen and nitrous 
oxide-oxygen in a ratio o f 3 to 2. Mus­
cular relaxation was provided by pancu­
ronium bromide (0.05 mg/kg). The sur­
gical technique was similar to that 
previously described,2 but the following 
brief account emphasizes several points 
pertinent to the adipose tissue wrap (Fig. 
1).
The thorax was opened through the 
fifth interspace and the lung mobilized, 
freeing it from the inferior pulmonary 
ligament. The pericardium was incised 
over the main pulmonary artery and the 
incision extended inferiorly to expose the 
anterior aspect o f the left atrium and the 
right inferior pulmonary vein which 
drains the diaphragmatic lobe of the right 
lung. The superior surface o f the pulmo­
nary artery was cleared, the perivascular 
space entered, the artery was divided and 
the dissection carried over the aortic arch, 
care being taken to preserve the recurrent 
laryngeal nerve. The lung was reflected 
anteriorly, exposing the posterior hilum, 
and a vertical dissection carried out 
anterior to the vagus nerve, extending
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from the aortic arch to the inferior pul­
monary ligament. During the procedure, 
an area of bronchus from the lobar 
orifices to a point a few millimetres dis­
tal to the carina was cleared by blunt dis­
section. The bronchial arteries accom­
panying the left main bronchus were 
ligated and transected, severing the vagus 
branches to the bronchus. The left main 
bronchus and atrium were clamped and 
divided; then the lung was flushed with 
a 2% solution of Rheomacrodex in 
R inger’s lactate and reim planted. 
Ischemic time averaged 104 minutes.
The animals were divided at random 
into four groups as follows: bronchial 
transections and reanastomoses were per­
formed at a level 5 to 6 mm distal to the 
carina in groups 1 (6 dogs) and 2 (7 dogs) 
and at a point 1 to 2 mm proximal to the 
bifurcation of the upper and lower lobes 
in groups 3(14 dogs) and 4 (7 dogs). With
several 5-0 Prolene sutures, peritracheal 
membranous adipose tissue was grafted 
to the peribronchial tissue over the left 
posterolateral and inferolateral aspects of 
the bronchial anastomosis in groups 1 and 
3 only. The other two groups served as 
controls. From control group 2, three 
animals had elastic Dacron fabric 
wrapped around the bronchial anasto­
mosis.
Antibiotics were administered for 6 
days and Demerol intramuscularly as 
needed for relief of pain. Blood-gas ana­
lyses were carried out before and during 
surgery and for 48 hours postoperatively 
in order to maintain the measurements 
within normal limits. Chest x-ray films 
were made routinely in the postoperative 
period.
All dogs were put to death 7 days after 
lung reimplantation and bronchial heal­
ing was evaluated.
To demonstrate that bronchial revas­
cularization had occurred from the adi­
pose tissue circulation, 20 ml of radio­
paque dye (Microfil, Canton Bio-Medical 
Products, Inc., Boulder, Colo.) was 
injected at a pressure of 120 mm Hg into 
the descending aorta which was clamped 
immediately above and below the origin 
of the bronchial vessels. After the 
Microfil injection was cured, the thoracic 
contents were removed en bloc with the 
wrap, the tracheobronchial tree was par­
tially dissected and roentgenograms of the 
specimen were obtained.
The cross-sectional area of the anasto­
mosis was estimated as previously 
described2 and expressed as a percentage 
of the cross-sectional area of the left 
bronchus 4 to 5 mm proximal to the 
anastomotic site. The left and right bron­
chial tree was then slit and photographed 
before fixing in formalin. Histologic sec-
Fig. la  Fig. lb
FIG. 1—(a) Operative view and (b) diagrammatic representation of peritracheal membranous adipose tissue (P.M.A.T.) wrap. Dog 
is in left lateral position; surgeon is standing at dog’s abdomen and lung and wrap are reflected anteriorly.
Fig. 2a Fig. 2b
FIG. 2—Group 1 dog 1 week after left lung autotransplantation just distal to carina with application of wrap, (a) Magnification roent­
genogram of distal trachea, main-stem bronchi and lobar bronchi. Bronchial arterial blood supply has been re-established at level of anastomo­
sis and is extending well beyond (arrow), (b) Microfil-injected autopsy specimen dissected from posterior aspect. Dye-filled bronchial capillaries 
are seen distal to anastomosis as demonstrated in roentgenogram. Mucosal pattern appears normal.
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tions of all anastomoses were stained with 
hematoxylin and eosin. The slides were 
randomized and the histologic features 
evaluated in a blind fashion by the pathol­
ogist (S.M.C.).
Statistical analysis of the cross-sectional 
areas was done by one-way analysis of 
variance. The data are presented as means 
± standard error of the means and p 
values.
All animals used in this study received 
care in compliance with the Guide to the 
Care and Use o f  Experimental Animals 
formulated by the Canadian Council on 
Animal Care.
Results
All dogs survived the operation. On
postoperative day 2, an intermittent 
cough, productive of blood-tinged spu­
tum, developed in two animals from 
group 1 and one from group 2; they all 
recovered without complication after 5 
days of anticoagulant therapy.
Chest X-Ray Films
In all groups of animals, serial chest x- 
ray films were generally clear within 48 
to 72 hours of surgery. In some cases, 
opacification of the autotransplanted 
lung was noted for 2 or 3 days after oper­
ation, thereafter the lung’s appearance 
returned to normal.
When the animals were put to death at 
7 days the gross appearance of all reim­
planted lungs was normal with the excep­
tion of a few adhesions and focal atelec­
tasis secondary to open thoracotomy.
Bronchial Anastomosis
Group 1—anastomosis just distal to the 
carina, with wrap.—At autopsy, gross 
examination of the wraps showed them 
to be adherent to the underlying bron­
chus. Microfil injection of the aortic seg­
ment containing the bronchial arteries 
demonstrated filling of the submucosal 
capillaries distal to the anastomotic site 
(Fig. 2).
Histologic examination revealed the 
presence of bundle fibres, numerous 
Microfil-injected capillaries and lym­
phatic channels, and a few patchy areas 
of fibrosis in well-preserved adipose-tissue
Fig. 3a Fig. 3b
FIG. 3—Group 2 control dog 1 week after left lung autotransplantation just distal to carina. (a) Magnification roentgenogram of 
distal trachea, main-stem bronchi and lobar bronchi. Bronchial circulation appears to stop at level of anastomosis (arrows), (b) Microfil-injected 
autopsy specimen dissected from posterior aspect. No dye is present beyond anastomosis; bronchoanastomotic line shows loss of epithelium 
and patchy areas of ischemic necrosis.
Fig. 4a Fig. 4b
> a
FIG. 4—Group 3 dog 1 week after left lung autotransplantation proximal to lobar orifice with application of wrap, (a) Magnification 
^ r roentgenogram of distal trachea, main-stem bronchi and lobar bronchi shows rich network of small vessels extending toward periphery of bron­
chial tree (arrows), (b) Microfil-injected specimen dissected from posterior aspect confirming roentgenogram study. Mucosa is abundantly vas­
cularized and well preserved.
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wraps. The bronchial mucosa was com­
pletely epithelialized with small areas of 
squamous metaplasia present at the suture 
line. The cartilage appeared viable except 
in focal areas of atrophy. Organized 
thrombus of a pulmonary vein with 
recanalization was noted in two dogs 
(nos. 31 and 34).
Group 2—anastomosis just distal to the 
carina, without wrap.— No filling of the 
bronchial circulation distal to the anasto­
mosis could be seen in these dogs (Fig. 3), 
except in no. 33 in which radiopaque dye- 
filled vessels were observed in the mucosa 
and near the cartilage.
Evidence of bronchial strictures was 
noted at autopsy in this group. Micro­
scopic examination of all anastomoses 
showed loss of epithelium at the suture 
line, patchy dystrophic calcification of the 
mucosa below the anastomosis with par­
tial calcification of the cartilage. Isolation 
of the bronchial anastomosis from the 
adjacent peritracheal membranous adi­
pose tissue with Dacron fabric resulted in 
sloughing of the mucosa, necrosis of the 
submucosa and acute inflammatory 
reaction.
Group 3—anastomosis proximal to the 
lobar orifices, with wrap.—Seven days 
after autotransplantation, multiple, 
small, Microfil-injected vessels were 
visualized crossing the anastomotic site 
and spreading out toward the periphery 
of the bronchial tree (Fig. 4). In all cases, 
the integrity of the wrap was similar to 
that noted in group 1 animals. Histologic 
sections of the left main bronchus rev­
ealed excellent restoration of bronchial 
epithelium, preservation of the smooth- 
muscle fibres above and below the suture 
line and abundant Microfil-injected ves­
sels distal to the anastomosis.
Group 4— anastomosis proximal to the 
lobar orifices, without wrap.—No bron­
chial circulation distal to the anastomo­
sis was apparent at 7 days. The distal 
bronchus displayed epithelialization but 
the subepithelial tissue was attenuated 
and distorted with some inflammation 
and ulceration at the suture line (Fig. 5).
Degree o f  Bronchial Patency
The mean cross-sectional areas of the 
bronchial anastomosis of control group 
2 dogs with (three) and without (four) 
elastic Dacron wrapped around the 
anastomotic site were 58.7% ± 1.9% and 
65.5% ± 2.3% of normal respectively. 
Since there was no significant difference 
between these two means, all cross­
sectional-area values for group 2 were 
pooled to give a mean value of 62.3% ± 
2.3% of normal. The mean value of the 
bronchial anastomosis of group 1 
exceeded that of group 2 by 20.1% and 
group 3 surpassed that of group 4 by 
21.2%; these differences were significant 
(p < 0.001; Table I). No significant 
difference in the degree of bronchial 
patency could be found between dogs of 
group 1 and group 3 at 7 days.
Discussion
Several techniques have been developed 
to promote bronchial healing following 
lung transplantation, but they add to the 
difficulty of the transplant operation and 
increase the operating time.3 9 An omen­
tal pedicle flap has been used successfully 
to revascularize the bronchial autograft 
after pneumonectomy in dogs.9 
Although the bronchial omentopexy
appears promising, it is time-consuming 
and certainly not free of postoperative 
complications such as incisional dia­
phragmatic hern ia10-12 and gastric 
obstruction.13
In a recent study2 we demonstrated 
that a pedicled intercostal muscle graft 
wrapped around the bronchial anastomo­
sis improved bronchial healing by restor­
ing vascular flow across the sutured bron­
chus as early as 7 days after canine lung 
autotransplantation. The efficacy of this 
technique has also been reported by 
others.14 They have shown that the 
application of an intercostal pedicle flap 
to the pneumonectomy bronchial auto­
graft, with and without concomitant 
administration of corticosteroids in dogs, 
provides early revascularization and ade­
quate bronchial healing.
Ideally, a graft should be developed 
within the chest and most importantly 
with minimal intervention. It should pos­
sess an adequate vascular, lymphatic and 
nervous supply to promote the develop­
ment of a rich capillary network at the 
critical line of repair and to reduce the 
degree of stenosis. The present study 
strongly suggests that the peritracheal 
membranous adipose tissue wrap could 
fulfil these requirements.
Table 1—Bronchial Patency (Percentage of
Cross-Sectional Area of Proximal Bronchus
7 Days After Operation*)
Group No. Patency, %
1 6 82.4 ± 2.0
2 7 62.3 ± 2.3
3 14 83.8 ± 2.5
4 7 62.6 ± 2.9
'Mean ± standard error.
Fig. 5a Fig. 5b
FIG. 5—Group 4 control dog 1 week after left lung autotransplantation proximal to lobar orifices, (a) Roentgenogram demonstrates 
bronchial circulation down to but not beyond anastomotic site (arrows), (b) Microfil-injected specimen dissected from posterior aspect parallels 
findings in (a). Distal bronchus displays epithelialization with some ischemic areas; parts of suture line are ulcerated.
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Light microscopic examination of this 
membranous tissue showed vessels and 
capillaries, peripheral nerve bundles and 
lymphatics. At the light microscopic level, 
there is no difference in the composition 
of this tissue in dogs and in that obtained 
from a similar location in human 
cadavers.
Our results demonstrated that the level 
of bronchial anastomosis does not alter 
the healing process of the distal bronchus 
when peritracheal membranous adipose 
tissue is wrapped around the anastomo­
sis. They also showed that the peritracheal 
membranous adipose tissue wrap is 
indeed effective in the anatomic reconsti­
tution of the bronchus as early as 7 days 
after lung transplantation.
A study is under way to assess the effi­
ciency of the wrap (a) in canine lung 
autografts with immunosuppressive ther­
apy and (b) in lung allograft rejection 
with and without immunosuppression.
We are indebted to Ken Austin and Luke 
Grenning for technical assistance in surgery, 
Gladys Jackson for expert technical assistance 
in radiology, Charles Chano for preparing 
histologic slides, Dr. Dave Bryan for his advice 
in the analysis of the data and Janet Dupree 
for providing excellent animal care. We thank 
the staff of the Department of Laboratory 
Medicine and Department of Medical Audi­
ovisual of the Health Sciences Complex and 
Linda Morrissey for her assistance. We also 
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BOOKS REVIEWS 
continued from page 316
Other groups discussed include the elderly and 
homosexuals.
The section on etiology reflects the lack of 
knowledge in this area and gives specific com­
ments on the importance of immunology and 
infection. The chapters on epidemiology are 
rather fragmented and describe the experience 
of three individuals, rather than giving a global 
assessment. More could be made of data avail­
able outside the United States. Pitfalls in the 
construction of epidemiologic studies and 
problems of data interpretation are discussed 
and are helpful.
Section three comprises short chapters on 
gynecologic complications and inflammatory 
bowel disease in pregnancy together with 
problems of cancer surveillance. The negative 
approach to the finding of dysplasia as a mar­
ker for malignant disease in ulcerative colitis 
is perhaps controversial.
The fourth section details the modalities 
available in the treatment of inflammatory 
bowel disease giving heavy emphasis to Crohn’s 
disease. The chapter on salazopyrin does not 
discuss the newer 5-ASA preparations and that 
on corticosteroids scarcely alludes to topical 
steroid preparations. As expected, the chap­
ter on the use of 6-MP reflects the enthusiasm 
of the Lenox Hill group. A later chapter on 
the use of 6-MP from the hematologic aspect 
further reinforces the local crusade. The impor­
tance of nutritional support and particularly
dietary management is superficially treated. A 
chapter on metronidazole completes this 
section.
From this point on the book rather loses its 
way. A chapter on flexible endoscopy is fol­
lowed by very short chapters on sig­
moidoscopy, pathology and radiology, all of 
which are of poor quality.
Section six deals with miscellaneous 
problems — 6-MP, substance abuse in inflam­
matory bowel disease, Crohn’s disease of the 
upper gastrointestinal tract, management of 
strictures in Crohn’s disease and toxic megaco­
lon, infectious agents and differential diagno­
sis of inflammatory bowel disease. There is lit­
tle new here.
The final section on surgery is of rather bet­
ter quality and describes indications, outcome, 
recurrence and quality of life. The effect of 
diversion procedures on defunctioned bowel 
figures prominently. The chapter on manage­
ment of strictures in Crohn’s disease is partic­
ularly useful. Sphincter-saving procedures 
receive scant attention and deserve more 
thorough review.
Clearly from its content this book was not 
designed to be presented in book form. Rather 
it represents topics gathered together in a 
haphazard way. The order of the chapters is 
not entirely logical, some are repetitive, some 
could be combined and some are so short that 
their impact is negligible. Other chapters are 
anecdotal and the enthusiasm for particular 
approaches is infrequently balanced by a review
continued on page 347
SESAP V Question
105. Which of the following statements about posttransfusion hepatitis 
in the United States is TRUE?
(A) <5%  of patients transfused will develop hepatitis within six 
months after transfusion
(B) Hepatitis B is not seen after transfusion if currently available 
screening tests for hepatitis B are properly used
(C) 5% to 10% of transfused patients show evidence o f exposure 
to hepatitis A virus or cytomegalovirus, or both, as a result 
of transfusion
(D) Posttransfusion hepatitis persists as chronic active hepatitis 
in over 25% of patients affected
(E) The highest risk o f contracting hepatitis is from exposure to 
the first donor; risk decreases steadily with exposure to sub­
sequent donors during the same hospitalization
For the critique of Item 105 see page 373.
(Reproduced by permission from SESAP V Syllabus; Surgical Education and 
Self-Assessment Program No. 5. For enrolment in the Surgical Education and 
Self-Assessment Program No. 5, please apply to the American College o f Sur­
geons, 55 East Erie St., Chicago, IL 60611.)
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There’s method to our madness here. We’re dramatizing a point about Marcaine:* 
The point is, Marcaine lasts a lot longer than other local anaesthetics. Up to 
twice as long, in fact. (See Covino, B.G. and Scott, D.B. Handbook of Epidural 
Anaesthesia and Analgesia. Grune & Stratton. In Orlando, 1985; 70.)
Since Marcaine lasts twice as long, our ad is twice as long. We understand 
that you may not have the time at one sitting to read and digest the amount of 
information shown here. But if you’ve read this far, you have the main point 
about Marcaine, the reason why it is so well respected and so well used, and later 
we’d like to table some discussion points about additional uses for Marcaine, 
and perhaps reacquaint you with its other advantages, such as the degree of 
participation it allows the mother in labour, and the fact it is 95% plasma protein 
bound which limits the amount of drug transfer across the placental barrier to 
the foetus.
Longer duration is the key benefit of Marcaine to the anaesthetist. It lasts 
up to twice as long as lidocaine which means that you can achieve optimum 
pain control during surgical procedures. It also saves the obstetric anaesthetist 
time because fewer top-ups are necessary with Marcaine (see Ostheimer, G.W, 
Regional Anaesthesia Techniques in Obstetrics, Breon Laboratories Inc., 1980, 
p.23). But another key point about Marcaine is that it separates sensory from 
motor block. Excellent sensory anaesthesia can be obtained with less motor 
block than any other local anaesthetic. This separation allows for complete pain 
relief during and after surgery, yet lessens immobility in the post-operative 
phase. In obstetrics, Marcaine can maintain the mother’s ability to bear down 
in labour while providing relief of pain. Greater involvement and cooperation of 
the mother are considered desirable in obstetrics for the 80’s. (The reference 
material in the above paragraph outlines data on this phenomenon as well as 
evidence for the duration of Marcaine.)
Indeed, the long duration of Marcaine (and in actual fact, Marcaine can 
last twice as long as other.injectable local anaesthetics) not only reduces the 
time you spend because of fewer top ups during a procedure, it produces an 
extended pain free period in the mother after the birth when perineal repair has 
been required. Unlike general anaesthesia, the mother is also conscious during 
and immediately after the delivery so bonding and breast feeding can occur 
earlier.
What are the advantages of Marcaine and epidural anaesthesia relative to 
general anaesthesia? First and foremost is the avoidance of one of the principal 
hazards of general anaesthesia, i.e. vomiting and aspiration of stomach contents. 
Secondly, consider the area of endocrine stress response to anaesthesia and 
surgery (Lindall, S., et al: Endocrine Stress Response during General and Epidural 
Anaesthesia for Elective Caesarean Sections, Acta Anaesthesiol Scand. 1983; 
27:50-55). With inhalation anaesthesia maternal plasma levels of cortisol and 
ACTH -  endocrine stress markers -  are consistently higher. The foetus may have a 
higher endocrine stress response.
And the argument can be effectively summarized by this statement: 
“Bupivacaine (Marcaine) is currently established as the safest and most 
effective amide-linked local anaesthetic for obstetric anesthesia!’ (Bromage RR: 
Choice of Local Anesthetics in Obstetrics. In Shnider, S.M. and Levinson, G. 
(eds.): Anesthesia for Obstetrics. The Williams & Wilkins Company, Baltimore, 
1979,113.) And this statement: “The clear advantages to the post-partum 
mother are sufficient grounds for encouraging the teaching and eventually the 
routine use of epidural anaesthesia for caesarean section on all suitable patients? 
(Morgan B.M., et al: Anaesthetic Morbidity Following Caesarean Section Under 
Epidural or General Anaesthesia. The Lancet. 1984: 328-330). We have already 
mentioned the longer duration of Marcaine and the additional benefit that 
Marcaine is 95% plasma protein bound which limits the amount of drug transfer 
across the placenta to the foetus. Marcaine also causes minimal foetal and neo­
natal depression of neuro behaviour and muscle tone.
At this point, please allow for a pertinent digression from the discussion 
on the longer duration of Marcaine and other benefits.
INDICATIONS: Peripheral nerve block, infiltration, sympathetic blockade, 
caudal, epidural, and pudendal blocks.
CONTRAINDICATIONS: Bupivacaine is contraindicated in persons with 
known sensitivity to local anesthetics of the amide type. The use of bupivacaine 
is contraindicated in the presence of sepsis near the site of proposed injection, in 
severe shock and in heart block.
WARNINGS: USAGE IN PREGNANCY: Decreased pup survival in rats and 
an embryocidal effect in rabbits have been observed when bupivacaine 
hydrochloride was administered to these species in doses comparable to nine 
and five times respectively the maximal recommended daily human dose 
(400 mg). There are no adequate and well-controlled studies in pregnant women 
of the effect of bupivacaine on the developing fetus. Bupivacaine hydrochloride 
should be used during pregnancy only if the potential benefit justifies the
potential risk to the fetus. This does not exclude the use of Marcaine 0.25% or 
0.50% at term for obstetrical anesthesia or analgesia.
OBSTETRICS: The highest (0.75%) concentration is not recommended for 
obstetrical anesthesia. There have been reports of cardiac arrest with difficult 
resuscitation or death following its use for epidural anesthesia in obstetrical 
patients. Due to the high risk to the fetus, paracervical block is no longer 
recommended. The obstetrician is warned that severe persistent hypertension 
may occur after administration of certain oxytocic drugs, if vasopressors have 
already been used during labor (e.g. in the local anesthetic solution or to correct 
hypotension). Until further experience is gained in children younger than 12 
years, administration of bupivacaine in this age group is not recommended. 
PRECAUTIONS: RESUSCITATIVE EQUIPMENT AND DRUGS SHOULD 
BE READILY AVAILABLE WHEN ANY LOCAL ANESTHETIC IS USED. 
The safety and effectiveness of local anesthetics depend upon proper dosage, 
correct technique, adequate precautions, and readiness for emergencies. 
Marcaine (bupivacaine) should be used cautiously in persons with known drug 
allergies or sensitivities, particularly to the amide-type local anesthetics. Caution 
is advised in administration of repeat doses of bupivacaine to patients with 
severe liver disease. The following precautions apply to all local anesthetics: 
Select needles of proper length and bevel for the technique employed. Inject 
slowly with frequent aspirations and if blood is aspirated, relocate the needle. 
Inadvertent intravascular injection may cause serious complications. Absorption 
is more rapid when injections are made into highly vascular tissues. In caudal or 
epidural anesthesia, abandon the method if the subarachnoid space has been 
entered, as shown by aspiration of spinal fluid. The lowest dosage that gives 
effective anesthesia should be used, to avoid high plasma levels and serious 
systemic side effects. Injection of repeated doses of bupivacaine may cause a 
significant increase in blood levels due to accumulation of the drug or its 
metabolites or slow metabolic degradation. Tolerance varies with the status of 
the patient. Debilitated, elderly and acutely ill patients may require reduced 
doses commensurate with age and physical condition. It should be remembered 
that solutions containing a vasopressor agent, e.g. epinephrine, should be used 
with caution, if at all, in patients who are receiving monoamine oxidase 
inhibitors or anti-depressants of the triptyline or imipramine type, because 
severe, prolonged hypertension may result. Dose-related cardiac arrhythmias 
may occur if preparations containing epinephrine are employed in patients during 
or immediately following the administration of chloroform, halothane, 
cyclopropane, trichloroethylene or other related agents. In deciding whether to 
use these products concurrently in the same patient, the combined action of 
both agents upon the myocardium, the concentration and volume of vasocon­
strictor used, and the time since injection, when applicable, should be taken into 
account. The decision to use a local anesthetic containing a vasoconstrictor in 
areas with a limited blood supply or in patients with peripheral vascular disease, 
will depend on the physician’s appraisal of the relative advantages and risks. 
Local anesthetics which contain preservatives, i.e. those supplied in multiple 
dose vials, should not be used for caudal or epidural anesthesia.
EPIDURAL USE: It is advised that a test dose, generally 2-3 mL of 0.5% 
bupivacaine (or other amide anesthetic) containing 1:200,000 epinephrine (10-15 
micrograms) be administered to check that the spinal canal or a blood vessel has 
not been entered while locating the epidural needle or catheter. In the event of 
spinal injection clinical signs of spinal block would become evident in a few 
minutes. In the event of intravascular injection a transient increase in pulse 
rate and possibly momentary increase in systolic blood pressure are usually 
detectable with a monitor The other symptoms and signs of “epinephrine 
response” are less dependable. The effects of other medication the patient has 
received may modify this response. When reinforcing doses are required the test 
dose should be used again to check the catheter location.
ADVERSE REACTIONS: Reactions to bupivacaine are characteristic of those 
associated with amide-type local anesthetics. A major cause of adverse 
reactions to this group of drugs is excessive plasma levels, which may be due to 
over-dosage, inadvertent intravascular injection, or slow metabolic degradation. 
Other causes of reactions to these local anesthetics may be hypersensitivity, 
idiosyncrasy, or diminished tolerance. Excessive plasma levels cause systemic 
reactions involving the central nervous system and the cardiovascular system. 
The CENTRAL NERVOUS SYSTEM EFFECTS are characterized by 
excitation or depression. The first manifestation may be nervousness, dizziness, 
blurred vision, or tremors, followed by drowsiness, convulsions, uncons­
ciousness, and possibly respiratory arrest. Since excitement may be transient or 
absent, the first manifestation may be drowsiness, sometimes merging into 
unconsciousness and respiratory arrest. Other central nervous system effects 
may be nausea, vomiting, chills, constriction of the pupils, or tinnitus. The 
CARDIOVASCULAR MANIFESTATIONS of excessive plasma levels may
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include depression of the myocardium, blood pressure changes (usually 
hypotension), and cardiac arrest. Recent clinical reports and animal studies 
suggest this may be more likely to occur with the long acting amide local 
anesthetics such as bupivacaine. .
ALLERGIC REACTIONS are characterized by cutaneous lesions (e.g. 
urticaria, edema) and other manifestations of allergy. Reactions following 
epidural or caudal anesthesia may include: high or total spinal block, urinary 
retention; fecal incontinence, loss of perineal sensation and sexual function; 
persistent analgesia, paresthesia, and paralysis of the lower extremities; 
headache and backache; and slowing of labor and increased incidence of forceps 
delivery. It should be noted that reactions due to systemic absorption may be 
slow or rapid in onset. Those of rapid onset include respiratory depression, 
cardiovascular collapse and cardiac arrest. This type of reaction necessitates a 
high degree of preparedness since it can occur with little warning.
In co-ordinated studies of 3200 procedures carried out by 15 investigators, 
there were 2 severe systemic reactions. Both patients experienced convulsions 
as a result of inadvertent vascular injection. Fetal bradycardia has been 
observed with the use of bupivacaine. Most cases, including a few fatalities, 
occurred when the paracervical route was used (see “Warnings”).
In some subjects bupivacaine may produce marked peripheral vasoconstric­
tion in unanesthetized areas which may last for several hours.
TREATMENT OF OVERDOSE AND SEVERE REACTIONS: Toxic effects of 
local anesthetics require symptomatic treatment; there is no specific cure. The 
physician should be prepared to maintain an airway and to support ventilation 
with oxygen and assisted or controlled respiration as required. Supportive 
treatment of the cardiovascular system includes intravenous fluids and, when 
appropriate, vasopressors (preferably those that stimulate the myocardium). 
Convulsions may be controlled with oxygen and intravenous administration, in 
small increments, of a barbiturate or muscle relaxant, as follows: preferably, an 
ultra short-acting barbiturate such as thiopental or thiamylal, if this is not 
available, a short-acting barbiturate (e.g. secobarbital or pentobarbital) or a 
short-acting muscle relaxant (succinylcholine). Intravenous muscle relaxants 
and barbiturates should only be administered by those familiar with their use. 
DOSAGE AND ADMINISTRATION: As with all local anesthetics, the dosage 
varies and depends upon the area to be anesthetized, the vascularity of the 
tissues, the number of neuronal segments to be blocked, individual tolerance, 
and the technique of anesthesia. The lowest dosage needed to provide effective 
anesthesia should be administered.
In recommended doses, bupivacaine produces complete sensory block, 
but the effect on motor function differs between the three concentrations.
0.25% when used for caudal, epidural, or peripheral nerve block, produces 
incomplete motor block. Should be used for operations in which muscle re­
laxation is not important, or when another means of providing muscle relaxation 
is used concurrently.
0.5% provides motor blockade for caudal, epidural, or nerve block, but 
muscle relaxation may be inadequate for operations in which complete muscle 
relaxation is essential.
0.75% produces complete motor block. This concentration is recommended 
only for epidural block (single dose) in abdominal operations requiring complete 
muscle relaxation without the aid of other medication. It is not recommended for 
epidural block in obstetrical patients.
The duration of anesthesia with bupivacaine is such that, for most pro­
cedures, a single dose is sufficient. Maximum dosage limit must be 
individualized in each case after evaluating the size and physical 
status of the patient, as well as the usual rate of systemic absorp­
tion from a particular injection site. Most experience to date is 
with single doses of bupivacaine up to 225 mg with epinephrine 
1:200,000 and 175 mg without epinephrine; more or less drug 
may be used depending on individualization of each case. At 
present there is insufficient clinical evidence with multiple 
dosage or intermittent dose techniques to permit precise re­
commendations for such procedures to be given. However 
limited clinical experience in this area of use indicates that 
bupivacaine may be repeated in 3 to 6 hours up to a maxi­
mum dose of400 mg in 24 hours. In most cases the duration 
of anesthetic effecr is prolonged by the addition of epine­
phrine. The following table is presented as a guide to the use 
of bupivacaine. The doses shown have generally proved 
satisfactory for the average adult. They may require adjust­
ment in relation to age and the physical condition of the 
patient.
RECOMMENDED CONCENTRATIONS AND DOSAGE FOR ADULTS
Type of Block Concentration mL Each Dose mg Motor Block1
Local Infiltration 0.25% up to max up to max
Epidural^ 0.75%1 10-20 75-150 Complete
0.50% 10-20 50-100 Moderate to Complete
0.25% 10-20 25- 50
Epidural^ 0.50% 2-3 10- 15
Test Dose w/epi (10- 15/ig
epinephrine)
Caudal 0.50% 15-30 75-150 Moderate to Complete
0.25% 15-30 37.5- 75 Moderate
Peripheral Nerves 0.50% 5-30 25-150 Moderate to Complete
0.25% 5-60 12.5-150 Moderate to Complete
Sympathetic 0.25% 20-50 50-125
1. With continuous (intermittent) techniques in caudal and epidural block using 0.25 and 0.5% solutions, 
repeat doses increase the degree of motor block. The first dose of 0.5% may produce complete motor block 
in most intercostal nerve blocks for intra-abdominal surgery, the 0.25% concentration has produced 
satisfactory motor blockade.
2. For single dose use not for intermittent technique.
3. Use of an appropriate test dose is recommended prior to injecting the full epidural dose (see “Precautions”)
AVAILABILITY: ISOTONIC SOLUTIONS:
0.25%-10 mL single dose vials (without preservative), (boxes of 5).
-20 mL single dose vials (without preservative) with and without 
epinephrine (boxes of 5).
-  50 mL multiple dose vials (containing methylparaben as preservative) 
without epinephrine (boxes of 1).
0.50% -  3 mL single dose ampuls (without preservative) with epinephrine (boxes of
-10 mL single dose vials (without preservative), (boxes of 5).
-20 mL single dose vials (without preservative) with and without 
epinephrine (boxes of 5).
-50 mL multiple dose vials (containing methylparaben as preservative) 
without epinephrine (boxes of 1).
0.75%>-3mL single dose vials (without preservative) without epinephrine (boxes 
of 5).
The solutions are made isotonic with NaCl and the pH is adjusted with 
NaOH or HC1. The pH range for solutions without epinephrine is 4.0-6.5 and 
for solutions with epinephrine is 3.4-4.5. Plain solutions may be autoclaved but 
those containing epinephrine may not. Each mL of solution with epinephrine 
contains 0.0091 mg epinephrine bitartrate with 0.5 mg sodium metabisulfite.
0.001 mL monothioglycerol, and 2 mg ascorbic acid as antioxidants, 0.002 mL 
60% sodium lactate buffer and 0.1 mg edetate calcium disodium as stabilizer 
Product Monograph is available on request.
Marcaine allows better participation of the mother in labour. Marcaine is 
95% plasma protein bound which limits the amount of drug transfer across the 
placenta to the foetus.
But first and foremost, Marcaine offers longer duration of pain control 
needed for surgical and obstetrical procedures.
Marcaine.
The local anaesthetic 
that lasts twice as long.
(fyiritlviop
Winthrop Laboratories 
Division of Sterling Drug Ltd.* 
Aurora, Ontario LAG 3H6 om
ADAPTIC*Trulynon-adheringdressing AA
A non-adhering dressing 
should be truly non-adhering.
It shouldn’t have heavy petrolatum  
or paraffin coatings that smear 
and clog. It shouldn’t have 
loose gauze fibres that adhere to 
closing wounds. It shouldn’t have wide 
open mesh that allows granulation 
to form  through and around it.
A non-adhering dressing should be 
like ADAPTIC*!
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Incidence of Mediastinal Node Involvement 
in Clinical T1 Bronchogenic Carcinomas
The incidence of mediastinal node 
involvement of T1 non-small-cell bron­
chogenic carcinomas was determined in 
262 patients for the period June 1981 
to January 1986. All patients underwent 
mediastinoscopy as part of their evalua­
tion. Thirty-five patients (13% ) had clini­
cal primary T1 lesions. There were 17 
adenocarcinomas. 10 squamous cell car­
cinomas, 6 large-cell anaplastic carci­
nomas and 2 bronchoalveolar carci­
nomas. Five patients had node 
involvement at mediastinoscopy: two 
had large-cell anaplastic carcinomas and 
one was a squamous cell carcinoma. 
Thoracotomy in the remaining 30 
patients revealed 2 with pleural 
metastases. 1 with left upper lobe 
adenocarcinoma with metastases to the 
subaortic nodal area (not assessed by 
cervical mediastinoscopy). The other 
patients underwent resection, for a 
resectability rate of 90% . Therefore the 
overall incidence of mediastinal node 
involvement in this series was 17%  (6 of 
35) and was found to be highest among 
patients with large-cell anaplastic carci­
nomas (2 of 6), followed by adenocarci­
nomas (3 of 19) and squamous cell car­
cinomas (1 of 10). The larger number of 
large-cell anaplastic carcinomas in this 
series probably accounts for the higher 
incidence of N2 disease found compared 
with that of previous studies in the liter­
ature. Accordingly, preoperative medi­
astinal staging is recommended for all T1 
large-cell anaplastic carcinomas and 
adenocarcinomas and for suspicious 
lesions of undetermined histology.
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sity o f  Toronto, Toronto, Ont.
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L'incidence des atteintes ganglionnaires 
mediastinales dans les carcinomes bron- 
chopulmonaires au stade T1, a I'exclu- 
sion des cancers a petites cellules, a ete 
determinee chez 262 patients qui ont ete 
vus au cours de la periode de juin 1981 
a janvier 1986. Parmi les examens d'eva- 
luation, tous patients avaient subi une 
mediastinoscopie. Trente-cinq patients 
(1 3 % ) presentaient des tumeurs primiti­
ves au stade T1. On comptait 17 adeno- 
carcinomes, 10 epitheliomas epidermof- 
des bronchiques, 6 carcinomes 
anaplasiques a grosses cellules et 2 can­
cers broncho-alveolaires. Cinq patients 
presentaient des atteintes ganglionnaires 
a la mediastinoscopie: il s'agissait de 
carcinomes anaplasiques a grosses cellu­
les dans deux cas et d’un epithelioma 
epidermoide bronchique. Chez les 30 
autres patients, la thoracotomie a revele 
deux metastases pleurales, un adenocar- 
cinome metastasie a la region ganglion- 
naire sous-aortique (qui n'avait pas ete 
vu a la mediastinoscopie cervicale). Les 
autres patients ont subi une resection , 
ce qui donne un taux de cas operables 
de 9 0 % . Done, dans cette serie, 
l'incidence des atteintes ganglion­
naires mediastinales a ete de 17%
(6 sur 35); elle etait plus elevee dans les 
patients avec les carcinomes anaplasi­
ques a grosses cellules (2 sur 6), suivi 
des adenocarcinomes (3 sur 19) et des 
epitheliomas epidermoVdes bronchiques 
(1 sur 10). Le plus grand nombre de car­
cinomes anaplasiques a grosses cellules 
dans cette serie est probablement res- 
ponsable de l'incidence plus elevee de 
cancers au stade N2 qui a ete trouvee, 
par rapport aux etudes deja publiees. II 
est done recommande d'etablir en preo- 
peratoire le stade d'atteinte mediastinale 
dans tous les cas de carcinomes anapla­
siques a grosses cellules et d'adenocarci- 
nomes au stade T1 de meme que 
lorsqu'on est en presence de lesions sus- 
pectes d'histologie indeterminee.
The incidence of mediastinal node 
metastases with small peripheral non- 
small-cell bronchogenic carcinomas is 
reported to be 10% or less.1-3 Conse­
quently, prethoracotomy mediastino­
scopy for staging is frequently thought to 
be unnecessary for such lesions.3 The 
impression that the incidence was higher 
than 10% led to this review which reports 
the incidence of mediastinal node 
metastases (N2) with T1 bronchogenic 
carcinoma in our patient population over 
a 4!/2-year period.
Patients and Method
Between June 1981 and January 1986, 
262 patients with lung cancer were consi­
dered candidates for surgical resection 
after initial clinical assessment. We first 
performed bronchoscopy and mediastino­
scopy before thoracotomy for all malig­
nant lesions and for any suspicious lesion 
of unknown histology, whatever its size 
and location on the chest x-ray film.
Transcervical mediastinoscopy with 
sampling of the paratracheal, tracheo­
bronchial angle and anterior subcarinal 
nodal areas was carried out as previously 
described.4 All sampling was done under 
general anesthesia with coincident bron- 
choscopic evaluation. For this study, a 
clinical T1N0 lesion is defined by radio- 
logic and clinical criteria as follows:
• A lesion 3 cm or smaller in diameter 
on plain posteroanterior chest x-ray film.
• Radiologic evidence of lung paren­
chyma or visceral pleura surrounding the 
lesion.
• A normal mediastinal shadow as 
seen radiologically.
• A lesion not visualized at bron­
choscopy.
• No clinical suggestion of more 
advanced disease as evidenced by hoarse­
ness, dysphagia, cervical adenopathy or 
symptoms associated with bone or brain 
metastases.
Hospital and office charts of the 262 
patients were available for review as were 
pathology reports and chest films.
Findings
Complications
There were no deaths and only two 
complications. One patient suffered a dis-
k
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located arytenoid, presumably due to 
endotracheal intubation. Another had 
transient, recurrent, nerve palsy but reco­
vered completely.
Clinical T1N0 Lesions
Thirty-five patients (13%) (21 men, 14 
women) were found to have clinical T1N0 
lesions. In 17 of these, the lesion was 2 
cm in diameter or smaller.
The 35 patients ranged in age from 44 
to 81 years (mean 64 years). Twenty-three 
had no symptoms and the lesion was iden­
tified by routine chest roentgenography. 
The following symptoms prompted inves­
tigation in the other 12 patients: cough 
(4), hemoptysis (3), chest pain (2) and 
postpneumonia follow-up (3).
A diagnosis of cancer was obtained 
preoperatively in 23 patients (66%) either 
by sputum or bronchial-washings cytol­
ogy or by percutaneous needle aspiration 
biopsy of the lesion. In the remainder, 
surgical intervention by mediastinoscopy 
or thoracotomy was necessary.
Twenty-one lesions were located in the 
left lung and 14 in the right. Upper lobe 
lesions were predominant (left upper lobe 
11, right upper lobe 8). Seventeen lesions 
(48.6%) were adenocarcinomas, 10 
(28.6%) squamous cell carcinomas, 6 
(17.1 %) large-cell anaplastic carcinomas 
and 2 (5.7%) bronchoalveolar carci­
nomas. Two peripheral T1 small-cell 
anaplastic carcinomas were encountered, 
but the chest x-ray film suggested medi­
astinal spread so the patients were 
excluded from this report.
T1N2 by Mediastinoscopy
By transcervical mediastinoscopy, 
nodal involvement was diagnosed in five 
patients. In four of these, both primary 
and secondary lesions were asympto­
matic. Three of the five patients had 
primary lesions 2 cm in diameter or 
smaller on the chest x-ray film. Histologic 
examination of the lesions revealed two 
adenocarcinomas, two large-cell anaplas­
tic carcinomas and one squamous cell car­
cinoma.
None of the patients with mediastino- 
scopically proven N2 disease underwent 
further surgery. Thoracotomy in the other 
30 patients revealed multiple pleural
metastases in 2 and subaortic N2 nodal 
spread in 1 patient with a left upper lobe 
adenocarcinoma. The aorticopulmonary 
window had not been assessed surgically 
before thoracotomy. The other 27 
patients underwent curative resection for 
a resectability rate at thoracotomy of 
90%.
The overall incidence of N2 disease was 
17% in our population, being highest 
among patients with large-cell anaplastic 
carcinoma (33%) (2 of 6), followed by 
adenocarcinoma (18%) (3 of 17) and 
squamous cell carcinoma (10%) (1 of 10) 
(Table I).
Age, sex, histologic distribution of the 
lesions and the presence or absence of 
symptoms were not predictive of the final 
outcome in this small group of patients.
Discussion
Mediastinal exploration has not rou­
tinely been carried out in patients with 
small peripheral bronchogenic carci­
nomas.1-3 The overall 17% incidence of 
peripheral T1N2 lesions in this retrospec­
tive series is somewhat higher than that 
previously reported.
In 1975, Stanford and colleagues' 
noted a 6.2% incidence of N2 disease 
among peripheral lesions of various sizes 
with normal mediastinum on plain chest 
film. Subsequently, Baggs and Braun2 
reported a 4.2% incidence in 42 lesions 
3 cm or smaller in diameter. These reports 
cover the period 1967 to 1975. Adenocar­
cinoma and large-cell anaplastic carci­
noma represented only 25% and 12%, 
respectively, of the lesions in the 1975 
report. The histologic distribution of the 
lesions was not specified in the latter. In 
1979, Baker and associates3 described a 
10% incidence in a group of 40 patients 
with peripheral T1 lesions who underwent 
mediastinoscopy. Again, the overall cell- 
type distribution of the lesions was not 
stated, but three of the four N2 lesions 
were of the squamous cell type. In view 
of these reports, routine mediastinoscopy 
in patients with such small peripheral 
lesions was not considered indicated, 
since the incidence of N2 lesions found 
was low.
More recently, McKenna and 
colleagues5 noted a slightly higher inci­
dence — 13% histologically proven N2
T a b le  1— C lin ic a l T 1 N 1  B ro n c h o g e n ic  C a r c in o m a s :  C o r r e la t io n  o f  H is to lo g ic  D is t r ib u t io n  
W ith  th e  P re s e n c e  o f  M e d ia s t in a l  N o d e  M e ta s t a s e s
P re s e n c e  o f N 2  d is e a s e
C e ll  t y p e N o . N o . %
A d e n o c a rc in o m a 1 7 3 1 8
S q u a m o u s  ce ll c a r c in o m a 1 0 1 1 0
L a r g e  c e ll a n a p la s t ic  c a r c in o m a 6 2 3 3
B ro n c h o a lv e o la r  c a r c in o m a 2 - —
T o t a ls /m e a n 3 5 6 1 7
lesions in 23 patients who appeared radi- 
ologically to have T1N0 cancers.
It is likely that the relatively larger 
proportion of adenocarcinomas and 
large-cell anaplastic type (65% of our ser­
ies) accounts for the increased incidence 
of T1N2 disease we found. In a study of 
32 patients, Hutchinson6 reported a 65% 
incidence of N2 disease with peripheral 
large-cell tumours 4 cm or smaller in 
diameter, compared with 15% with 
adenocarcinoma and 0% with squamous 
cell carcinoma. Even though we describe 
lesions of smaller size, a similar trend of 
incidence according to cell type is 
observed: large-cell anaplastic 33%, 
adenocarcinoma 18% and squamous cell 
10% .
Conclusions
Our data suggest that the incidence of 
T1N2 bronchogenic carcinomas in 
patients who appear radiologically to 
have T1N0 lesions is probably higher than 
that previously reported.
In view of our results and of the poor 
outcome of patients with stage III (N2) 
lung cancer who undergo resection, we 
recommend routine preoperative medi­
astinoscopy for all peripheral T1 bron­
chogenic carcinomas. This approach is 
also suggested for suspicious T1 lesions 
of undetermined histologic type.
The finding of positive mediastinal 
nodes may prevent an unnecessary thora­
cotomy or radically alter the approach. 
One may also request further investiga­
tion for metastases in this setting. To 
avoid mediastinoscopy is to accept a 
definite incidence of N2 disease at thora­
cotomy. We feel this is not in the patient’s 
best interest. The influence of cell type is 
less clear cut. Although our series shows 
fewer N2 metastases with squamous cell 
tumours, the difference is not significant. 
Further study on larger numbers of 
patients is indicated to elucidate this 
aspect.
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A logical first choice 
for serious 
polymicrobial 
infections...
Da lac in C
Phosphate
Sterile Solution (clindamycin phosphate)
• Bacteroides fragilis and other 
anaerobes
...common pathogens in poly­
microbial infections
• Staphylococcus aureus
...the most common organism in 
post-op wound infections
to reduce the 
threat of 
post-surgical 
complications
Dalacin C Phosphate Sterile Solution
(clindamycin phosphate)
Antibiotic
Recommended Applications
Action: Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis and also by 
causing a reduction in the rate of synthesis of nucleic acids.
Indications: Dalacin C Phosphate (clindamycin phosphate) is indicated for the treatment of infections 
where the oral route is not indicated or feasible.
Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic 
bacteria, such as Bacteroides species, peptostreptococcus, anaerobic streptococci, Clostridium 
species and micro-aerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms 
(staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci) 
when the patient is intolerant of, or the organism resistant to other appropriate antibiotics.
* Superinfection is a complication of antibiotic therapy in general and is not necessarily a true side 
effect of clindamycin phosphate.
* * Due to underlying myocarditis in this patient.
Clinical and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphate* 
(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology, 
urinalysisandliverandkidneyfunctiontests. Someofthesetestswereabnormalinitiallyand returned ^  
to normal during therapy with Dalacin C Phosphate, while others were normal initially and became , 
abnormal,during therapy. Overall evaluation of clinical laboratory values in these patients does not 
indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic or rena, *  
systems. Transient elevations of serum transaminases have occured in some patients, but other liver 
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and A  
there have not been clinical signs of drug-induced hepatic toxicity.
*
Symptoms and Treatment of Overdosage: No cases of overdosage have been reported. No specific 
antidote is known. Doses as high as 1200 mg every six hours (4800 mg/day) by infusion for five days^ 
have been given without adverse effects.
Contraindications: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated in 
patients previously found to be hypersensitive to this compound, the parent compound, clindamycin, or 
clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride) has not 
been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have 
demonstrated lincomycin sensitivity.
Until further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn (in­
fants below 30 days of age), or in pregnant women.
Warnings: Some cases of severe and persistent diarrhea have been reported during or after therapy 
with Dalacin C Phosphate (clindamycin phosphate). This diarrhea has been occasionally associated with 
blood and mucus in the stools and has at times resulted in acute colitis. When endoscopy has been 
performed, some of these cases have shown pseudomembrane formation.
If significant diarrhea occurs during therapy, this drug should be discontinued or, it necessary, con­
tinued only w ith close observation. Significant diarrhea occuring up to several weeks post-therapy 
should be managed as if antibiotic-associated.
It colitis is suspected, endoscopy is recommended. Mild cases showing minimal mucosal changes 
may respondtosimpledrugdiscontinuance.Moderatetoseverecases.includingthoseshowingulcera- 
tion or pseudomembrane formation, should be managed with fluid, electrolyte, and protein 
supplementation as indicated. Corticoid retention enemas and systemic corticoids may be of help in 
persistent cases. Anticholinergics and antiperistaltic agents may worsen the condition. Other causes 
of colitis should be considered.
Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a principal 
cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this 
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg of vanco­
mycin were administered orally four times a day tor 5 -1 0  or more days, there was a rapid ob­
served disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea.
It should be noted that serious relapses have occurred up to one month after apparently successful 
treatment. A relatively prolonged period of continuing observation is therefore recommended.
Precautions: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed with 
caution in atopic individuals. Dalacin C Phosphate must be diluted for intravenous administration. 
(See Dosage and Administration)
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly 
yeasts. Should superinfections occur, appropriate measures should be taken as dictated by the 
clinical situation.
As with all antibiotics, perform culture and sensitivity studies in conjunction with drug therapy.
Since abnormalities of liver function tests have been noted occasionally in animals and man, periodic 
liver function tests should be performed during prolonged therapy. Blood counts should also be 
monitored,during extended therapy.
Dalacin C Phosphate may be used in anuretic patients. Since the serum half-life of clindamycin in 
patients with impaired hepatic function is greater than that found in normal patients, the dose of 
Dalacin C Phosphate should be appropriately decreased. Hemodialysis and peritoneal dialysisare not 
effective means of removing the compound from the blood. Periodic serum levels should be deter­
mined in patients with severe hepatic and renal insufficiency.
Adverse Reactions: Local
(a) Intramuscular Injections: Of 404 patients treated with Dalacin C Phosphate (clindamycin 
phosphate) intramuscularly (with a solution containing 150 mg/ml), six (1.5%) demonstrated local 
reactions as follows: Two complained of pain at the injection site, two demonstrated induration at 
the injection site and two developed sterile absesses.
(b) Intravenous Infusions: Of 192 patients treated with Dalacin C Phosphate by intravenous infusion, 
14 (7.3%) demonstrated local reactions. Eleven patients developed superficial thrombophlebitis and 
one patient developed both superficial and deep thrombophlebitis. The majority of these cases 
developed in conjuction with the useof indwelling I.V.cathetersand it isdifficulttoknow how much the 
drug contributed to the irritation. Two patients developed localized erythema, swelling and pain at 
the site of the infusion.
Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin 
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as follows:
Number o f Patients
Rash.............................................................................................................................................................  7
Urticaria......................................................................................................................................................... 1
Pruritus.........................................................................................................................................................  '
Fever, Leucocytosis..................................................................................................................................... 1
Nausea, with or withoutvom iting.............................................................................................................  1
Diarrhea (See also under ' Warnings')........................................................................................................ 4
Hypotension.................................................................................................................................................  1
Hypertension................................................................................................................................................  1
Shortness of Breath.................................................................................................................................... 1
Superinfection' ...........................................................................................................................................  4
Cardiac a rres t**.......................................................................................................................................... 1
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DOSAGE AND ADMINISTRATION
Adults
K
Intramuscular Injection: 600 mg/day in 2 equal doses.
Moderately severe infections: 600 to 1200 mg/day in 2 or 3 equal doses.
Severe infections: 1200 to 2400 mg/day in 2 ,3  or 4 equal doses. Intramuscular injections of more tharrt- 
600 mg into a single site are not recommended.
Intravenous Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted prior to -* 
I.V. administration to a dilution of 300 mg in 50 mL of diluent (6mg/mL) or more, and infused in not less 
than 10 minutes. Administration of more than 1200 mg inasingle 1 hourinfusion is not recommended A  
Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.
Moderately severe infections: 900 to 1800 mg/day by continuous drip or in 2 or 3 equal doses, each A 
infused over 20 minutes or longer.
Severe Infections: 1800 to 2700 mg/day by continuous drip or in 3 or 4 equal doses, each infused over*
20 minutes or longer. In life-threatening infections, doses of 2700 to 4800 mg/day by continuous drip or 
in 3 or 4 equal doses each infused over 20 minutes or longer may be given.
Dilution and infusion rates: y .
Dose Diluent Time ir —
300 mg 50 mL 10 min.
600 mg 100 mL 20 min.
900 mg 150 mL 30 min.
1200 mg 200 mL 45 min.
Alternatively, drug may be administered in the form of asingle rapid infusion of the first dose followed 
by continuous I.V. infusion as follows:
To maintain serum Rapid Maintenance 4
clindamycin levels infusion rate infusion rate
Above 4 mcg/mL 10mg/m in.for30min. 0.75 mg/min.
Above 5 mcg/mL 15mg/m in.for30min. 1.00 mg/min. 't
Above 6 mcg/mL 20mg/m in.for30min. 1.25 mg/min.
Children: (Over one month of age)
Intramuscular injection: 10 to 15 mg/kg/day in 2 ,3  or 4 equal doses.
Moderately severe infections: 15 to 20 mg/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 30 mg/kg/day in 3 or 4 equal doses.
Intravenous Administration: 4
Moderately severe infections: 15 to 25 mg/kg/day by continuous drip or in 3 or 4 equal doses, each 
infused over 20 minutes or longer. r
Severe infections: It is recommended that children be given no less than 300 mg/day regardless of body 
weight. (Dilute Dalacin C Phosphate Sterile Solution in the same manner as for adults.) *  ♦
Dilution and Compatibility:
4 mL (600 mg) Dalacin C Phosphate when diluted with 1000 mL of the following commonly used in- i  
fusion solutions was found to be physically compatible and demonstrated no significant change in pH 
or antimicrobial potency over a period of 24 hours:
Sodium chloride injection 
Dextrose 5% in water
Dextrose 5% insaline y
Dextrose 5% in Ringer’s Solution
Dextrose 5% in half-strength saline plus 40 mEq potassium chloride *  "
Dextrose 21/2% in Lactated Ringer's Solution (Hartmann's Solution)
Dalacin C Phosphate was not stable when added to Dextrose 5% in water plus vitamins. Therefore it is ** 
not recommended that Dalacin C Phosphate be mixed with any infusion solution containing B vitamins.
h
Supplied:
Dalacin C Phosphate contains the following per mL of sterile solution: ^
Clindamycin phosphate equivalent to clindamycin base 150 mg
Benzyl alcohol 5 mg *  ^
Disodium edetate 0.5 mg
Water for injection q.s. i__
When necessary the pH is adjusted with sodium hydroxide and/or hydrochloric acid to maintain a pH’~ 
range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 mL and 4 mL ampoules. *- •*
NOTE: Do not store below 15°C.
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Thoracoplasty; Its Forgotten Role in the Management 
of Nontuberculous Postpneumonectomy Empyema
The role of thoracoplasty in the manage­
ment of empyema complicating pneu­
monectomy is controversial because 
alternative techniques, such as pedicled 
muscle transplants or open-space sterili­
zation, have now replaced the conven­
tional collapse procedures.
Among 46 patients treated for post­
pneumonectomy empyema during the 
years 1975 to 1984, 17 underwent 
space-reducing thoracoplasty as the final 
step in pleural space management. Tech­
nical considerations, critical in the suc­
cess of the operation, were: (a) single- 
stage extramusculoperiosteal resection of 
the second to the seventh rib, (b) spar­
ing of the first rib to maintain integrity of 
the neck and shoulder girdle, (c) inter­
costal muscle closure of large fistulas 
and (d) adequate drainage of pleural and 
extrapleural spaces.
Immediate control of the empyema 
was obtained in 15 (88%) patients. 
Fourteen patients were alive at the time 
of follow-up (mean 4.5 years) and none 
had major thoracic deformity or residual 
infection.
Our data show that thoracoplasty is an 
excellent therapeutic option for patients 
with chronic postpneumonectomy 
empyema. Adherence to strict surgical 
principles ensures that the space is
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obliterated and the cosmetic result is 
satisfactory.
Le role de la thoracoplastie dans le traite- 
ment de I'empyeme compliquant la pneu- 
monectomie est controversy depuis que 
cette operation classique a ete supplante 
par les greffes musculaires pediculees et 
par les techniques ouvertes de sterili­
sation.
Parmi les 46 malades traites pour 
empyeme post-pneumonectomie entre 
1975 et 1984, 17 ont subi une 
thoracoplastie dans le but d'obtenir un 
controle definitif de I'espace infecte. 
Plusieurs considerations techniques sont 
jugees importantes pour realiser avec 
succes cette intervention: a) resection 
extra-musculo-periostee de la 2eme a la 
7eme cote en un seul temps operatoire, 
b) premiere cote laissee en place afin de 
maintenir I' integrite du cou et de 
I'epaule, c) fermeture par muscle inter­
costal pedicule des grosses fistules 
broncho-pleurales et d) drainage adequat 
des espaces pleural et extra-pleural.
Le controle immediat de I'empyeme a 
ete obtenu chez 15 (88%) patients. Au 
moment du suivi ulterieur (moyen de 4.5 
ans), 14 malades etaient vivants sans 
infection residuelle ou deformity thora- 
cique importante.
L'analyse de ces donnees nous permet 
de conclure que la thoracoplastie est une 
excellente option dans la therapeutique 
de I'empyeme post-pneumonectomie en 
phase chronique. L'adherence a des prin- 
cipes stricts de chirurgie et I'attention 
donnee aux details techniques previen- 
nent les echecs de traitement tout en 
assurant un resultat cosmetique satis- 
faisant.
The management of postpneumonectomy 
empyema presents a unique problem in 
view of the large infected space and high 
incidence of associated life-threatening 
bronchopleural fistulas. Although emer­
gency treatment is standardized and con­
cerned mainly with dependent thoracic 
drainage, definitive control of the infected 
space is more controversial because in 
recent years collapse procedures1’2 have
been supplanted by filling operations 
(pedicled muscle transplants)3,4 or sterili­
zation techniques.5’6
The surgical principle behind thoraco­
plasty is to collapse the chest wall over the 
mediastinum by multiple rib resections. 
Although it was originally described as a 
treatment for active tuberculosis,1 this 
concept was subsequently applied to 
management o f nontuberculous post­
resection empyemas. Over the last 30 
years collapse therapy has lost much o f  
its popularity, being referred to as 
mutilating5,7,8 and poorly tolerated by 
patients who have not yet recovered from 
their pneumonectomy.5
We report a 10-year experience with 
extramusculoperiosteal thoracoplasty for 
the elective treatment o f nontuberculous 
empyema complicating pneumonectomy. 
This study is an attempt to redefine the 
role of thoracoplasty in the modern ther­
apeutic approach to postpneumonectomy 
empyema and to review surgical princi­
ples relevant to preservation o f thoracic 
cage integrity.
Patients and Methods
Between January 1975 and December 
1984, 46 patients with documented 
nontuberculous postpneumonectomy 
empyema were treated at a regional centre 
for thoracic surgery. Although in 40 
patients the condition was diagnosed dur­
ing the early postoperative period, 6 
patients presented with a late-onset 
empyema (signs and symptoms more than 
6 months after resection).
Seventeen patients (37%) (13 men, 4 
women) underwent thoracoplasty as the 
primary treatment for permanent space 
control. The remaining 29 (63%) were 
denied definitive surgery because o f early 
death (15 patients), proven or suggestive 
cancer recurrence (11), or less than 
optimal medical status (3). The records 
of all 17 thoracoplasty patients were 
reviewed to determine indications and 
selection for surgery, safety of the proce­
dure and its adequacy as a method for 
treating postpneumonectomy empyema.
The age range of the 17 patients was 
from 39 to 70 years (mean 57.4 years).
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The underlying condition was broncho­
genic carcinoma in 12 patients and non- 
tuberculous inflammatory disease in 5. 
Management of the empyema during the 
early purulent phase included dependent 
drainage of the space, culture-specific sys­
temic antibiotic therapy and intensive 
cardiorespiratory supportive care. In 
addition, seven patients required some 
form of nutritional support during a 4- 
to 8-week period.
The sole indication for thoracoplasty 
was a persisting infected space following 
pneumonectomy for nontuberculous dis­
ease. Operative selection was based on 
adequate control of sepsis, satisfactory 
nutritional and cardiorespiratory status 
and absence of detectable recurrent car­
cinoma. The interval between diagnosis 
of the empyema and thoracoplasty was 
2 to 38 weeks (mean 10 weeks).
Seven patients had an associated bron­
chopleural fistula at the time of 
thoracoplasty but only two of the fistulas 
were considered important (more than 
2 mm of bronchial stump dehiscence).
Operative Technique
The thoracoplasty  consists of 
extramusculoperiosteal resection of a 
sufficient number of ribs to collapse and 
obliterate the pneumonectomy space 
completely. As shown by Hopkins and 
colleagues,2 adherence to strict princi­
ples, knowledge of local anatomy and 
attention to technical detail will ensure 
that the space is obliterated and the cos­
metic result is satisfactory. There are four 
basic principles in posterolateral single- 
stage thoracoplasty:
1. The operation is done through the 
original pneumonectomy incision, using 
a double-lumen endotracheal tube when 
a bronchopleural fistula is present or sus­
pected. Although classically performed in 
two or even three stages,1 thoracoplasty 
can obliterate almost any pneumonec­
tomy space in a one-stage procedure.
2. Technical considerations relevant 
to rib resections are critical if one wants 
to perform the surgery successfully. The 
second to the seventh or eighth ribs 
are resected extramusculoperiosteally. 
Sloping resection of their anterior portion 
(progressively less anterior rib being 
resected) will preserve the normal config­
uration of the anterolateral thoracic wall. 
Removal of more of the lower ribs 
does not contribute to space collapse but 
accentuates the postoperative deformity. 
Structural integrity of the neck, shoulder 
girdle and upper thorax is maintained by 
preserving the first rib (Fig. 1). To mobi­
lize the cavity lining, the periosteum over 
the rib is incised, using diathermy, and 
stripped from its superior surface. Once 
the rib is freed, the space can be collapsed 
by digital pressure. To maximize paraver­
tebral collapse, the ribs should be divided 
as far back as possible so that the resected 
specimen includes the costovertebral 
joints and sometimes part of the verte­
bral transverse processes. The chances of 
extrapleural or wound contamination are 
minimized if the cavity is collapsed 
without entering it.
3. There should be no attempt to 
close a small bronchopleural fistula since 
collapse of the chest wall over the medi­
astinum will nearly always result in spon­
taneous closure. If a large fistula is 
present, a posteriorly pedicled intercostal 
muscle flap is brought down through the 
space to cover the bronchial stump.
4. Adequate intra- and extrapleural 
drainage is mandatory. The extrapleural 
drain can be removed within 5 days of 
surgery, and the intrapleural catheter is 
progressively withdrawn (2.5 cm per 
week) over several weeks.
Results
There were no operative deaths and 
88% of the patients had a normal 
postoperative course or only minor com­
plications. Respiratory failure occurred in 
two; both were weaned off the respira­
tor after periods of 10 and 21 days.
All patients under review were followed 
up for a minimum of 1 year after 
thoracoplasty or until they died. The 
empyema was considered cured if the 
space was collapsed completely, with 
closure of any bronchopleural fistula 
present. Poor results included incomplete 
obliteration of the space, failure to close 
the fistula or persistence of a draining 
sinus for more than 2 months after 
removal of the intrapleural drain.
Immediate control of the empyema was 
obtained in 15 patients (88%). One of the 
two remaining patients had a discharging 
sinus for 3 months postoperatively while 
the second had a residual space for 15 
months but is alive and well 5 years after 
pneumonectomy.
Fourteen patients were alive at the time 
of review (mean follow-up 4.5 years) and 
none had disabling thoracic deformity or 
residual pleural infection.
Discussion
The first reported surgical attempt to 
treat empyema was that by Hippocrates9 
who performed intercostal tube and open 
drainage (Table I ' .4-5.8- 10) in young 
patients with infection of the pleural 
space.
The concept of resecting ribs to 
decrease the size of the thorax and col­
lapse the infected space was described in 
the late 19th century by Scheede and East- 
lander.10 John Alexander1 reintroduced 
these principles during the golden years 
of surgery for active tuberculosis by 
proposing a posterior extramusculoperi-
Fig. la
Fig. lb
FIG. 1—(a) Chest x-ray film and (b) photo­
graph of 53-year-old woman 6 months after 
right-sided collapsing thoracoplasty. Empyema 
space is completely obliterated without signifi­
cant thoracic cage deformity. Structural 
integrity of neck and shoulder girdle is main­
tained by retaining first rib (arrow).
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osteal approach through which he could 
close the cavity in the majority of 
patients.2 With the advent of effective 
chemotherapy for tuberculosis in the 
mid-1940s, thoracoplasty is now used 
almost exclusively for postresection obli­
teration of the empyema space.
One of the most important contribu­
tions to the management of postpneu­
monectomy empyema was the description 
by Clagett and Geraci5 of space steriliza­
tion by irrigating with half-strength 
D akin’s solution through an open 
thoracic window. Surgical closure of the 
drainage site was accomplished when the 
pleural space was considered clean and 
sterile, generally 8 to 10 weeks later. 
Stafford and Clagett11 and others12,13 
have reported success rates of 60% to 
70%, but our own experience and that of 
Shamji and associates7 has not come 
close to these results. Pro van8 was able 
to sterilize an infected postpneumonec­
tomy space in two patients by using 
thoracic catheters to drain and irrigate the 
pleural space. These sterilization tech­
niques have the advantage of a signifi­
cantly low morbidity and mortality.
More recently, extrathoracic skeletal 
muscle flaps have been used to fill the 
empyema cavity and close the associated 
bronchopleural fistula. An early report by 
Miller and colleagues3 showed encourag­
ing results, but all patients with postpneu­
monectomy empyema reported by 
Pairolero and colleagues4 needed multi­
ple operative procedures (mean 4.3 per 
patient) and prolonged hospitalization.
Thoracoplasty is a major undertaking 
that presents specific advantages when 
performed in appropriately selected 
patients. Treatment failures are uncom­
mon and due to improper selection of 
patients or to violation of basic surgical 
principles noted earlier in this paper.
Selection for operation, timing of sur­
gery and preoperative preparation are all 
important considerations if good results 
are to be achieved. Figure 2 outlines the 
overall plan of management for patients 
with documented postpneumonectomy 
empyemas.
Emergency treatment is primarily con­
cerned with drainage of the dependent 
closed pleural space, aggressive cardiopul­
FIG. 2—Overall management of postpneu 
monectomy empyema.
m onary resuscitation and specific I 
antimicrobial therapy. If the patient sur­
vives the acute episode, we suggest a 
3-month waiting period during which the 
empyema cavity is irrigated daily with an 
antiseptic solution and the patient’s med­
ical status brought to an optimal level. To 
improve response to therapy and prepare 
the patient for a major surgical proce­
dure, nutritional support may be 
required. If there is no evidence of recur­
rent carcinoma, single-stage thoracoplasty 
should be considered as the next step.
In the presence of documented or sus­
pected recurrent carcinoma or if the med­
ical state is less than optimal, an open- 
window thoracostomy should be done for 
better control of local sepsis and easier 
home nursing care.
We conclude tha t extrapleural 
thoracoplasty is an excellent therapeutic 
option for management of postpneu­
monectomy empyema in the chronic 
organization stage. Selection for opera­
tion must be rigorous and should include 
careful evaluation for recurrent neoplas­
tic disease. Retention of the first rib will 
prevent major thoracic deformity.
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CANADIAN ASSOCIATION OF GENERAL SURGEONS
H . T h o m a s  W il l ia m s , m b , ch  b , fr c s , fa c s , frcsc
Presidential Address, 1986. The Future of General Surgery
The future of general surgery is assured 
provided the discipline remains flexible, 
adaptable and innovative. A strong and 
continuing emphasis on education and 
research at all levels is essential to main­
tain these qualities.
Le futur de la chirurgie generate sera 
assure en autant que la discipline sait 
conserver flexibility, capacite d'adapta- 
tion et innovation. Pour maintenir ces 
qualites. il est essentiel que I’accent soit 
mis de facon importante et continue sur 
la formation et la recherche.
I have enjoyed being on the Executive of 
the Canadian Association of General Sur­
geons from its inception. A year ago, Mr. 
Gerry Nason, executive director of the 
association, fascinated and, no doubt, 
bemused by our discussions in commit­
tee on the definition of general surgery 
and the future prospects for general sur­
geons, suggested the setting up of a task 
force to study the future of general sur­
gery, which the association asked me to 
do. First of all I needed to crystallize my 
own thoughts and, to this end, I discussed 
the matter with surgeons from many parts 
of the world. There were diverse views 
and opinions, but the experience did pro­
vide me with some insight.
Surgery may be likened to a stately 
deciduous tree with its roots deeply 
embedded in the basic sciences. The stout 
trtink has a number of fine lateral
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branches representing the other surgical 
specialties. The crown of the tree, which 
largely determines its shape, is general 
surgery; the crown is not static but is 
characterized by a slow and continuous 
change which makes it so adaptable.
There have been striking changes in 
general surgery over the last 40 years. In 
our larger hospitals, the plastic surgeons 
do most of the hand and peripheral nerve 
surgery and the management of burns; 
fractures are handled by orthopedic sur­
geons and, in some cities, head and neck 
surgery by the otolaryngologist.
These changes have been more than 
compensated for by important advances 
in surgery of the esophagus, liver, biliary 
tract, pancreas, peripheral vessels and 
the endocrine system. Furthermore, 
endoscopy, transplantation, access sur­
gery for renal failure, the management of 
multiple injuries and organization of 
trauma care have evolved, and real 
advances have been made in the under­
standing and treatment of shock and 
infection.
In 1982, the Canadian Association of 
General Surgeons adopted a definition of 
general surgery, primarily as a guide for 
developing curricula, training programs 
and examinations. But the definition was 
sufficiently broad to allow general surgery 
to adapt readily to advances in knowl­
edge, to changes in disease processes and 
to the needs of the community. In par­
ticular, the definition emphasizes a prime 
concern of general surgeons, which is the 
management of the whole patient rather 
than one area or system.
If we accept that general surgery has 
been successful in adapting to change over 
the last 40 years, how are are we to main­
tain this flexibility in the future? The 
answer, of course, is through education.
Education is the major thrust of your 
association and we have been fortunate 
in our selection of chairmen and members 
of the education committee and the three 
subcommittees concerned with under­
graduate, graduate and continuing med­
ical education.
Let us first consider undergraduate
education, at which level general surgeons 
do most of the teaching. Surgical patients 
provide excellent opportunities for clini­
cal teaching and, just as important, they 
provide experience for students to learn 
how to handle nervous, worried and even 
difficult patients and their families.
To quote Albert Schweitzer, “ L’exam- 
ple, ce n’est pas la chose principale quand 
nous voulons influence les autres: c’est la 
seule chose.” [Example is not the main 
thing in influencing others, it is the only 
thing.]
As newer disciplines in medical schools 
demand undergraduate teaching time, 
there has been a tendency across the coun­
try to erode the surgical quota. Surgeons 
are poorly represented on most curricu­
lum committees and many internists and 
even a few surgeons (especially those in 
the other surgical specialties) claim that 
the teaching of surgical principles to med­
ical students and their exposure to the 
management of surgical patients is 
unnecessary. It is, therefore, not difficult 
to understand why many medical students 
graduate with the attitude that surgeons 
are mere technicians to be directed by 
internists, an attitude that can lead to 
inappropriate consultation and unneces­
sary, expensive investigations.
We must work hard to avoid conflicts 
between the demands of the operating 
room, the bedside, the lecture room, the 
laboratory and the committee room. The 
prescription for retaining teaching hours 
and maintaining a strong influence on the 
undergraduate teaching program is to 
teach well and enjoy doing it. The Ameri­
can Society for Surgical Education was 
established with this in mind. Canada has 
a strong representation in this society so 
that each medical school has a nucleus of 
general surgical teachers who not only 
teach effectively but are actively involved 
in getting the best out of their colleagues.
Many general surgeons are well quali­
fied to teach in the basic science depart­
ments — certainly in gross anatomy and 
perhaps also in physiology and microbi­
ology. I know of a number of senior sur­
geons energetically lecturing and demon-
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strating in the anatomy laboratories who 
have considerable influence on the recep­
tive minds of first-year medical students. 
I commend this idea to the more senior 
members of the association.
There is no doubt in my mind that 
Canada has developed, over the last 40 
years, the best surgical residency training 
program in the world. A measure of 
credit must go to those who strove to keep 
this country from falling into the trap of 
a two-tiered system of medical care which 
can seriously undermine surgical training; 
this would be especially so in a relatively 
underpopulated country. We are also for­
tunate that the Royal College of Physi­
cians and Surgeons of Canada and the 
Professional Corporation of Quebec are 
responsible for both the accreditation of 
training programs and the process of cer­
tification, and this gives them unique 
powers that have always been used for the 
good of society. A number of well-known 
Canadian general surgeons contributed 
much to the evolution of these institutions 
and we are indebted to them. Time and 
again they emphasize that the surgeon is 
responsible for the decision to operate, 
for the preoperative care, the procedure 
itself, for postoperative management and 
follow-up, including an unbiased assess­
ment of the result. It may seem more con­
venient and possibly more economically 
advantageous to abrogate our responsi­
bilities in one or other of these areas — 
but we do so at our peril. To see what can 
occur, we need only look at the situation 
in some hospitals south of the border. 
Similar tendencies are evident in our 
larger hospitals, and if we do not heed 
these warnings, there is a real danger that 
surgeons will revert to the status of the 
barber-surgeons, who simply did as they 
were directed by physicians.
Our graduate education committee was 
instrumental in developing the Canadian 
Association of General Surgeons’ “ in­
training examination” which is held 
annually in February. All general surgery 
trainees in the country take this exami­
nation each year, and it has proved to be 
an excellent predictor of their perfor­
mance at the Royal College examinations. 
This committee also strongly endorses the 
advanced trauma life support course of 
the American College of Surgeons; it has 
done much to improve the standard of 
care of the seriously injured patient.
Are we training a sufficient number of 
general surgeons? In his presidential 
-address last year, Dr. Richard Railton 
clearly showed that we are not. In today’s 
economic climate there is little hope that 
governments will fund additional train­
ing positions in general surgery — even 
though they recognize a need in many 
parts of Canada.
How then can we make up any defi­
ciency? General surgeons could work 
harder and most already do so, but if they
simply spend longer hours in the operat­
ing room this can be at the expense of 
other duties and obligations. An answer 
lies in the more efficient use of working 
hours, even though this may mean higher 
costs for hospital administrations. One 
very unfortunate consequence of the 
shortage of general surgeons is that it will 
become increasingly difficult to find 
young surgeons who are prepared to work 
in smaller centres.
Continuing education is a vital activity 
of any professional association. The 
influence of scientific meetings, talks, 
journals, books, films, tapes and videos 
produces a slow but inexorable change in 
surgical practice. It is difficult for those 
engaged in active practice to appreciate 
this, but it is only too obvious to a per­
son who has been away from practice for 
a few years.
Your association has established spe­
cial committees on endoscopy, head and 
neck surgery and colorectal surgery, so 
that surgeons with a particular interest in 
these fields can have a ready focus for 
their scientific endeavours and also so 
that these areas are perceived as part of 
general surgery. Our trauma committee 
was instrumental in establishing the 
Trauma Association of Canada and is 
now charged with keeping in close touch 
with this body. More recently new com­
mittees on surgical oncology and critical 
care were struck. These special commit­
tees, working with the education commit­
tee and program committee have, this 
year and in previous years, organized a 
number of valuable postgraduate courses 
and symposia.
In arranging the scientific program, 
your program committee tries hard to 
reach a reasonable balance between the 
number of organized symposia and 
individual paper sessions, and between 
practical and scientific communications.
We rely on research, both in the clini­
cal and basic sciences, to provide new 
ideas and new concepts. Many of these 
will be gleaned from other disciplines, but 
new ideas developing within our own 
ranks are just that much sweeter. Your 
research committee has done much to 
integrate and encourage research in 
general surgery in Canada. Government 
support for surgical research has been 
declining for many years, both in Canada 
and the United States. Direct support of 
research within our membership by the 
association calls for money and provid­
ing this is a prime function of the Cana­
dian Foundation for the Advancement of 
General Surgery.
Therefore, it is only by concentrating 
on education in its widest sense, and this 
includes all forms of research, can we 
ensure that general surgery remains a flex­
ible discipline capable of adapting suc­
cessfully to the inevitable changes that the 
future holds.
As surgeons, let us continue as we have 
done in the past, striving to fulfil our 
tasks as scientists with professional abil­
ity and integrity, as human beings with 
kind hearts and high ideals, and as mem­
bers of society with honesty and effi­
ciency.
We can do so much to shape the future, 
but more by what we do than by what we 
say. ■
BOOK REVIEWS 
continued from  page 337
of the literature. On the positive side, certain 
aspects of inflammatory bowel disease that 
often receive little attention are highlighted 
here. The book is heavily biased towards 
Crohn’s disease as opposed to ulcerative colitis.
The audience for this work is limited. For 
those familiar with the literature it adds little. 
For those beginning gastroenterology, there is 
insufficient broad detail. It might be useful for 
the trainee in gastroenterology and the gas­
troenterologist in clinical practice to keep in 
touch with trends in this area. I think that there 
will be relatively few buyers at the recom­
mended price.
K .N . J e e je e b h o y , m d , frcsc
Rm. 3-302,
College Wing,
Toronto General Hospital,
Toronto, Ont.
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METHODS AND CONCEPTS IN HAND  
SURGERY. Edited by Neil Watson and 
Richard J. Smith. 357 pp. Illust. Butter- 
worth and Co. (Publishers) Ltd., London; 
Butterworth Publishers, Stoneham, Mass., 
1986. $59.95 (US). ISBN 0-407-00428-9.
This latest volume in Butterworths’ interna­
tional review series in orthopedics is coedited 
by two well-respected hand surgeons and con­
tains chapters written by international contri­
butors, all recognized authorities in their field. 
The book has been designed particularly for 
those who are not full-time hand surgeons and 
aims to provide a clear up-to-date review of 
important present-day issues in hand surgery.
The 12 chapters cover a wide range of sub­
jects, chosen because they contain areas of con­
troversy or present difficult problems: cerebral 
palsy, rheumatoid arthritis, osteoarthritis, 
Dupuytren’s disease, infections, injuries to 
skin, tendon, nerve and joint, replantation and 
the painful hand. A brief introduction, often 
reviewing historical landmarks, is followed by 
assessment and classification of the subject. 
Basic science information is included when it 
is important and this was particularly well done 
in the chapters on Dupuytren’s contracture, 
tendon injuries and nerve injuries. Diagnosis 
and management is then discussed with empha­
sis on basic principles rather than technical
confined on page 353
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Surgical Treatment of Anal Incontinence
The records of 18 consecutive patients 
operated upon for fecal incontinence 
between January 1983 and March 1986 
were reviewed. Anterior sphincteroplasty 
was performed on 11 patients with 
direct sphincter trauma. The results were 
excellent in eight, fair in two and poor in one. 
A postanal repair was performed on seven 
patients, with excellent results only in 
two, fair in four and poor in one. The 
indications for surgery and the results 
were assessed clinically and manometri- 
cally.
A careful classification of the physio­
logic and anatomic derangements of the 
anal sphincter aids in the appropriate 
selection of candidates for surgical treat­
ment. In general, anterior sphinc­
teroplasty gives good results, whereas 
results of postanal repairs are less satis­
factory. Manometry is of some use in 
providing objective measurements.
On etudie les dossiers medicaux d'une 
serie de 18 patients operes pour inconti­
nence fecale entre janvier 1983 et mars 
1986. Une sphincteroplastie anterieure 
fut pratiquee chez 11 patients souffrant 
d'une lesion directe au sphincter. 
D'excellents resultats ont ete obtenus 
chez huit patients; ils etaient moyens chez 
deux et mauvais chez un. On eut recours a 
une reparation post-anale chez sept patients 
avec des resultats excellents chez seule- 
ment deux sujets, moyens chez quatre et 
mauvais chez un. Les indications chirur- 
gicales et les resultats furent I'objet 
d’une evaluation clinique et manome- 
trique.
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Une classification soigneuse des per­
turbations physiologiques et anatomiques 
du sphincter anal aide a choisir de facon 
appropriee les candidats a un traitement 
chirurgical. En general, la sphincteroplas­
tie anterieure donne de bons resultats 
alors que ceux des reparations post- 
anales sont moins satisfaisants. La 
manometrie est d'une certaine utilite 
pour objectiver les resultats.
Although the rate of occurrence of fecal 
incontinence is difficult to obtain, it is 
likely more common than generally 
thought. Fecal soiling is a distressing 
problem and may be socially disabling. 
In most cases the problem can be 
managed nonoperatively. However, 
properly selected patients can achieve 
excellent results from appropriate 
surgery.
We present the rationale for surgical 
intervention in fecal incontinence and the 
results of our initial experience.
Method
We reviewed the hospital records of 18 
patients (17 women, 1 man) treated sur­
gically for total primary anal incontinence 
between January 1983 and March 1986. 
The mean age was 47 years (range from 
18 to 84 years). Patient assessment 
included a complete history, physical 
examination, proctosigmoidoscopy and 
anal manometry. A Narco MMS 100 digi­
tized recorder (Narco Scientific Ltd., 
Health Dyne Co., Downsview, Ont.) and 
a probe using three radially positioned 
force strain gauges were used for mano- 
metric assessment. The patients were 
divided into two groups: group 1, those 
who had anterior sphincteroplasty (11) 
and group 2, patients treated by posterior 
sphincter repair (7).
Anterior sphincteroplasty was per­
formed on six patients who had suffered 
obstetrical injuries, four with iatrogenic 
incontinence secondary to previous fistula 
surgery and one patient with congenital 
absence of 180° of anterior external 
sphincter musculature. The technique of 
sphincteroplasty was that described by
Slade and colleagues.1 It includes ade­
quate mobilization of approximately 180° 
of anterior external sphincter and scar tis­
sue followed by overlapping (Fig. 1).
Posterior repair was carried out on 
seven patients with the anatomic disorder 
described by Parks2 as primary idi­
opathic incontinence (shortened canal, 
descending perineum and flattened 
anorectal angle) (Fig. 2). This repair is 
based on plication of the puborectalis 
muscle after posterior intersphincteric dis­
section (Fig. 3).
The results were classified as excellent 
(complete continence to all forms of rec­
tal contents, solid, liquid or gas) fair (con­
tinence to solid stool) or poor (no 
improvement in continence).
FIG. 1—(a) Mobilization of external sphinc­
ter with preservation of scar (adapted from 
Goldberg SM, Gordon PH, Nivatvongs S10). 
(b) Overlapping of sphincter.
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Results
Patient follow-up ranged frpm 7 to 
40 months.
Anterior Repair
The results were excellent in 8 of the 
11 patients, fair in 2 and poor in 1. Seven 
of the eight excellent repair results were 
in patients operated on were for obstetri­
cal injury and the other in a patient who 
had incontinence as a result of previous 
fistula surgery. One fair result was 
obtained in a patient who had undergone 
a previous fistula repair and one in a 
patient who had congenital incontinence. 
The poor result was obtained in a patient 
who had undergone surgery previously 
for a fistula.
Posterior Repair
The results in two of seven patients in 
this group were excellent, fair in four and 
poor in one.
Of the two patients with excellent
FIG. 2—Idiopathic deformity described by 
Parks.2
FIG. 3—(a) Posterior intersphincteric dissec­
tion. (b) Posterior plication of puborectalis and 
levator muscles.
results, the procedure followed a prolapse 
repair in one and in the other the repair 
was the sole procedure. Major morbidity 
occurred in one patient who had an 
ascending retroperitoneal abscess and 
subsequently a pulmonary embolus.
The effects of the repairs on squeeze 
pressures determined manometrically are 
illustrated in Fig. 4.
Discussion
Anal incontinence is probably more 
common than previously believed. 
Although frequency rates are few in the 
literature, Leigh and Turnberg3 noted 
that 50% of patients who present with 
diarrhea will have associated inconti­
nence. The reluctance of patients to dis­
cuss incontinence and physicians’ lack of 
knowledge of the condition are likely rea­
sons for underestimating the frequency of 
this disease.
An understanding of the physiology of 
normal continence and defecation and a 
good classification system for inconti­
nence are necessary for accurate diagno­
sis and treatment of associated disorders. 
Normal anorectal competence is based 
upon three components — the storage 
capacity of the rectum, sensory mechan­
isms and sphincter function. Patients may 
be classified as having total or partial, 
primary or secondary incontinence. 
Causative factors for primary inconti­
nence include reduced rectal capacity, 
sphincter trauma, anorectal anatomic 
changes and neurogenic disorders. Secon­
dary incontinence results from systemic 
diseases or psychogenic conditions that 
overcome the threshold of competence in 
the face of “ normal” continence 
mechanisms.4' 7
The majority of patients do not need 
surgical treatment. Partial incontinence, 
primary incontinence due to reduced rec­
tal capacity, neurogenic disorders and 
secondary incontinence are best treated by
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FIG. 4—Preoperativc and postoperative 
ranges of manometric results, not statistically 
significant.
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FIG. 5—Algorithm for surgical treatment of 
fecal incontinence.
dietary manipulation, drug therapy and 
biofeedback training.8 Electrical stimula­
tion is reserved for refractory cases.9 
Surgery is recommended for patients who 
have mechanical sphincter or anatomical 
anorectal disorders. An algorithm for 
treatment is presented in Fig. 5.
The excellent results of anterior sphinc­
teroplasty in the present study are con­
sistent with the overall 80% success rates 
reported in the literature.1 The proce­
dure requires meticulous mobilization of 
the remaining undamaged anterior 
sphincter without injuring the pudendal 
nerves. Preservation of the fibrous mid­
line scar is vital for a good result.10
Patients with anatomic derangements, 
as described by Parks, are treated by 
posterior sphincter repair. Although he 
has reported excellent results, our 
experience is otherwise. This repair is 
designed to restore the anorectal angle 
and plicate the puborectalis muscle. If 
procidentia coexists, repair of the 
prolapse, usually transabdominally, 
should be performed first as this will 
restore continence in about 50% of 
patients.11
We suggest that improved patient selec­
tion is necessary to elevate the results of 
posterior sphincter repair to those of 
anterior repair. Various methods of 
assessment have been tried to assist in 
selection; electromyograms in various for­
mats (conventional needle electrode and 
single fibre) have been used in assessing 
continence.12 We have not found elec­
tromyograms particularly helpful in selec­
tion. Defecography has recently been 
described as having some discriminating 
value in defecation disorders.13 This 
modality may prove of future value, par­
ticularly in selecting patients for postanal 
repair. Our present ability to interpret 
defecograms is inadequate as a basis for 
clinical decisions. Manometric studies in 
our hands are of some use in document­
ing changes in sphincteric pressures, but 
not in affecting clinical decisions.
Conclusions
A sound understanding of anorectal 
physiology allows the physician to assess 
and classify properly patients with anal 
incontinence. When performed for the 
appropriate indications, anterior sphinc­
teroplasty is an excellent procedure. 
Although patients with primary idi­
opathic incontinence may benefit from 
posterior sphincter repair, results are less 
favourable than for anterior sphinc­
teroplasty.
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Should Cholecystectomy Be Done En Passant 
for Asymptomatic Cholelithiasis?
The management of asymptomatic gall­
stones discovered during abdominal sur­
gery is controversial. Should 
cholecystectomy be performed en 
passant? The authors report a 4-year sur­
vey of 109 patients with asymptomatic 
cholelithiasis who underwent surgery for 
other abdominal conditions: colorectal 
(31), gastric (24), vascular (20), gyneco­
logic (21) and miscellaneous (13). 
Cholelithiasis was established preopera- 
tively by ultrasonography in 52 of 55 
examinations (9 5 % ). In the other 54, the 
gallstones were discovered at operation. 
Cholecystectomy was performed in 78 
patients and in 31 the gallbladder was 
left in place. In the former group, 11 
(1 4 % ) had complications, 2 being 
attributable to the cholecystectomy. 
Intraoperative cholangiograms were 
obtained in 43 and led to common-bile- 
duct explorations in 8. Common-bile-duct 
stones were found in seven. In the non- 
cholecystectomized group, three died 
postoperatively and three were lost to 
follow-up. Twelve of the remaining 25 
are still asymptomatic and 13 have had 
symptoms: 7 underwent cholecystec­
tomy (4 for acute cholecystitis) between
From the Department o f  Surgery, Univer­
sity de Montreal, the Division o f  Gastroin­
testinal Surgery and Division o f  Vascular 
Surgery, Hopital Saint-Luc, Montreal, PQ
Presented at the 9th annual meeting o f  the 
Canadian Association o f  General Surgeons, 
held in conjunction with the 55th annual 
meeting o f  the Royal College o f  Physicians 
and Surgeons o f  Canada, Toronto, Ont., 
Sept. 23, 1986
Accepted fo r  publication Jan. 6, 1987
Reprint requests to: Dr. Denis Bernard, 
Departement de chirurgie, Hopital Saint- 
Luc, 1058, rue Saint-Denis, Montreal, PQ 
H2X 3J4
2 weeks and 11 months after the initial 
laparotomy. Because of the low mor­
bidity and the relatively high number of 
cholecystectomies that were subse­
quently necessary, the authors recom­
mend cholecystectomy en passant 
unless there is a specific contraindica­
tion. They also recommend ultrasonogra­
phy before major gastrointestinal or vas­
cular surgery in order to plan for 
cholecystectomy.
La conduite a tenir face a une choleli- 
thiase asymptomatique rencontree en 
cours de laparotomie pour une autre 
pathologie pose le dilemme suivant: doit- 
on enlever la vesicule biliaire ou est-il 
preferable de la laisser en place? Les 
auteurs rapportent une etude de 4 ans 
portant sur 109 patients avec une chole- 
lithiase asymptomatique chez lesquels 
une chirurgie abdominale a ete pratiquee 
pour pathologie colo-rectale dans 31 cas, 
gastrique dans 24, vasculaire dans 20. 
gynecologique dans 21 et d’autres 
pathologies chez 13 autres. L'echogra- 
phie preoperatoire avait demontre la pre­
sence de lithiases dans 52 des 55 exa- 
mens faits (95% ). Chez les 54 autres les 
calculs ont ete decouverts a ('interven­
tion. Soixante dix-huit patients ont subi 
une cholecystectomie et la vesicule 
biliaire a ete laissee en place chez 31 
autres. Dans le premier groupe, 11 
(14% ) ont eu des complications postope- 
ratoires dont 2 directement reliees a la 
cholecystectomie. Une cholangiographie 
preoperatoire a ete faite chez 43 et a 
conduit a une exploration des voies biliai- 
res chez 8 dont 7 avaient des calculs 
des voies biliaires. Dans le groupe de 
patients non chol6cystectomises il y eut 
trois deces postoperatoires et trois 
autres patients ont ete perdus de vue. 
Des 25 autres, 12 demeurent asympto-
matiques et 13 devinrent symptomati- 
ques: 7 ont subi une cholecystectomie 
dont 4 pour cholecystite aigue dans un 
intervalle de 2 semaines a 11 mois apres 
la chirurgie initiate. A moins qu'une 
contre-indication soit presente les 
auteurs recommandent done une cho­
lecystectomie "en passant" se basant 
sur la faible morbidity et sur le pourcen- 
tage relativement eleve de patients chez 
qui une cholecystectomie est devenue 
indiquee par la suite. Ils recommandent 
egalement qu'une echographie preopera­
toire a la recherche de cholelithiase soit 
pratiquee avant toute chirurgie gastro­
intestinal ou vasculaire afin de prevoir si 
une cholecystectomie est requise.
Cholecystectomy remains one of the most 
common abdominal operations in North 
America1 and its value as a cure for 
symptomatic gallstones has stood the 
test o f time.2 The need for cholecys­
tectomy in asymptomatic persons is 
controversial3 as is the advisability of 
removing a diseased gallbladder disco­
vered incidentally during laparotomy, 
because of the increased risk to the 
patient.4 Several investigators have 
recently reviewed the question of con­
comitant cholecystectomy and have 
reported no notable added morbidity.5”12 
On the other hand, few authors have 
addressed the issue of leaving a diseased 
gallbladder in place during laparotomy 
for another condition and the subsequent 
course of these patients relative to their 
biliary disease.5,10,n
Our study addressed two questions.
• Does cholecystectomy en passant 
increase the risk of the main operation?
• How many patients will eventually 
require another operation for biliary 
problems if the gallbladder is left in 
place?
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Patients and Methods
The charts of patients with cholelithi­
asis who underwent laparotomy during 
the 4-year period from January 1981 to 
December 1984 were reviewed retrospec­
tively. We excluded patients in whom 
acute or chronic cholecystitis was the indi­
cation for surgery, also those operated on 
for liver or pancreatic disorders, because 
cholecystectomy is often part of the 
procedure, and patients in whom previ­
ous symptoms of pain from gallbladder 
disease could be elicited. Left were 109 
patients with asymptomatic cholelithiasis 
who had undergone abdominal surgery 
for another condition. There were 34 men 
and 75 women with a mean age of 61 
years (ranging from 30 to 87 years). 
Colorectal disease was the most common 
indication for surgery (31 cases). The 
other conditions were: gastric, including 
hiatus hernia (24), gynecologic (21), vas­
cular (20), urologic (6), small intestinal (3) 
and miscellaneous (4) (Table I).
The study was bipartite. First, we exa­
mined the outcome of 78 patients (group 
1) who underwent concom itant 
cholecystectomy (Table I). Then we con­
ducted a follow-up study of the 31 
patients (group 2) in whom the surgeon 
elected not to remove the gallbladder 
(Table I). In group 1, the results of 
preoperative abdominal ultrasonography 
were obtained for 45 patients and the 
presence of gallstones was identified in 
43. In the other two and also in the 33 
who did not undergo ultrasonography, 
cholelithiasis was diagnosed intraopera- 
tively by palpation. In group 2 patients 
ultrasonography demonstrated stones in 
9 out of 10 cases; in the other 22, the 
presence of stones was established at 
operation (Table II).
Results
Group 1
The in-hospital death rate was 5% (4 
of 78). The causes of death were pneu­
monia, sepsis from anastomotic leakage, 
myocardial infarction and metastatic car­
cinoma, none of which could be directly 
related to the cholecystectomy. Compli­
cations occurred in 11 patients (14%) 
(Table III). Two complications were 
directly related to the cholecystectomy: 
bleeding from the gallbladder bed in one 
and stricture of the second portion of the 
duodenum in another patient who also 
underw ent transduodenal sphinc­
teroplasty. Both patients underwent 
reoperation and subsequently have done 
well. Intraoperative cholangiograms were 
obtained in 43 (55%) and led to common- 
bile-duct exploration in 8. Stones were 
recovered in seven, including the one who 
needed transduodenal sphincteroplasty.
Group 2
The reasons why the surgeon elected 
not to do the cholecystectomy in 31 
patients are listed in Table IV. Follow-up 
was available in 25 of them, 3 died 
postoperatively and the other 3 were lost 
to follow-up. Twelve of the 25 are free 
of gallbladder symptoms; 13 (52%) 
became symptomatic between 2 weeks 
and 2 years after their operation, 
although not during their initial hospital 
stay. Cholecystectomy was performed in 
7 of the 13 between 2 and 11 months after 
the initial operation: in 4 for acute 
cholecystitis, in 1 for acute biliary pan­
creatitis and in 2 for attacks of biliary 
colic.
Discussion
The decision to undertake chole­
cystectomy when gallstones are dis­
covered during an operation for an 
unrelated condition is not always easy. 
The obvious benefit to the patient is 
avoidance of biliary symptoms or com­
plications later, so eliminating the risk 
and inconvenience of another operation. 
If this sequence of events was common 
there would be very little controversy. On 
the other hand, the addition  of 
cholecystectomy to a major surgical 
procedure in an elderly patient may 
present technical difficulties, prolong 
operating time and be associated with an 
increased mortality and morbidity. This 
set of events could occur in people who 
may never have symptoms from their 
cholelithiasis.
In recent years several authors have 
addressed the problem of concomitant 
cholecystectomy in relation to its 
increased risk and morbidity. The results 
of nine of these studies are summarized 
in Table V.5' 13 Biggers and colleagues,7 
Kovalcik and colleagues9 and Shennib’s 
group13 reported no complications from 
cholecystectom y. Biggers studied 
cholecystectomy in association with colec­
tomy (242 patients at the Mayo Clinic)7 
and commented that there was no differ­
ence in mortality and morbidity from 
patients having undergone colectomy 
alone at the same institution.14,15 Specific 
complications arising from the biliary 
procedure are recorded in only 10 (1.5%) 
of the total o f 681 concom itant 
cholecystectomies from the studies listed 
in Table V, including ours.
Cholecystectomy at the time of vascu­
lar reconstruction, using prosthetic 
material, adds a different dimension to
T a b le  I - ■ N a tu re  o f  S u r g e r y
M a in  p ro c e d u re
T o t a l  n o . 
o f  p a t ie n t s G ro u p  1 G ro u p  2
C o lo re c t a l 31 2 7 4
G a s tr ic 2 4 2 3 1
G y n e c o lo g ic 21 1 2 0
V a s c u la r 2 0 18 2
U ro lo g ic 6 5 1
In te s t in a l 3 — 3
O th e r* 4 4 -
T o t a l s 1 0 9 7 8 31
' A b d o m in a l ly m p h o m a  1, v e n t r a l  h e r n ia  2 , a p p e n d e c to m y  1.
T a b le  I I— D ia g n o s is  o f  C h o le lit h ia s is
P r e o p e ra t iv e T o t a l  n o . G ro u p  1 G ro u p  2
u lt r a s o n o g r a p h y o f  p a t ie n t s (n -  7 8 ) (n =  3 1 )
D o n e 5 5 4 5 10
S to n e s 5 2 4 3 9
N o  s to n e s 3* 2 1
N o t  d o n e 5 4 * 3 3 21
' D ia g n o s is  e s ta b lis h e d  i n t r a o p e r a t iv e ly  b y  p a lp a t io n  o f  th e  g a llb la d d e r.
T a b le  I l l - M o r b i d i t y  in  11 G r o u p  1 P a t ie n t s
C o m p lic a tio n
N o . o f  
p a t ie n t s
Il io f e m o ra l  a rt e r ia l  th r o m b o s is 3
W o u n d  d e h is c e n c e 2
In t r a o p e r a t iv e  s p le n ic  t r a u m a 2
T r a u m a t i c  e n t e r o t o m y 1
In f e c t io n  a ro u n d  g a s t r o s t o m y  tu b e 1
H e m o rr h a g e  f r o m  g a llb la d d e r b ed 1
D u o d e n a l s t r i c t u r e 1
T a b le  I V — R e a s o n s  f o r  N o t  D o in g  th e  
C h o l e c y s t e c t o m y  in G ro u p  2
R e a s o n
N o . o f  
p a t ie n t s
In a p p ro p ria te  in c is io n 19
E m e r g e n c y  p ro c e d u re 3
L iv e r  m e t a s t a s e s 2
T o o  m a n y  a d h e s io n s 1
S t o n e s  n o t p a lp a te d 1
C ir r h o s is  a n d  a s c it e s 1
O ld  a g e 1
N o t  s ta t e d 3
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the risk factor — potential graft infection 
by contamination from hollow viscus. 
Thom as and colleagues8 compared 
results of nonvascular procedures, 39 of 
which were cholecystectomies, at the time 
of 76 aortoiliac reconstructions with those 
of 43 vascular procedures alone and 
found no difference in mortality (9% 
versus 8.5%) and little difference in mor­
bidity (17% versus 9.6%) in the two 
groups. However, O uriel and 
colleagues10 reported one instance of late 
graft infection among 18 patients who 
underwent abdominal aortic resection and 
concomitant cholecystectomy. In this 
case, the operation was performed for a 
ruptured aneurysm, the retroperitoneum 
was not closed over the graft until after 
the cholecystectomy, the gallbladder bed 
was not closed, external drains were used 
and a gastrostomy tube was put in place, 
providing several other risk factors for 
infection in addition to the cholecystec­
tomy. String12 reviewed his experience 
with 250 abdominal aortic reconstruc­
tions. Concomitant cholecystectomy was 
performed in 16 with no subsequent graft 
infection. Ameli and associates16 
reported no graft infections in 56 patients 
who underwent combined cholecystec­
tomy and abdominal aortic surgery. Not­
withstanding the specific risk of late graft 
infection, most vascular surgeons8’10,12,16 
have recommended that concomitant 
cholecystectomy be performed unless 
acute cholecystitis is present10 or 
common-duct exploration is needed. In 
the former situation, cholecystectomy 
should be performed and the vascular 
procedure deferred10 and in the latter, 
the biliary procedure is best omitted at the 
time of the vascular reconstruction. 
Specific situations when cholecystectomy
en passant should be discouraged include 
emergency laparotomy for acute condi­
tions,13 inappropriate incision,11 exten­
sive dissection for exposure, patient 
instability5 and preterminal or terminal 
conditions.11
The outcome in patients with cholelithi­
asis who did not have cholecystectomy is 
less well documented. Biliary problems 
may occur early or late in the postopera­
tive period. Some authors studied series 
of acute cholecystitis occurring in the 
early postoperative period.17-19 Ottinger17 
in a review of 40 cases reported a high 
incidence of acalculous disease (35%) and 
a high death rate (42%). Bell and 
Holubitsky18 mentioned one death in 26 
patients, 20% of whom had acalculous 
cholecystitis. Gately and Thomas19 also 
mentioned one death in 17 cases of 
cholecystitis, 62% of which were acal­
culous. So it seems that the etiology of 
early postoperative cholecystitis might be 
different because of the greater number 
of men than women — 1.2:1 in Ottinger’s 
study17 and 2.4:1 in Gately’s19 — and of 
the high percentage of acalculous 
cholecystitis. Factors such as fasting, 
dehydration, ischemia, narcotics, blood 
transfusions, anesthesia, positive-pressure 
ventilation and use of total parenteral 
nutrition20 have been incriminated. In 
our study, no biliary problems occurred 
in the immediate postoperative period. In 
the aforementioned reports, stones were 
present in the majority of gallbladders, 
representing the most common factor, for 
which prevention could have been 
achieved by concomitant cholecystec­
tomy had the cholelithiasis been recog­
nized at the time of the initial surgical 
procedure. Few studies have examined the 
long-term outcome of undisturbed
cholelithiasis after an abdominal opera­
tion and the incidence and nature of late 
biliary problems.5,10,11 G rade’s3 and 
Ransohoff’s21 studies are widely quoted 
for the low incidence of biliary problems, 
with the passage of time, in an asympto­
matic population with demonstrated gall­
stones. From these studies which con­
tained a very high proportion (89%) of 
men under 60 years of age (mean 54 years) 
it would be difficult to conclude that con­
comitant cholecystectomy should not be 
performed. Our study and those of others 
(Table V) have shown that cholelithiasis 
is found incidentally, usually in older 
women being subjected to major abdomi­
nal surgery. Most of the time the gallblad­
der is easily removed with little additional 
operating time and trauma. In Thomson’s 
study,11 cholecystectomy was not per­
formed in 23 patients with cholelithiasis 
found incidentally; biliary problems 
including acute cholecystitis (11), jaundice 
(2) and symptomatic cholelithiasis (3) 
developed within 6 months. One patient 
died and three suffered postoperative 
complications. Schreiber and associates5 
studied 44 patients in whom cholelithia­
sis was found incidentally; in only 4 was 
the gallbladder left in place. One of them 
required emergency cholecystectomy on 
postoperative day 8. Ouriel and 
colleagues10 studied 11 patients operated 
on for abdominal aortic aneurysm in 
whom cholelithiasis was found inciden­
tally and the gallbladder was not 
removed. Nine eventually had biliary 
problems, in the early postoperative 
period in two. In String’s report,12 gall­
stones were retained in 17 patients; 11 
(65%) later had symptoms and 9 (53%) 
required cholecystectomy from 2 weeks 
to 108 months after the vascular proce-
Table V—Mortality and Morbidity of Concomitant Cholecystectomy
Series
Type of 
surgery
No. of
cases 
(n = 681)
Mean
age,
yr
Mortality,
%
Complications,
%
Cholecystectomy-
related
complications
(no.)
Schreiber and associates, 19785 Abdominal 39 78 0 16 Bile leak (1)
McSherry and Glenn, 1981® Abdominal 137 62 7 15 Bile leak (1) 
Retained CBD 
stones (2)
Biggers and associates, 19827 Colorectal 242 NS 0.8* 2* None
Thomas and associates, 1983s Vascular 39 64 9t 17t Pancreatic 
pseudocyst, hernia 
(drain site) (1)
Kovalcik and associates, 19839 Abdominal 54 NS 2 20 None
Ouriel and associates, 198310 Aortic
aneurysm
18 67 6 6 Late graft 
infection (1)
Thompson and associates, 1984" Abdominal 33 > 6 0 3 27 Subphrenic 
abscess (1)
String, 198412 Vascular 16 NS 6 0 None
Shennib and associates, 198613 Colorectal 25 69 12 0 None
Present study Abdominal 78 61 5 14 Bleeding (1)
Duodenal 
stricture (1)
*No difference with colectomy alone. 
tNo difference with vascular procedure alone. 
NS -  not stated, CBD = common bile duct.
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dure (7 within the first year). In our 
follow-up study of 25 patients, 13 became 
symptomatic even though our follow-up 
was relatively short and cholecystectomy 
was performed in 7 (28%) of the 25 within 
11 months. These secondary operations 
could have been prevented had cholecys­
tectomy been done at the time of initial 
procedure, especially if we consider that 
many of these were emergency procedures 
for acute cholecystitis and that the death 
rate from cholecystectomy for acute 
cholecystitis in people over 60 years of age 
is 9.8% compared with 5% for chronic 
cholecystitis.21-24
Finally, asymptomatic gallstones are 
discovered with increasing frequency by 
abdominal ultrasonography performed 
during work-up for other abdominal 
problems such as aortic aneurysm, liver 
screening for metastasis from gastrointes­
tinal tumours and almost all gynecologic 
and kidney problems. In our study there 
was a recognition of gallstones preoper- 
atively in 48% of patients. Ultrasonog­
raphy achieved a sensitivity of 95%. 
Preoperative knowledge of gallstones is 
valuable23 to allow discussion with the 
patient, to obtain consent,9,11 and to 
plan an appropriate incision, adequate 
operative time and proper instrumenta­
tion, including possible intraoperative 
cholangiography and perhaps the availa­
bility of a general surgeon when the oper­
ator is not familiar with biliary surgery.
In conclusion, we recommend that 
cholecystectomy en passant for cholelithi­
asis found incidentally be performed dur­
ing laparotomy for other conditions, 
unless specific contraindications are 
present. Low morbidity related to the 
cholecystectomy supports such an atti­
tude. In a substantial number o f people 
concomitant cholecystectomy will prevent 
further problems that could result from 
the presence o f untreated cholelithiasis. 
The widespread use of ultrasonography 
as part o f the work-up for several other 
conditions should be encouraged and 
oriented toward the status of the gallblad­
der to determine the presence or absence 
of unsuspected lithiasis.
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continued from page 347
details of specific methods. Throughout each 
chapter, authors concentrate on explaining the 
issues in controversial areas and have managed 
to bring together a large amount of informa­
tion that previously was scattered through the 
medical literature. It was pleasing to see a chap­
ter devoted to the painful hand as this presents 
great difficulty in daily practice. This section 
could have probably been enhanced, however, 
by extending the discussion on the diagnosis 
of wrist pain.
The book is well illustrated with good qual­
ity black-and-white photographs and clear line 
drawings. The liberal use of subheadings 
produces a format that is easy to follow. The 
text successfully uses lists and summaries to 
emphasize important issues and options and 
is written in a style that is lively and interest­
ing. The reference section is particularly impor­
tant in this type of publication, and 1 was 
impressed with the excellence of the reference 
lists in this volume.
In conclusion, this volume achieves its aim 
of complementing standard textbooks by 
providing an up-to-date review of key issues 
in hand surgery. It can be highly recommended 
to those wishing to keep abreast of current 
thinking in this rapidly evolving specialty. All 
surgeons with an interest in hand surgery, 
whether primarily orthopedic, plastic or 
general, will find this book useful. They will
enjoy reading it and will find great interest in 
the discussion of controversial areas.
V a u g h a n  Bo w e n , m b , c h  b , f r c s c
Department of Orthopedics,
University Hospital,
University of Saskatchewan,
Saskatoon, Sask.
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MITRAL VALVE DISEASE. Diagnosis and 
Treatment. Edited by Marian I. Ionescu 
and Lawrence H. Cohn. 368 pp. Ulust. But- 
terworths and Co. (Canada), Ltd., Scar­
borough, Ont. 1985. Price not stated. ISBN 
0-407-00267-7.
This authoritative textbook has been written 
by a number of well-known experts on the 
pathophysiology and surgical treatment of 
mitral valve disease. The book is divided into 
four sections.
The first section is devoted to the anatomy, 
physiology and pathology of the mitral valve. 
Noninvasive and invasive investigations cur­
rently used for the diagnosis of mitral valve dis­
ease are described in a lucid manner.
The next two parts of the book deal with the 
techniques of conservative mitral valve surgery 
and mitral valve replacement using a variety 
of prostheses.
The chapters on the conservative surgical 
management of mitral valve disease are excel­
lent and give good descriptions of closed and 
open mitral valvotomy. The various types of
mitral valve annuloplasty are discussed in 
detail. The text is a little deficient insofar as 
it does not deal in detail with the various tech­
niques of chordal shortening, resection of 
redundant valvular tissue and repair of rup­
tured papillary muscle.
The section devoted to prosthetic mitral 
valve replacement consists of discussions of the 
results achieved with a variety of mitral 
prostheses. Although each chapter is excellent 
and authoritative, the data presented do not 
permit true comparisons between one type of 
prosthesis and another.
The final part of the book describes the par­
ticular problems of rheumatic mitral valve dis­
ease in children, congenital mitral valve disease 
and the complications of mitral valve replace­
ment. The chapters are excellent and provide 
up-to-date and useful knowledge.
This book provides an excellent overview of 
mitral valve disease. It is principally of interest 
to cardiologists, cardiac surgeons and students 
of those specialties. It is somewhat expensive 
but would be a useful addition to a medical 
library.
J .  GUNSTENSEN, MB, CH B, FRCS(EDIN),
FRCSC
HGH -  McMaster Clinic,
Hamilton General Hospital,
237 Barton St. E,
Hamilton, Ont.
L8L 2X2
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ROYAL COLLEGE SYMPOSIUM
4
Symposium on Alternatives to Ileostomy in Ulcerative Colitis
P .H . G o r d o n , m d , fr c sc , facs
1. Introduction
Symposium presented at the 54th annual 
meeting o f  the Royal College o f  Physicians 
and Surgeons o f  Canada by the Royal Col­
lege in cooperation with the Canadian 
Association o f  General Surgeons, Vancou­
ver, BC, Sept, fl, 1985
Accepted fo r  publication Jan. 27, 1987
Correspondence to: Dr. P.H. Gordon, 
Department o f  Surgery, The Sir Mortimer 
B. Davis-Jewish General Hospital, 3755 
Cote Ste-Catherine, Montreal, PQ  
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Over the past decade the type o f opera­
tion offered to patients suffering from the 
intractable symptoms associated with 
ulcerative colitis has evolved. Until 
recently, when there has been a surge o f 
enthusiasm for pelvic reservoirs, the gold 
standard against which other procedures 
were compared was total proctocolec­
tomy and Brooke ileostomy. Is there still 
a place for this operation and, if so, what 
is its current status and its future? What 
are the roles o f  total abdominal colectomy 
and ileorectal anastomosis and continent 
ileostomy? What are the merits o f the
different types o f pelvic reservoirs and 
what might be the immediate and long­
term physiologic and metabolic conse­
quences o f the establishment o f intra­
abdominal reservoirs?
The assembled panel o f speakers for 
this symposium includes leaders in the 
field o f colon and rectal surgery, in par­
ticular, inflammatory bowel disease. They 
have acquired a great deal o f  experience 
in managing patients with ulcerative coli­
tis. They have been asked to share their 
experience with you and try to answer 
these questions.
Br ia n  M o r g a n , m d ; D a v id  G le n n , m d ; C h ris  V ic k e r s , m d
»
' t
2. Colectomy and Ileostomy in the Management of
Ulcerative Colitis
For 3 0  years, co lectom y w ith  ileostom y 
has been the m ainstay o f the surgical 
trea tm e n t fo r ulcerative colitis. Between 
1963  and 1985, 535  patients w ith  
in flam m ato ry  bow el disease were adm it­
ted to  the  Royal Prince A lfred  Hospital in
From the Department o f  Surgery, Royal 
Prince Alfred Hospital, Sydney, Australia
Presented as part o f  a symposium on alter­
natives to ileostomy in ulcerative colitis, at 
the 54th annual meeting o f  the Royal Col­
lege o f  Physicians and Surgeons o f  
Canada, by the Royal College in coopera­
tion with the Canadian Association o f  
General Surgeons, Vancouver, BC, Sept. 
11, 1985
Accepted fo r  publication Jan. 27, 1987
Reprint requests to: Dr. Brian Morgan, 
Royal Prince Alfred Hospital Medical 
Centre, 100 Carillon A ve., Newtown 2042, 
Australia
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Sydney, Austra lia ; 471 had ulcerative 
co litis  and 6 4  C rohn's colitis. One 
hundred and e ight-s ix o f these patients 
underw ent co lonic resection. The propor­
tion  of patients w ho  underw ent surgery 
was the same fo r both disorders. There 
have been no deaths resulting from  the 
surgical m anagem ent o f inflam m atory 
bow el disease at our hospital since 
1965. These patients should be treated 
safely by standard means before the 
more elaborate sphincter-saving proce­
dures, currently recommended, are tried.
Depuis 30 ans, la colectom ie avec ileos- 
tom ie  est le standard du tra item ent chi- 
rurgical de la co lite  ulcereuse. De 1963 a 
1985, 535 malades sou ffran t d'une 
pathologie in flam m atoire  de I'in testin  ont 
ete recus au Royal Prince Alfred Hospital 
de Sydney en Australie; 471 avaient une
colite ulcereuse et 64  une maladie de 
Crohn. Cent quatre-vingt-six patient* ont 
subi une resection colique. Le pourcen- 
tage des malades qui ont passe a la chi- 
rurgie e ta it le meme pour les deux a ffec­
tions. Depuis 1965, on n 'a  enregistre a 
notre hopita l aucun deces attribuable au 
tra item ent chirurgical des pathologies 
intestinales inflam m atoires. Ces patients 
do ivent etre tra ites prudem ment par les 
moyens conventionnels avant de tenter 
des in terventions plus compliquees 
visant a sauvegarder les sphincters.
Until 1952 when Bryan Brooke described 
the technique for constructing an everted 
stoma, it was unusual for a surgical con­
sultation to be obtained for a patient with 
severe ulcerative colitis. In his report o f 
10 patients, 2 died postoperatively. 
Brooke’ s work was considered a major
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advance, and stimulated management 
of the disease by more aggressive 
surgery. Two enlightened physicians 
at this hospital formulated a protocol, 
especially applicable to severe colitis, 
that included early surgical interven­
tion. We became involved in the pro­
gram in 1965 and since then 162 patients 
with ulcerative colitis have been treated 
surgically. The number of patients oper­
ated on each year remained strikingly 
constant until the sphincter-saving proce­
dures became available when the numbers 
increased. The proportion of patients 
with Crohn’s colitis (14%) has remained 
fairly constant. A similar proportion of 
patients with ulcerative colitis underwent 
operation as did those with Crohn’s 
disease.
Methods and Results
Of the patients treated surgically, 71 
(38%) were admitted to hospital with 
severe acute disease. One-third of these 
had a history of inflammatory bowel dis­
ease of less than 6 months. It was our 
policy to treat all patients intensively, giv­
ing medications, including hydrocorti­
sone, intravenously. The routine use of 
antibiotics ceased in 1973. The initial 
remission rate was 53% in these patients 
with acute disease. Forty-five colectomies 
were performed for fulminant colitis and 
a further 11 operations on patients who 
had relapse within 6 weeks. Three patients 
were operated on because of very severe 
bleeding. Toxic dilatation, as measured 
radiologically, was evident in 11 patients, 
9 of whom had urgent colectomy, but 
only one colon had perforated.
From the start our policy was to carry 
out total abdominal colectomy and 
ileostomy with an external mucous fistula 
for acutely ill patients, the only exceptions 
being patients with massive hemorrhage 
or with a perforation close to the rectum. 
“ Blow-hole” procedures, ileostomy alone 
and other forms of partial colectomy were 
not used. We believe that this relatively 
conservative surgical policy in severely ill 
patients is largely responsible for the 
absence of any deaths in the series.
One hundred and fifteen patients had 
elective surgery, 28 (24%) because of a 
suspicion of cancer. However, only half 
of these had invasive cancer when the 
specimen was examined histologically. In 
the electively managed patients, total 
proctocolectomy was the operation of 
choice. Early in the series, many were 
treated by a two-stage procedure, but 
recently a one-stage operation with inter­
muscular proctectomy keeping close to 
the bowel wall has usually been per­
formed. One surgeon routinely preserves 
the greater omentum, but the other rarely 
does so.
There has been a decline in serious sep­
sis since the importance of intestinal
anaerobes was recognized. Intestinal 
obstruction requiring reoperation has 
become more common since pelvic 
pouches were introduced.
Failure of the perineum to heal in a 
reasonable time, although uncommon in 
ulcerative colitis, has often been a feature 
of Crohn’s disease, particularly in the 
early part of our experience. In two 
patients it took 3 and 5 years respec­
tively for their perineal wounds to heal.
An ongoing problem has been the 
difficulty of differentiating between 
Crohn’s disease and ulcerative colitis in 
certain patients. The diagnosis was 
changed from ulcerative colitis to Crohn’s 
disease in six patients and from Crohn’s 
disease to ulcerative colitis in four, after 
the operative specimen was examined 
histologically. There were five other 
patients who, even now, remain in a grey 
zone. We believe this is a serious problem 
as many authors have drawn attention to 
what may happen if pouch surgery is done 
on patients with Crohn’s disease. Despite 
thorough investigation and multiple biop­
sies, we have already created an ileal 
pouch in a patient who was found 
postoperatively to have Crohn’s disease.
Discussion
Good results from the surgical treat­
ment of colitis demand close cooperation 
between physicians, who commonly see 
the patients first, and surgeons 
experienced in the management of the dis­
ease. There is often a difference of opin­
ion about the timing of an operation and 
a surgeon can only speak with confidence 
if his experience is considerable. Despite 
our interest, only 10 patients per year 
have been treated surgically in this 1000- 
bed university teaching hospital over the 
20-year period of our study. Happily, res­
tricting the performance of operative 
treatment to two surgeons has enabled 
them to gain experience and has led to the 
team effort necessary in carrying out 
pouch operations quickly and safely.
Surgeons attracted to the challenge of 
total proctocolectomy and pouch forma­
tion should be warned that this surgery 
is justifiable only in a unit that can carry 
it out with few or no deaths, particularly 
because most of the patients are young.
Our experience with ileal pouches is 
small but has encouraged us to adopt the 
procedure in the majority of our patients. 
In those with Crohn’s disease or diseased 
anal sphincter mechanisms and in the 
elderly, the anal mechanism should be 
preserved if possible. Those who have had 
previous anal disease and women who 
have borne children should also be care­
fully selected as a defective sphincter may 
lead to a life of misery.
There is little doubt that our ability to 
offer sphincter-saving operations will lead 
to earlier surgical treatment of this
debilitating disease. In so doing, we 
should be able to prevent the development 
of cancer, which unfortunately still occurs 
despite attempts to diagnose dysplasia by 
multiple endoscopic biopsies.
We believe there is a group of patients 
in whom proctocolectomy and ileostomy 
remain the definitive management for 
inflammatory disease. For surgeons who 
rarely have the opportunity to operate on 
patients with ulcerative colitis, we advise 
an abdominal colectomy with preserva­
tion of ileocolic vessels, the formation of 
a mucous fistula and ileostomy. 
Subsequent referral for consideration of 
a pouch procedure is often in the patient’s 
best interests. ■
BOOK REVIEWS 
continued from page 353
PERIOPERATIVE CARDIAC DYSFUNC­
TION. Volume III. Edited by Joe R. Utley 
and Rosanne Betleski. 289 pp. Illust. Wil­
liams & Wilkins, Baltimore, 1985. $49. 
(US). ISBN 0-683-08503-4.
This book represents a collection of topics dis­
cussed at two symposia held in San Diego in 
1982 and 1983, dealing with perioperative dys­
function of the heart. It is a welcome addition 
to the cardiac surgery literature, complement­
ing the standard textbooks.
Since the book is divided into 21 chapters, 
each with a different author, there is some 
unevenness in format and quality and some 
repetition. These disadvantages are outweighed 
by the obvious advantage that, for the most 
part, each topic is dealt with by an expert in 
the field who presents the topic concisely and 
with clear discussion, in sufficient depth to 
satisfy most readers.
This monograph represents our current 
understanding of the pathophysiology and 
management of perioperative cardiac dysfunc­
tion, which is usually ischemic in origin. Much 
of the material has not yet found its way into 
the standard texts. Of particular interest are 
the discussions of myocardial blood flow and 
performance, afterload mismatching, perioper­
ative coronary spasm, infarction and reanima­
tion of the heart. Lacking, however, is a dis­
cussion of cardiac dysfunction during the 
ever-increasing reoperations for coronary 
artery disease, particularly the problem of 
coronary atheroemboli.
Despite its minor flaws, this text provides an 
excellent review of the topic. It is a necessary 
addition to the library of all surgeons, 
anesthesiologists, internists and nurses who 
care for patients who undergo cardiac proce­
dures.
R oy G. Master s, m d , frcsc 
Cardiac surgeon,
University of Ottawa Heart Institute,
1053 Carling Ave.,
Ottawa, Ont.
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Several options can be considered when 
medical management of ulcerative colitis 
fails or if a serious complication 
develops. One alternative to proctocolec­
tomy with ileostomy or ileoanal pull- 
through is the ileorectal anastomosis. Its 
main advantage is preservation of the 
rectal reservoir without risking injury to 
the pelvic nerves or anal sphincter. It is 
not indicated when the rectum is 
severely diseased or stenosed or in the 
presence of rectal carcinoma. Patients 
older than 55 to 60 years can expect a 
good functional result in a relatively 
short time compared with the prolonged 
adaptation period associated with pull- 
through procedures.
Plusieurs options s'offrent devant I'echec 
du traitement medical de la colite ulce- 
reuse ou ('apparition de complications 
serieuses. A la proctocolectomie avec 
ileostomie ou anastomose ileo-anale, on 
peut preferer I'anastomose ileo-rectale. 
Son principal avantage est de pouvoir 
conserver I’ampoule rectale sans risquer 
une blessure aux nerfs pelviens ou au 
sphincter anal. Cette operation n'est pas 
indiquee en presence d'une atteinte ou 
d'une stenose grave du rectum, ou 
encore d'un cancer rectal. Les patients 
de plus de 55 a 60 ans peuvent s’atten- 
dre a de bons resultats fonctionnels 
apres relativement peu de temps, compa- 
rativement a la periode d'adaptation pro- 
longee que necessite l operation de 
Swenson-Bill.
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In selected cases of ulcerative colitis, total 
abdominal colectomy with ileorectal 
anastom osis remains the simplest 
sphincter-saving procedure. As early as 
1903, Lilienthal1 mentioned the proce­
dure of ileosigmoidostomy and in 1943 
Devine2 reported the use of extraperi- 
toneal ileosigmoidostomy; Wangensteen 
and Toon3 used a one-stage ileoproc- 
tostomy. Aylett, after performing the 
operation in 1952, became the leading 
proponent of ileorectal anastomosis and 
carried out this procedure in 384 
patients.4 Few reports have been so 
favourable to this operation, but, with the 
advent of newer ileoanal reservoir proce­
dures, it is questionable whether ileorec­
tal anastomosis still has a place in surgery 
for ulcerative colitis.
Review of the Literature
Aylett’s group4 in 1978 reported on 
their total experience with 384 patients — 
178 males and 206 females whose mean 
age was 36.2 years (range from 11 to 72 
years). The operation was preceded by a 
colectomy and ileostomy in 169 patients 
who had active colitis; in the other 215 
the procedure was done electively with a 
protective diverting ileostomy. Five car­
cinomas were found in the latter group. 
There were 10 (2.6%) postoperative 
deaths. Of the remaining 374 patients, 41 
had the rectum removed at a later date 
for the following reasons: carcinoma in 
18, dysplasia without carcinoma in 3 and 
a large villous adenoma in 1; severe rec­
tal disease, stricture formation, anal 
fistula and incontinence were the indica­
tions in the 19 other patients. There were 
three deaths postoperatively. Overall, 265 
(71%) patients were alive and well with 
the ileorectal anastomosis. The authors 
calculated the risk of rectal carcinoma 
from the 22 (5.7%) cases in the entire ser­
ies and related them to the length of his­
tory of the disease. There were no cases 
with a history of less than 10 years; with 
a longer history the risk was 1 in 200 
patient-years and 1 in 51 with a history 
over 40 years.
Hawley5 recently reported on the
experience at St. Mark’s Hospital, Lon­
don, of 125 cases from 1953 to 1984. In 
elective cases the anastomosis was done 
as a one-stage procedure without a pro­
tective ileostomy at the sacral promon­
tory, leaving 12 to 15 cm of rectum; in 
urgent cases a colectomy and ileostomy 
were done initially. The rectum was later 
excised in 33 (26%) for unsatisfactory 
function in 18, technical failure in 5, 
bleeding in 1, severe dysplasia in 6 and 
carcinoma in 3. There was one postoper­
ative death and only one patient (0.8%) 
died of carcinoma of the rectum. Func­
tional results were encouraging in that 
83% had six or less bowel movements per 
day and 4% had a regular bowel move­
ment at night. Half the patients used 
medications to decrease stool frequency 
and 9% were treated medically for proc­
titis. These results are similar to those 
reported by Newton and Baker;6 of 92 
patients with ileorectal anastomosis, 82% 
had less than six movements per day.
Farnell and colleagues7 reviewed the 
results of treatment in 63 patients from 
the Mayo Clinic and used one of the fol­
lowing criteria to define an unsatisfactory 
outcome: more than eight bowel move­
ments per day, systemic use of steroids, 
severe perianal disease, incontinence, 
poor general health. Of the 49 patients 
who could be followed up, 55% had a 
satisfactory result. However, 15 of 63 
patients, whose mean age was 29 years, 
underwent proctectomy while those in 
whom the rectum was preserved had a 
mean age of 43 years (p < 0.01), suggest­
ing that younger patients were more likely 
to have unsatisfactory results. The failure 
rate was no higher in those with moder­
ately diseased rectal mucosa than in those 
with normal mucosa.
In another series of 122 patients with 
ileorectal anastomosis for ulcerative coli­
tis, 84 (69%) retained a functioning 
anastomosis.8 The rectal stump was 
excised in 30 (25%) and 5 remained with 
a loop ileostomy while 3 died of pre­
existing cancer. Of the patients with 
ileorectal anastomosis, five (4%) suffered 
from carcinoma, and all had a disease his­
tory longer than 13 years.
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Discussion
The main indication for performing 
ileorectal anastomosis is to avoid a per­
manent ileostomy and preserve the reser­
voir function of the rectum. Patient selec­
tion is important, and the operation 
should not be offered to those with rec­
tal stricture, rectal carcinoma, severe dis­
ease not responding to locally applied 
steroids and inadequate sphincter func­
tion from complicated abscesses and 
fistulas. Certain authors9 have advocated 
its consideration in children and adoles­
cents to allow development of physical 
and sexual interests without the problems 
of an ileostomy. Similarly, another 
study7 has suggested that older patients 
with ulcerative colitis treated with this 
procedure are less likely to need proctec­
tomy later.
The risk of anastomotic leakage does 
not appear to be great if the procedure 
is done meticulously and on rectal stumps 
with only mild to moderate disease.7,9 
Baker and colleagues4 reported a 
postoperative death rate of 2.6%, half of 
these from anastomotic leakage; they 
advised using a tem porary loop
ileostomy, although others5,7-9 have not 
employed this routinely.
The risk of cancer at follow-up was 
estimated at 6% at 20 years and 15% at 
30 years in one large study.4 The use of 
regular sigmoidoscopy and random biop­
sies every 6 months in search of dyspla­
sia in chronic ulcerative colitis10 has 
added greatly to the patient’s safety. With 
severe dysplasia, the risk of carcinoma is 
greater than expected and excision o f the 
rectum should be advised before frank 
invasive carcinoma develops.5 Hence, 
because of the small but significant risk 
of carcinoma, only patients willing to par­
ticipate in a rigorous and careful 
postoperative surveillance and to accept 
further surgery if biopsy reveals severe 
dysplasia should have this procedure sug­
gested to them.
In conclusion, satisfactory results can 
be expected in two-thirds of selected 
patients. When the disease is moderately 
severe, the rectum can be treated with 
steroid enemas before reanastomosis to 
lessen the degree of inflammation and 
reduce the chance of exacerbation 
postoperatively. Personal experience with 
this procedure is limited and has been
reserved for patients over 55 years of age 
who may not be suitable candidates for 
ileoanal restorative operations.
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4. Current Status of the Continent Ileostomy
The continent ileostomy has substantial 
advantages over the standard ileostomy 
in that it provides a socially acceptable, 
odourless, appliance-free stoma. The 
author presents the experience at the 
Toronto General Hospital from 1977 to 
1984 with this procedure which was 
performed on 123 patients, in conjunc­
tion with proctocolectomy (36) and as a 
conversion from an ileostomy or colostomy 
(87). There were no postoperative deaths. 
Modifications to prevent nipple valve 
sliding have included the addition of staples 
across the valve and synthetic mesh
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slings around the outlet. Reservoir ileitis 
remains a difficult problem, most likely 
due to stagnant bacterial overgrowth.
The operation should not be performed 
on patients with Crohn's disease, and in 
the obese, technical difficulties present 
considerable risk. The procedure should 
be confined to large centres where the 
surgeons are experienced in the 
procedure.
L'ileostomie continente presente des 
avantages marques par rapport a I'ileos- 
tomie traditionnelle: elle procure un 
stoma inodore, socialement acceptable et 
exempt d'appareil. L'auteur decrit son 
experience, entre 1977 et 1984, au 
Toronto General Hospital alors que cette 
operation a ete pratiquee chez 123 
patients, en association avec une procto- 
colectomie (36) ou une conversion d'une 
ileostomie a une colostomie (87). II n'y a 
eu aucun deces postoperatoire. Des modi­
fications destinees a prevenir le glissement 
de la valve d'attache comprennent la 
pose de broches au dessus de la valve 
et des courroies de reseau synthetique 
autour de I'ouverture. L'ileite de reservoir 
demeure un probleme difficile; elle est 
vraisemblablement due a une stagnation 
du contenu ileal et a une surcroissance
bacterienne subsequente. Cette interven­
tion ne doit pas etre pratiquee chez les 
patients qui souffrent de maladie de 
Crohn et, chez I'obese, des difficultes 
techniques posent un risque considera­
ble. Cette operation doit etre reservee 
aux grands centres oil les chirurgiens 
possedent ('experience de la technique.
The continent ileostomy has been a great 
advance, allowing hundreds of patients 
around the world an appliance-free stoma 
and thus improving the quality of life.1 
In addition, its development has stimu­
lated many surgeons to continue their 
efforts not only to obviate the need for 
a conventional ileostomy appliance, but 
to develop a pelvic pouch procedure 
without any type of permanent stoma. 
Psychosocial difficulties related to a con­
ventional ileostomy and external appli­
ance remain the most important indica­
tion for the continent ileostomy in 
patients with proven ulcerative colitis. We 
do not knowingly perform a continent 
ileostomy in patients who have had 
Crohn’s disease, and technical difficulties 
in the obese can present considerable 
risk.2,3 Patients who have had a large 
amount of small bowel resected should be
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viewed cautiously for a continent 
ileostomy. They lose a greater amount of 
fluid, electrolytes and bile salts and are 
therefore at an increased risk for 
chololithiasis and urolithiasis.
Surgical Technique and Results
During the years 1977 to 1984 we per­
formed a continent ileostomy on 123 
patients (mean age 33 years), 115 of 
whom had ulcerative colitis. In 36 patients 
the procedure was performed in conjunc­
tion with a proctocolectomy and in 87 it 
followed conversion from a conventional 
ileostomy or colostomy. There have been 
no deaths perioperatively as a direct result 
of the procedure, but one patient com­
mitted suicide during the first year 
postoperatively and one had a fatal pul­
monary embolus at 3 months. Three of 
our continent ileostomy pouches have 
been removed.
Of the first 17 patients operated upon, 
10 (59%) required surgical revision, 
mainly because the nipple valve was slid­
ing. Since 1977, the procedure has been 
modified substantially in an effort to 
decrease the rate of nipple-valve sliding. 
The first modification, which we under­
took in 1978, was the use of the GIA sta­
pler with SGIA staples across the valve. 
This was done to stabilize the valve in 
position and prevent complete elongation 
or eversion of the valve itself. It was used 
in conjunction with a modification, origi­
nally described by Boley and Fazio,4 in 
which a fascial sling around the base of 
the outlet further secured the valve in 
position. However, even with these 
modifications, valve sliding continued to 
be a problem and 30% of the next 45 
patients in our series still required surgi­
cal revision, mainly for this problem.
From 1979 to 1981, in addition to the 
staples across the valve, a synthetic mesh 
sling was used around the outlet, encir­
cling the base in order to act as a bridge 
between the pouch and the abdominal 
wall. This allowed the pouch to be 
anchored to the mesh and also the 
abdominal wall to the mesh in an attempt 
to prevent the nipple valve from sliding 
on the weakened mesenteric aspect. Lift­
ing the outlet into the ileostomy opening 
tended to stabilize the mesenteric mass, 
decrease the likelihood of eversion of the 
valve and shorten the amount of outlet 
required to reach the skin surface.
With these modifications, the compli­
cation of valve sliding has decreased sig­
nificantly, but a surgical revision rate of 
19% still exists, due mainly to erosion 
caused by the Marlex mesh with subse­
quent abscess and fistula formation. 
Because of these septic complications we 
are now using a softer weave Prolene 
mesh or an even softer Mersilene mesh in 
preference to Marlex. To date, only one 
fistula has been attributable to Mersilene
mesh in the 30 patients who have been 
operated upon by this technique.5,6
A further recent modification is 
stapling the nipple valve to the side of the 
continent ileostomy reservoir itself, thus 
preventing eversion. We have used this 
technique in one continent ileostomy and 
in three continent urinary diversions with 
initial success.
In our last 48 patients there was an 8% 
revision rate and only one patient 
presented with true nipple sliding — a 
marked improvement in results. Our 
study also suggests that the major com­
plication seen more recently (that of 
fistulas) occurs mainly in the first 3 
months postoperatively, whereas sliding 
has occurred up to 2 years or more after 
construction of a continent ileostomy. Of 
the pouches formed in our 123 patients, 
three have been removed and there have 
been two deaths as already noted, leaving 
118 patients with a continent ileostomy 
who have been followed up for a mean 
of 46 months. Of these, 114 (97%) do 
not wear an ileostomy appliance, 2 
always wear one and 2 occasionally do 
so. One constant user is awaiting 
further surgical revision.
Other Complications and Concerns
The complication of reservoir ileitis is 
both intriguing and often difficult to 
manage. On gross inspection of the reser­
voir it appears similar to Crohn’s disease, 
but the two should be considered separate 
entities. In our series 7% of the patients 
have had pouch ileitis and in two patients 
it was difficult to treat. The most likely 
cause for this syndrome is bacterial over­
growth due to stagnation of ileal content. 
Even in the normal reservoir the bacterial 
flora approaches that of normal colonic 
flora with a preponderance of anaerobes. 
Stool samples should be analysed in an 
attempt to isolate abnormal pathogens 
such as ameba, Yersinia, Campylobac­
ter and Clostridium difficile and toxin. 
Then appropriate treatment should be 
instituted. When no specific organism is 
isolated, the reservoir should be placed on 
straight drainage to prevent further stag­
nation. We have found that metronida­
zole is the most effective agent in the 
treatment of pouch ileitis. Other antibi­
otic and anti-inflammatory drugs have 
been tried with some degree of success.
The long-term effects of a continent 
ileostomy are still not fully known. No 
consistent long-term metabolic distur­
bances have been reported. The stagna­
tion and bacterial overgrowth in continent 
ileostomies coupled with a tendency to the 
formation of a colonic mucosa may place 
these patients at an increased risk of 
developing carcinoma within the pouch; 
to date none have been reported. Our own 
results have shown that fecal mutagens, 
as measured in an AMES assay, as well 
as fecal nitrite and nitrate levels, are lower
in continent ileostomies than in fecal sam­
ples from normal controls.7 The availa­
ble data suggest that the cancer risk is not 
increased, but the potential remains until 
further follow-up has been completed. 
These potential risks are also applicable 
to a pelvic pouch created for an ileoanal 
pull-through anastomosis. In this regard, 
the two procedures are similar with no 
advantage for either.
Comment
The continent ileostomy provides sub­
stantial physical and psychosocial benefits 
over a conventional ileostomy. However, 
it carries a substantial morbidity, so 
prospective candidates should be made 
aware not only of the advantages but also 
the potential complications. It is a major 
abdominal operation requiring meticu­
lous attention to detail and should be con­
fined to centres capable of acquiring a 
large experience. The complication rate 
in our series and in other centres that have 
reported on this procedure has decreased 
notably. This is due to increased 
experience and to modifications in surgi­
cal technique.
During the past 3 Vi years the number 
of conventional ileostomies in our series 
has decreased substantially. At the same 
time there has been a rise in the number 
of colectomies with mucosal proctectomy 
and ileoanal anastomosis. Currently at 
our hospital most patients choose to have 
an abdominal colectomy, mucosal proc­
tectomy and ileoanal anastomosis, rather 
than a continent or conventional 
ileostomy. This procedure, when the out­
come is satisfactory, offers a quality of 
life approaching normal. However, one 
must still approach an ileoanal anastomo­
sis with a degree of caution, mainly 
because the functional results are some­
times unpredictable. At present we 
strongly believe that the main use of the 
continent ileostomy is for patients in 
whom a proctectomy and conventional 
ileostomy have already been performed. 
Here, the continent ileostomy continues 
to offer an advantage of an appliance-free 
odourless stoma that alleviates the psy­
chosocial stigma of conventional 
ileostomy appearance and care.
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5. Proctocolectomy and Ileoanal Anastomosis 
With an S Pouch: Functional Results
Patients with total colonic ulcerative coli­
tis or familial polyposis traditionally 
require a proctocolectomy. In an effort 
to preserve the normal pathway for defe­
cation and avoid the nuisance of an 
abdominal stoma, a continence­
preserving procedure involving a pelvic 
reservoir has been performed at the 
University of Minnesota Hospitals on 
120 patients. The majority were oper­
ated on for colonic ulcerative colitis. 
There were no deaths. The mean hospi­
tal stay after restorative proctocolectomy 
was 10 days and after ileostomy 
takedown the mean stay was 7 days. 
Functional results were assessed in 52 
patients. Daytime bowel movements 
averaged 6.4 and night-time movements 
1.4. Major daytime incontinence 
occurred in 6% of the patients, 21%  had 
moderate soiling at night and 70%  wore 
a perineal pad in the evening. Ninety-two 
percent of the patients expressed satis­
faction with the procedure. The most 
serious complication was pelvic sepsis. It 
occurred in nine patients, six of whom 
required subsequent surgery. The Parks 
S pouch provides a means of maintaining 
anal continence. This series and others 
have shown that young, healthy, well- 
motivated persons will benefit most from 
a restorative proctocolectomy.
Traditionnellement, les patients souffrant 
de colite ulcereuse ou de polypose fami- 
liale necessitent une proctocolectomie. 
Dans I'espoir de conserver les voies nor- 
males de defecation et d'eviter I'embar-
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ras d'un stoma abdominal, une operation 
visant a sauvegarder la continence et 
necessitant un reservoir pelvien a ete 
pratiquee chez 120 patients des hopitaux 
de I'Universite du Minnesota. La majorite 
des operes souffraient de colique ulce­
reuse. On n'a enregistre aucun deces. Le 
sejour hospitalier moyen a <ite de 10 
jours apres proctocolectomie reconsti- 
tuante et de 7 jours apres ileostomie.
Les resultats fonctionnels ont ete appre- 
cies chez 52 patients. On a compte en 
moyenne 6.4 defecations diurnes et 1 .4  
nocturnes. On a observe une inconti­
nence diurne majeure chez 6% des 
patients, 21% se souillaient de facon 
moyenne durant la nuit et 70% met- 
taient un tampon perineal en soiree. 
Quatre-vingt-douze pourcent des patients 
etaient satisfaits de I'operation. La com­
plication la plus serieuse a ete la sepsie 
pelvienne. Elle est survenue chez neuf 
patients dont six durent etre reoperes. La 
poche en S de Park offre un moyen de 
maintenir la continence anale. Les etudes 
chez ce groupe de malade et chez 
d'autres ont demontre que les personnes 
jeunes, en sante et bien motivees vont 
beneficier le plus d'une proctocolectomie 
reconstituante.
Patients with total colonic ulcerative coli­
tis or familial polyposis traditionally 
require a proctocolectomy. This is fol­
lowed by an ileostomy, which generally 
is consistent with good health and a 
productive life. Emotional and psycho­
logic problems are often associated with 
the stoma. In an effort to preserve the 
normal pathway for defecation and to 
avoid the nuisance of an abdominal 
stoma, continence-preserving procedures 
have attracted great attention. Parks and 
colleagues1 first described total proc­
tocolectomy with rectal mucosectomy fol­
lowed by construction of a pelvic reser­
voir with three limbs of ileum giving the 
pouch an “ S” configuration. This proce­
dure evolved naturally from pull-through 
procedures, which can be traced to the 
initial work of Nissen. In 1933,2 he first 
reported an ileoanal anastomosis in which 
a double-barrelled ileostomy was sutured 
to the anal sphincters. Numerous
postoperative complications, primarily 
infection and incontinence, have plagued 
this procedure and have prevented its 
widespread acceptance. We first per­
formed ileoanal anastomosis in adults at 
the University of Minnesota Hospitals in 
1980 and it has now been performed on 
120 patients. This report centres on the 
functional results obtained with the first 
70 patients.
Patients
Only patients with ulcerative colitis or 
familial polyposis were chosen for the 
operation. Crohn’s disease is contraindi­
cated because of the fear that it will recur 
in the neorectum. Fulminant colitis and 
steroid usage are not contraindications, 
but a staged approach is probably best if 
toxic megacolon is present. The procedure 
was performed in 43 males and 27 
females, ranging in age from 13 to 60 
years (mean 31 years), between 1980 and
1984 by surgeons in t_Division of C^lon
and Rectal Surgery at the University of 
Minnesota. The indication for operation 
was ulcerative colitis in 64, familial poly­
posis in 5 and recurrent colonic hemor­
rhage in 1 patient. An S pouch was con­
structed in 65 patients, while the J pouch 
or the Balcos modification of the latter 
was used in 5. The S pouch consists of 
three 10-cm segments and a 2-cm spout 
or efferent limb. Loop or end ileostomy 
is now performed in all patients after 
early experience showed a high rate of 
pelvic abscess in those operated on 
without a covering ileostomy.
Technique
With the patient in a m odified 
lithotomy position, the operation is car­
ried out by two teams, beginning with 
exploratory laparotomy through a mid­
line incision to exclude the presence of 
C ro h n ’s disease, cancer or o ther 
unsuspected malady. Subsequently, the 
sigmoid colon is encircled and tied off 
with umbilical tape to prevent distal pas­
sage of colonic debris. Total abdominal 
colectomy is then carried out first by tran­
secting the ileum close to the cecum with 
a stapling device to preserve as much ter-
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minal ileum as possible and then by main­
taining the plane of dissection close to the 
bowel wall down to the levator ani mus­
cles, thus avoiding neurologic damage.
Simultaneously the perineal operator, 
after submucosal injection of 1:200 000 
epinephrine and saline solution, carries 
out the rectal mucosectomy beginning at 
the dentate line in a sleeve-like circum­
ferential manner for 4 to 6 cm, using 
either electrocautery or scissors. The rec­
tal muscle is transected posteriorly by the 
perineal operator and the remaining por­
tion by the abdominal operator, thus 
ensuring en-bloc resection of the rectal 
mucosa and submucosa with the entire 
colon.
The abdominal surgeon mobilizes the 
small bowel, dividing the posterior 
peritoneum to the duodenum, pancreas 
and superior mesenteric artery. To ena­
ble the ileum to swing freely and reach the 
anus, the ileocolic artery is divided prox- 
imally, carefully preserving the distal 
mesenteric arcade.
The distal 26 to 33 cm of terminal ileum 
is aligned with stay sutures in an S shape, 
with each limb measuring 8 to 10 cm, 
while the efferent limb measures 2 to 3 
cm. Once it has been assured that the 
pouch will reach the dentate line without 
tension, anastomosis between the three 
ileal limbs is completed with a continu­
ous 3-0 polyglycolic acid suture. The 
peritoneal cavity is protected against con­
tamination with laparotomy pads.
Having assured meticulous hemostasis 
in the pelvis and rectal muscular sleeve, 
the abdominal operator passes the pouch 
through the sleeve to the perineal opera­
tor who excises the staple line and per­
forms the ileoanal anastomosis. Initially, 
four anchoring sutures of 3-0 polyglycolic 
acid are placed in four quadrants at right 
angles incorporating full-thickness ileum, 
internal sphincter and anoderm. The 
anastomosis is completed with more 
superficial sutures between each anchor­
ing stitch. A sump drain is then placed in 
the pelvis and a temporary loop or end- 
ileostomy is constructed. Ileostomy 
closure, usually through a peristomal inci­
sion, is subsequently completed within 12 
weeks, after a contrast enema has con­
firmed anastomotic healing and anatom­
ical position of the reservoir.
Method of Assessment
To assess postoperative morbidity with 
accuracy, a comprehensive chart review 
of prospectively collected data was under­
taken. All patients who underwent a 
restorative proctocolectomy were in­
cluded. Functional results were assessed 
by questionnaire sent to patients or by 
telephone interview. Patients were ques­
tioned about frequency of bowel move­
ment, leakage, soilage, perineal irritation, 
use o f  medications, adjustments of diet
to regulate bowel movements, and over­
all satisfaction.
Results
Mean hospital stay of patients after 
restorative proctocolectomy was 10 days 
and a mean of 7 days was reported after 
ileostomy takedown. The procedure was 
completed in one stage in 7 patients, in 
two stages in 54 and in three stages in 9 
patients.
Functional results were assessed in 52 
patients. The follow-up was 2 to 35 
months (average 19 months) from 
ileostomy closure. Daytime bowel move­
ments averaged 6.4 (range from 2 to 14) 
and night-time bowel movements aver­
aged 1.4 (range from 0 to 5). Forty-six 
(88%) patients evacuated at night an aver­
age of twice (range from 1 to 5). Spon­
taneous evacuation occurred in 89% of 
the patients, while the remaining 11% 
required catheter intubation of the pouch. 
Of the latter group, the majority were in 
the initial group of patients in which a 
larger S pouch and a longer efferent limb 
were constructed.
Although no postoperative deaths 
occurred, major postoperative morbidity 
was experienced. Major daytime incon­
tinence occurred in 6% of the patients, 
the remaining 94% were always or usually 
continent. Twenty-seven percent stated 
that they could not control flatus, and 
42% wore some perineal protection. Con­
tinence was more difficult at night, with 
21% of the patients having significant 
soiling and 70% wearing a perineal pad 
in the evening.
Twenty-three patients (44%) used 
antidiarrheal medication to decrease stool 
frequency, usually a bulking agent. 
Twelve (23%) of the patients modified 
their diet and excluded dairy products, 
fibre and spicy foods. A small number 
were unable to eat an evening meal.
Bladder function was disturbed in eight 
patients (15%) with urinary retention, 
decreased stream and recurrent urinary 
tract infections reported. None of the 31 
men had problems with impotence. One 
of the 21 women had temporary dys- 
pareunia following the procedure.
All 38 patients who held full-time 
employment outside the home returned to 
work. Forty-eight (92%) patients 
expressed satisfaction with the procedure.
Since the most troublesome effects of 
this operation related to continence and 
stool frequency, the eight patients (15%) 
considered to have poor results were ana­
lysed further. Their average age was 34 
years compared to 29 years for those 
patients considered to have good results. 
They also had 10.5 bowel movements 
daily compared with 5.6 for the younger 
group. The most frequent postoperative 
complication was small-bowel obstruc­
tion, which occurred in 18 patients, 13 of
whom required surgery. “ Pouchitis” was 
a recognized problem in 14 patients. It 
was so marked in one patient that an 
ileostomy had to be constructed. The 
most serious complication was pelvic sep­
sis which occurred in nine patients; six of 
them required subsequent surgery.
Comment
Much criticism has been levelled 
against the S ileoanal pouch, especially 
the need for intubation, which has been 
necessary in as many as 50% of 
patients.1 Motility studies revealed that 
this reservoir configuration was more 
likely to become distended and atonic 
because of low peristaltic and contractile 
activity. Closer scrutiny of our data rev­
ealed that the small number of patients 
who have to intubate their pouch were in 
the early group who had a long efferent 
spout. Since we have decreased the size 
of the pouch and the length of the effer­
ent limb, the incidence of intubation has 
dropped to 4%.
The Parks S pouch provides a means 
of maintaining anal continence. This ser­
ies and others have shown that young, 
healthy, well-motivated persons will 
benefit most; in older patients the results 
are not as good. Above all, only meticu­
lous attention to detail by a surgeon well 
trained in the procedure will provide 
acceptable results.
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6. J Pouch With Ileoanal Anastomosis
The physical inconvenience and adverse 
psychological impact of ileostomy on 
patients led surgeons to seek a more 
normal and acceptable alternative. This 
is a report of the Mayo Clinic experience 
with, and modifications of, the ileoanal 
reservoir procedure. The hospital charts 
of 188 patients who had a J-pouch con­
struction were reviewed. The operative 
technique is described. There were no 
hospital deaths. In 10 patients the opera­
tion was a failure. Complications 
included pelvis sepsis (21 patients), 
anastomotic sinus (15), anastomotic 
stricture (22), small-bowel obstruction 
(43), peritonitis after ileostomy closure 
(10) and pouchitis (15). Careful patient 
selection for the procedure is important. 
Crohn's disease is a contraindication. Of 
the patients studied, 95% found life 
more acceptable with an ileoanal anasto­
mosis than with a loop ileostomy.
Les inconvenients physiques et les dom- 
mages psychologiques de I'ileostomie 
pour le malade, ont pousse les chirur- 
giens a rechercher des solutions plus 
normales et mieux acceptables. On fait 
ici le point sur I'experience acquise a la 
Clinique Mayo avec une technique de 
reservoir ileo-anale ainsi qu’avec des 
modifications de cette operation. Les 
dossiers de 188 patients qui ont recu 
une poche en J sont examines. La tech­
nique operatoire est decrite. II n'y a eu 
aucun deces hospitalier. On a enregistre 
10 echecs. Parmi les complications 
observees, on compte des infections pel- 
viennes (21 patients), des sinus anasto- 
motiques (15), des stenoses anastomoti- 
ques (22), des obstructions de I'intestin
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grele (43), des peritonites apres ferme- 
ture de I'ileostomie (10) et des infections 
du reservoir (15). Une selection soi- 
gneuse des patients s'impose. La mala- 
die de Crohn est une contre-indication. 
Parmi les patients, 95% ont trouve la vie 
plus acceptable apres une anastomose 
ileo-anale qu'apres une ileostomie en 
anse.
The most attractive surgical procedure for 
preserving fecal incontinence is an 
ileoanal anastomosis. It consists of a total 
abdominal colectomy, mucosal proctec­
tomy and endorectal ileoanal anastomo­
sis. It removes the rectal disease, preserves 
innervation to the anus, bladder and 
genitalia and retains the usual pathway 
for defecation.
However, since its introduction, 
ileoanal anastomosis has enjoyed only 
periodic popularity because of the 
numerous postoperative complications 
associated with it, primarily infection and 
incontinence. Recently, improved results 
have been reported, based upon a better 
understanding of the physiology of con­
tinence.
In 1978 at the Mayo Clinic we began 
performing the ileoanal procedure in 
adults. Our initial experience, 50 adults 
without a reservoir, was reported in 
1982.1 That experience and simultaneous 
laboratory evaluation of these patients 
convinced us, in 1981, to incorporate a 
reservoir at the end of the ileum. It was 
our hope that a reservoir would increase 
both the capacity and capacitance of the 
neorectum.
Patients with ulcerative colitis or 
familial polyposis are chosen for this 
procedure; Crohn’s disease is contraindi­
cated because of fear of recurrence in the 
neorectum. Fulminant colitis and steroid 
usage are not contraindications, but a 
staged approach is probably best in the 
presence of toxic megacolon.
Technique
After appropriate bowel preparation, 
the patient is placed on the operating table 
in the combined synchronous position 
with legs elevated and abducted about
15°. Through a midline incision an 
abdominal colectomy and rectal mobili­
zation are completed, taking care to avoid 
trauma to the nervi erigentes and the 
hypogastric sympathetic nerves. Dissec­
tion is carried down to the level of the 
prostate in men and the middle portion 
of the vagina in women, and posteriorly 
past the end of the coccyx. The sigmoid 
is transected and the colon removed. A 
pathologist verifies that the condition is 
chronic ulcerative colitis and not Crohn’s 
disease. A rectal mucosal stripping from 
the dentate line to above the levator mus­
cles is then performed from the perineal 
end. The stripped mucosa and remaining 
proximal rectum are removed, leaving a 
short cuff of denuded rectal muscle dis- 
tally for a few centimetres above the den­
tate line. A J-shaped ileal reservoir is 
created by a long side-to-side anastomo­
sis of the terminal 15 to 20 cm of ileum, 
and this is pulled down to the dentate line 
after the small-bowel mesentery is ade­
quately mobilized. An anastomosis is car­
ried out between the J pouch and the den­
tate line and a proximal defunctioning 
ileostomy created. Two suction drains are 
placed in the presacral space and brought 
out in the left lower quadrant. The abdo­
men is then closed. Patients are usually 
discharged home after 10 to 14 days and 
return 2 to 3 months later to have the tem­
porary ileostomy closed. We can close the 
ileostomy with a peristomal incision 80% 
of the time, but in the other 20% the 
abdomen must be reopened.
Findings
Among 188 patients having a J pouch 
constructed were 177 who had ulcerative 
colitis (3 with coexistent carcinoma) and 
11 with polyposis coli (2 with coexistent 
carcinoma). A temporary diverting 
ileostomy was constructed at the time of 
colectomy in 180 patients. Radiologic 
contrast studies of the neorectum were 
obtained 2 to 3 months postoperatively, 
and if anastomotic healing was demon­
strated the ileostomy was closed. The 
average hospital stay was 14 days after 
colectomy and 10 days after stomal 
closure.
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There were no hospital deaths but two 
patients died of metastatic carcinoma dur­
ing the follow-up period. Ten patients had 
their ileostomies re-established and are 
therefore considered failures (5 for pel­
vic sepsis, 2 with recurrent Crohn’s dis­
ease and 3 with excessive stool frequency).
Twenty-one patients had pelvic sepsis; 
12 required laparotomy and 5 of these 
had the pouch removed. Five patients 
were treated with antibiotics alone and 
five had spontaneous resolution by 
decompression of the abscess into the 
pouch.
Fifteen patients had anastomotic 
sinuses, demonstrated by contrast studies, 
at the time of planned ileostomy closure. 
Seven of these had pelvic sepsis. Eleven 
of the 15 subsequently underwent uncom­
plicated ileostomy closure after healing of 
the sinus was demonstrated radiologi- 
cally. In three patients with radiologic evi­
dence of a sinus, ileostomy closure was 
attempted. Two had evidence of localized 
sepsis requiring temporary ileostomy.
Anastomotic strictures developed in 22 
patients; 8 required one dilatation, 8 more 
than one and 6 required intermittent dila­
tation.
Clinical evidence of small-bowel 
obstruction occurred in 43 patients after 
either colectomy (27) or ileostomy closure 
(16). Laparotomy was required to relieve 
bowel obstruction in 13 patients after 
colectomy and in 3 after stoma closure.
Peritonitis developed in 10 patients 
after ileostomy closure; this occurred 
after peristomal incision and was 
managed by primary repair in 7 patients 
and by repair and temporary ileostomy 
in 3.
No men were impotent but nine 
experienced at least transient retrograde 
ejaculation. Six women had uncompli­
cated pregnancies, and four of them deli­
vered vaginally without compromise of 
anal function.
Pouch inflammation (“ pouchitis” ) 
occurred late in 8% of patients. Clinically 
this is manifest by watery diarrhea, 
hematochezia, abdominal and pelvic dis­
comfort, malaise and, occasionally, fever. 
This syndrome, which is likely secondary 
to stasis and anaerobic bacterial over­
growth, is similar to that found in patients 
with Kock pouches and usually responds 
within 48 hours to the oral administration 
of metronidazole. Three patients have 
had recurrent episodes of pouchitis.
Functional results were assessed using 
a mean interval from stomal closure of 
375 days. Mean stool frequency was six 
per day and one per night. Minor seepage 
occurred more than twice a month in 25% 
during waking hours and 47% noctur- 
nally. Frank fecal soilage was experienced 
by 2.5% of patients while awake and 
4.5% at night. Fifty percent of patients 
use stool bulking agents (psyllium seed) 
and 40% use antidiarrheal agents to
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decrease stool frequency. Forty-one per­
cent require no medications. Clinical 
results clearly improve with time and 
patients with a longer follow-up consis­
tently have better functional perfor­
mance. Of the 188 patients, 179 (95%) 
preferred their experience with the 
ileoanal anastomosis to that with a loop 
ileostomy.
Patients’ gender had little effect on 
functional results, but younger patients 
had a lower daily stool frequency than 
those over 50 years of age (5.8 versus 8.8). 
Patients with polyposis had fewer stools 
daily than those with colitis (4.3 versus 
6 . 1).
Discussion
Fonkalsrud and colleagues,2 Parks 
and Nicholls,3 Peck4 and Utsunomiya 
and associates5 used various types of 
ileal reservoirs to prevent the excessive 
stool frequency associated with ileoanal 
anastom osis. From our anorectal 
manometry studies it appears that the 
improved results are secondary to 
increased ileal compliance and decreased 
ileal motility after construction of the J- 
pouch ileal reservoir. Nicholls6 found 
that almost 50% of his patients had to 
catheterize the S-shaped ileal reservoir 
pouch; in the other 50% defecation was 
spontaneous. This complication was not 
seen with the J pouch developed by 
Utsunomiya and associates,5 and all of 
our patients can defecate spontaneously. 
Rothenberger and colleagues,7 using a 
modification of Parks’ S reservoir, re­
ported that 57% of patients could defecate 
spontaneously. They subsequently re­
ported8 that shortening the efferent con­
duit seems to improve the results.
Because of unsatisfactory results in 
patients with a straight end-to-end 
ileoanal anastomosis and the impeded 
defecation after the S-pouch procedure, 
we now use the J-shaped ileal reservoir 
whenever possible. The optimal reservoir 
remains to be defined, but larger is not 
necessarily better.
Careful patient selection for the 
ileoanal anastomosis is important. 
Crohn’s disease is a contraindication to 
the procedure. Patients should be medi­
cally fit as the operative procedure can be 
long and the potential postoperative com­
plications are serious. The patients should 
be well motivated and understand that the 
operation will not make them normal — 
they will still have an increased frequency 
of bowel movements. Sphincter function 
must be normal preoperatively. If there 
is any question of incontinence, we uti­
lize manometry to distinguish between 
sphincter dysfunction and, more com­
mon, loss of reservoir capacity. Sphinc­
ter function decreases with advancing age 
so patients over the age of 50 years should 
be carefully screened.
The ileoanal anastomosis is now estab­
lished as a viable alternative in the 
management of patients with ulcerative 
colitis and polyposis coli. It can be done 
primarily at the time of proctocolectomy 
or secondarily in a patient who has had 
an abdominal colectomy with a Brooke 
ileostomy or ileorectal anastomosis. Des­
moids and intra-abdominal scarring may 
limit small-bowel mesenteric mobility and 
prevent the anastomosis. Increasing 
understanding of the mechanisms of con­
tinence will likely allow us to offer 
patients even more cosmetic and func­
tional alternatives in the future.
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NOTICES
continued from page 325
Extended Programs in 
Medical Education
The University of California in San Fran­
cisco is sponsoring a course entitled 
“ Update on Common Cancers for the 
Primary Care Physician: Colon and 
Prostate” Oct. 29-30, 1987. The program 
covers the etiology of breast, colon and 
prostate cancer, current screening techni­
ques, evolving treatment methods and 
complications of therapy and meets the 
criteria for 12 credit hours in Category 1. 
The University’s School of Medicine is 
also presenting a course entitled “ Oph­
thalmic Plastic and Reconstructive Sur­
gery — Past, Present and Future” Dec. 
10-11. Discussion will focus on the major 
topics of ptosis, entropion, ectropion, 
eyelid reconstruction, cosmetic eyelid and 
facial surgery, lacrimal abnormalities and 
orbital disease. Further information on 
these courses can be obtained by writing: 
Extended Programs in Medical Educa­
tion, University of California School of 
Medicine, Room 569-U, San Francisco, 
California 94143 or calling: (415) 
476-4251.
continued on page 381
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7. Physiopathologic Aspects of Ileal Reservoirs
The author reviews some aspects of 
fecal continence after ileoanal anastomo­
sis with an ileal reservoir. Also, the con­
sequences of fecal stasis on small-bowel 
absorption and morphologic and bacterio- 
logic features are discussed. Some 
recommendations for the follow-up of 
these patients are outlined.
L'auteur etudie quelques aspects de la 
continence fecale apres anastomose ileo- 
anale avec reservoir ileal. II commente 
egalement les consequences d'une stase 
fecale sur I'absorption de I'intestin grele 
ainsi que les caracteristiques morphologi- 
ques et bacteriologiques. On propose 
quelques recommandations sur la surveil­
lance que necessitent ces patients.
In the assessment of continence- 
pi eserving operations, two physiopatho­
logic aspects are of clinical interest: the 
mechanisms of fecal continence and the 
consequences of fecal stasis on small- 
bowel morphology, bacteriology and 
absorption. An understanding of these 
aspects may help to improve surgical care 
and to identify problems that occur in the 
long-term follow-up of these patients.
Mechanisms of Fecal Continence
Many factors participate in the 
mechanism of continence:1 the anal 
sphincters, the angulation between the 
rectum and anus, the rectoanal reflexes,
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the reservoir capacity of the rectum, the 
sensory mechanisms, the propulsion of 
the distal bowel and the volume and con­
sistency of stools. In the evaluation of 
continence-preserving operations, all 
these factors must be considered. When 
the absorptive function of the colon is 
abolished, the average fecal output 
increases from 150 ml/d to 600 m l/d.2 
This increase in stool volume is similar 
after an ileoanal anastomosis, a Brooke 
ileostomy and a well-functioning Kock 
pouch. In our early experience of 12 
patients with a straight ileoanal anasto­
mosis,2 we noted a strong correlation 
between stool frequency and the volume 
capacity of the distal ileum as measured 
by the maximal tolerable degree of dis­
tension. The greater the capacity and 
compliance of the distal bowel, the fewer 
the number of stools per day.
Neal and colleagues3 have shown that 
when a reservoir is constructed the capac­
ity of the distal bowel increases faster 
than without a reservoir. The adaptation 
is easier for the patient because of a 
reduced stool frequency in the early 
postoperative period. At 1 year after sur­
gery, the capacity of an ileal reservoir is 
similar to that of normal rectum. The 
rationale2 5 for using an ileal reservoir is 
to provide an adequate replacement for 
the rectum in creating a low-pressure, 
compliant and quiescent reservoir that 
can still evacuate spontaneously at a 
reasonable volume of distension.
The usefulness of anorectal manome­
try in evaluating continence after an 
ileoanal anastomosis has been well illus­
trated by Taylor and colleagues.5 The 
clinical result is excellent when the sub­
ject has good sphincter pressure, large 
reservoir compliance and ileal contrac­
tions of small amplitude. Only one abnor­
mal value is needed to explain a poor 
result. Low resting pressure of the sphinc­
ter and poor compliance, measured 
before closure of the diverting ileostomy, 
can be associated with a poor outcome.6
After a straight ileoanal anastomo­
sis,2'5>7 large phasic contractions of more 
than 100 cm H20  pressure are often 
detected. These contractions can over­
come anal sphincter resistance and result
in incontinence. The frequency of the 
contractions increases substantially after 
a meal.5’7 Construction of an ileal pouch 
reduces the amplitude of these contrac­
tions.5 Stryker and colleagues8 have 
shown that when the reservoir is empty, 
a few small-amplitude contractions are 
seen. When the ileal pouch is full, the fre­
quency and amplitude of ileal contrac­
tions are so intense that the subject must 
evacuate. The better the emptying of the 
pouch, the longer it takes for the contrac­
tions to appear so that continence is facili­
tated. Using a semi-solid radionuclide 
enema we found, however, that the ileal 
pouch empties substantially less than a 
normal rectum.9
The effect of rectal mucosectomy on 
sphincter pressure has been evaluated 
before and after the operation, in the 
same patients, by Becker.10 Resting anal 
sphincter pressure was shown to be 
reduced after the operation. Voluntary 
contractions of the anal sphincter 
remained unchanged.
In healthy control patients sudden dis­
tension of the rectal wall is associated 
with a reflex relaxation of the internal 
sphincter1 which may facilitate emptying 
and be associated with the sensory 
mechanisms. The effect of rectal muco­
sectomy on the rectoanal reflex has been 
a controversial subject in the literature. 
We found that the reflex is abolished 
probably because our distending balloon 
was positioned in the ileum above a short 
rectal cuff.2 Recently, Grant and 
colleagues11 compared the functional 
and manometric results of a short and 
long rectal cuff and found more compli­
cations with a long cuff. No differences 
in manometric findings were detected. 
Moreover, the rectoanal reflex was absent 
in both the long and short groups, but this 
had no adverse effect on continence.
Effect of Fecal Stasis
Fecal stasis in an ileal reservoir may 
lead to overgrowth of bacteria and 
changes in mucosal morphology that are 
of concern for the future.12 The patho­
genesis of nonspecific inflammation of an 
ileal reservoir (“ pouchitis” ) remains
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unknow n. Kelly and colleagues13,14 
observed an increased number of anaero­
bic bacteria in the jejunum of patients 
with malfunctioning Kock pouches and 
diarrhea. The malabsorption and the 
number of jejunal and ileal anaerobic 
bacteria decreased during treatment with 
metronidazole, thus implicating an over­
growth of anaerobic bacteria in the 
pathogenesis of this syndrome.
It has been speculated that the motil­
ity of the proximal bowel may be altered 
by pouch distension. Using an assembly 
of catheters to record intestinal contrac­
tions, Stryker and colleagues8 studied the 
motility patterns of the jejunum and 
ileum of patients who had an anastomo­
sis o f an ileal pouch to the anus. At the 
same time, motility of the pouch was 
recorded by another catheter inserted in 
the pouch per anum. When compared to 
control patients, the pattern of motility 
in the proximal small intestine remained 
unchanged after the operation. The 
migrating interdigestive contractions that 
clean the bowel from the jejunum to the 
ileum between meals were found to be 
normal. The pattern of motility after 
feeding was also unchanged. Interest­
ingly, the migrating contractions were not 
detected in the ileal pouch. No relation 
between proximal small-bowel motility 
and the pattern of stooling was observed. 
The latter is related to the capacity, com­
pliance and emptying of the ileal 
reservoir.
Another aspect of concern is the alter­
ation of mucosal histologic characteris­
tics after an ileoanal anastomosis. A 
decrease in villous height, an increase in
the number of mucus-producing cells and 
mild chronic inflammation are seen in 
most patients.2,15 A colonic type of 
mucosa replaced the typical ileal villous 
pattern. The long-term consequences of 
such metaplasia are still unknown. The 
longest follow-up of the effect of fecal 
stasis on mucosal morphology or on the 
ileum has been reported by Nilsson and 
colleagues16 in patients with the Kock 
pouch. The increased number of mitoses 
seen at 1 year returned to normal 6 to 10 
years after surgery. Similarly, the villous 
height, which was reduced at 1 year, 
increased over time. Absorption of vita­
min B,217 was normal in 235 patients 
with the Kock pouch but subnormal in 
7%. Because of the risk of permanent 
neurologic damage, it is recommended 
that vitamin B12 levels be checked regu­
larly.
In summary, several factors are of 
prognostic concern: absorption of vita­
min B12, pouchitis, mucosal metaplasia 
and the effect of aging on the anal sphinc­
ter.18 Rectal mucosectomy and ileoanal 
anastomosis with a reservoir is a good 
alternative to permanent ileostomy for 
well-selected patients with ulcerative coli­
tis or familial polyposis. It is recom­
mended, however, that these patients be 
followed up indefinitely.
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8. Discussion
[Questions directed to specific panelists 
were answered as follows.]
Question: Following a colectomy and 
before establishment of an ileorectal 
anastomosis, are there ways of preparing
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the rectum to improve the outcome of the 
operation?
Dr. Belliveau: Yes. The rectal stump can 
be irrigated daily with steroid enemas 
before a staged ileorectal anastomosis. 
This allows mild to moderate disease to 
improve and reduces the troublesome 
bleeding and escape of mucus from the 
rectum.
Question: If the rectum has to be excised 
for persistent or worsening disease after 
ileorectal anastomosis, what would the 
next step be?
Dr. Belliveau: If, after ileorectal anasto­
mosis, the symptoms of proctitis become 
severe or if dysplasia becomes worrisome, 
excision of the rectum with the creation 
of an ileal reservoir with ileoanal pull-
through becomes a viable option. Under 
these circumstances the results are 
encouraging, since the ileum has already 
adapted to a higher bacterial colonization 
and has hypertrophied allowing for satis­
factory bowel control. If rectal carcinoma 
has developed, proctectomy and perma­
nent Brooke ileostomy should be done. 
Question: Is the history of a fistula-in-ano 
a relative contraindication to ileorectal 
anastomosis?
Dr. Belliveau: A previous fistula-in-ano 
is not a contraindication to ileorectal 
anastomosis as long as continence is 
preserved. Anorectal manometry may be 
used in certain cases.
Question: Are there any foreseeable 
future modifications that might reduce
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the morbidity associated with the Koch 
pouch?
Dr. Cohen: The most recent modification 
has been the use of the stapling instru­
ment to secure the nipple valve in the 
pouch. This should significantly reduce 
the complication of nipple-valve sliding. 
I do not feel that major modifications will 
be made in the future. The operation itself 
will never be perfect and will always carry 
with it a substantial morbidity. This is the 
reason that patients who choose to have 
this procedure must be carefully 
scrutinized.
Question: How long do you treat and 
what are the possible long-term compli­
cations of “pouchitis” ?
Dr. Cohen: Pouchitis is extremely 
difficult to treat. Our drug of choice has 
been Flagyl, but in some patients we have 
not been able to discontinue its use. In 
one patient in particular, when Flagyl was 
discontinued, the symptoms of pouchitis 
returned within 10 days. We have 
removed a continent pouch as well as a 
pelvic pouch because of pouchitis. We are 
obviously concerned about the develop­
ment of carcinoma within pouches that 
have been chronically inflamed but to this 
date we have not seen a report of a carci­
noma in either the continent ileostomy 
pouch or the pelvic pouch. I would treat 
these patients with appropriate antibiotics 
for as long as was necessary and some­
times that might be 3 to 6 months. 
Question: In the event that you find some 
suggestion of Crohn’s disease in the small 
intestine at the time of exploration for an 
ileoanal reservoir, what is your approach? 
Dr. Goldberg: I would probably do the 
colectomy and either an ileorectal anasto­
mosis if the rectum was uninvolved or an 
ileostomy and leave the rectum in place.
I would then follow up the patient and 
see how he does clinically, see what the 
final pathology report is and consider an 
ileoanal reservoir at a later date if the con­
dition turns out not to be Crohn’s disease. 
Question: Should an ileoanal reservoir be 
constructed in the emergency situation? 
Dr. Goldberg: Since we now have an 
established pouch team and an experience 
of 120 cases, we are not shy about oper­
ating on a patient in an emergency situa­
tion. Once the colon comes out and if, 
technically, the operation goes well, we 
do not hesitate to go ahead and construct 
the pouch and bring up a split ileostomy. 
Question: Are there any physiologic 
studies that have predictive value with 
respect to patient selection and patient 
outcome after ileoanal reservoir anasto­
mosis?
Dr. Heppell: It is not necessary in all cases 
of ulcerative colitis or familial polyposis 
to use anorectal manometry to select 
patients for operation. When the patient 
complains of incontinence before the 
operation it is of value to know whether 
the sphincter tone and voluntary contrac­
tions of the anal sphincter are adequate, 
because incontinence in ulcerative colitis 
may be related to the presence of a 
microrectum with a normal anal sphinc­
ter mechanism. Under these circum­
stances we can do the operation with the 
confidence of knowing that sphincter tone 
will be adequate and that the microrec­
tum of ulcerative colitis can be replaced 
by an adequate ileoanal reservoir. Simi­
larly, in older patients or those who have 
undergone previous anal surgery, 
manometry can be used to assess the 
sphincter tone. If the patient has good 
sphincter tone on rectal examination and 
had no previous problem with continence, 
manometry is not justified. If a patient 
has a poor functional outcome after sur­
gery I usually perform endoscopy of the 
reservoir, anal manometry to measure the 
sphincter tone, the capacity and compli­
ance of the pouch, and an emptying study 
of the pouch using a radionuclide enema. 
These tests can be useful to assess whether 
the poor functional outcome is related to 
poor sphincter tone, large volumes of 
stool, inadequate emptying, or pouchitis. 
Question: How would you decide which 
operation you will offer your patient? 
Dr. Beart: I try objectively to present the 
alternatives, emphasizing the advantages 
and disadvantages of each and let the 
patient have a major role in deciding 
which alternative will offer him the 
highest quality of life.
Question: Would you tell us a little more 
about the implications of incontinence 
and leakage and the impact that this has 
on the quality of life and management of 
these symptoms?
Dr. Beart: Some stool frequency and 
leakage occur initially in virtually all 
patients. These can be decreased by 
encouraging the patient to take enough 
psyllium to thicken the stools and occa­
sionally Lomotil to decrease bowel motil­
ity. In spite of these recommendations, 
some patients have unacceptable fre­
quency and discharge. The discharge is 
most common at night. The anus should 
be protected from this discharge with a 
zinc oxide-based cream. Fortunately, the 
magnitude of symptoms related to minor 
discharge is not great. If these recommen­
dations are not adequate, the patient 
should be evaluated for outlet obstruc­
tion, bacterial overgrowth, recurrent 
inflammation or pelvic inflammation, 
partial small-bowel obstruction and 
inadequate sphincter function. If no cor­
rectable disorder is identified and symp­
toms have not improved within 6 months, 
conversion to an ileostomy should be 
recommended.
Question: What is the influence of 
pouch-anal anastomosis on sterility, 
impotence and subsequent term preg­
nancy?
Dr. Beart: None of the 90 men in our 
reported series has been rendered impo­
tent. Realistically, however, we do expect 
a small incidence of impotence after an 
extensive pelvic dissection. Six women 
have become pregnant and none have had 
subsequent complications related to the 
ileoanal procedure. Four of the six deli­
vered vaginally.
Question: What factors might be predic­
tors of success and what factors might 
predict failure or at least lessen good clin­
ical results?
Dr. Beart: Crohn’s disease and gross 
sphincter dysfunction are strong contrain­
dications to this procedure, and age over 
50 years is a relative contraindication. 
Younger age and familial polyposis seem 
to predict a more favourable clinical 
result.
Question: What technical factors might 
prevent performance of this procedure 
and how might they be predicted preoper- 
atively?
Dr. Beart: The presence of a mesenteric 
desmoid is the only factor that seems 
almost uniformly to be associated with 
failure to achieve an anastomosis. Obesity 
can foreshorten the small-bowel mesen­
tery, but with careful dissection adequate 
length can be achieved.
Question: What tricks can you suggest to 
make the J pouch reach the anus?
Dr. Beart: Careful dissection of the 
mesentery over the third portion of the 
duodenum must initially be carried out. 
That portion of the terminal ileum which 
reaches the furthest over the pubis is then 
identified and tethering vessels can be 
divided and ligated. If the bowel reaches 
past the pubic bone, adequate length has 
usually been achieved. Several mesenteric 
vessels can be ligated if necessary, as long 
as the marginal vessels are preserved.
[Certain questions were directed to the 
entire panel and were answered in the fol­
lowing manner.]
Question: Would you do a pouch proce­
dure on a person who has had a previous 
fistula-in-ano?
Dr. Morgan: I would be prepared to con­
struct a pouch in a patient who had had 
previous fistula-in-ano, provided that the 
anal sphincter was not impaired.
Dr. Cohen: A fistula-in-ano does not 
necessarily preclude doing a pelvic pouch 
procedure; however, I would worry that 
the patient had Crohn’s disease rather 
than ulcerative colitis. If the fistula was 
rather superficial and did not require a 
significant portion of the sphincter to be 
incised and if the patient still had ade­
quate sphincter tone as measured clini­
cally and on anorectal manometry, and 
I was completely satisfied that pathologi­
cally ulcerative colitis was present, I 
would do a pelvic reservoir on that 
patient.
Dr. Belliveau: Yes. If the fistula surgery 
was successful and if the residual sphinc-
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ter function, as assessed by anal manom­
etry, was adequate.
Dr. Goldberg: I would assess the patient 
preoperatively with anal manometric 
studies. If the results were within the nor­
mal range I would certainly go ahead and 
do so. Obviously if a patient has had a 
trans-sphincteric type of fistula, I would 
probably discourage him from undergo­
ing an ileoanal reservoir procedure. Also,
I would be highly suspicious that the 
patient has Crohn’s disease and not a true 
mucosal ulcerative colitis.
Dr. Heppell: I would do a pouch in a 
patient who had an intersphincteric fistula 
that had healed completely. If there was 
any doubt about Crohn’s disease, I would 
not do the operation.
Dr. Beart: If the patient was continent 
preoperatively, I assume he will be con­
tinent after surgery regardless of previous 
anorectal disease.
Question: Have you seen many patients 
who have required excision of the pelvic 
pouch?
Dr. Heppell: Rarely.
Dr. Cohen: In our own series, four 
patients have required removal of the pel­
vic pouch, two because of fistulas from 
the anal anastomosis, one because of 
pouchitis and one because of excessive 
stool frequency.
Dr. Goldberg: We have had 7 patients out 
of 120 who have had their pouches 
excised. Most of these were related to pel­
vic sepsis, unrecognized Crohn’s disease 
and our attempt to do this operation 
without a covering ileostomy.
Dr. Belliveau: In my personal experience 
with 45 such procedures, one patient has 
had the pouch excised for a recurrent pel­
vic sinus track with a chronic abscess in 
the retrorectal area.
Dr. Beart: Our group has seen about 5% 
of our patients fail because of technical 
issues or stool frequency. Recently 12 
patients have had their defective pouch 
removed, repaired and replaced.
Dr. Morgan: I have not had to excise a 
pelvic pouch. In fact sepsis has not 
occurred in any of our patients. We 
attribute this to a meticulous bowel prepa­
ration which is a combination of oral 
mannitol, neomycin and tinidazole. 
Question: Should an ileoanal reservoir 
ever be constructed without a covering 
ileostomy?
Dr. Goldberg: I realize that certain sur­
geons have done this operation without 
a covering ileostomy. However, we have 
had experience with seven of them, and 
our pelvic sepsis rate and complication 
rate were so high that I strongly recom­
mend this operation be done with a cover­
ing ileostomy. I also feel that the patient 
them knows what it is like to live with an 
ileostomy. In the event that stoma 
problems occur, the patient is certainly 
familiar with the alternative.
Dr. Belliveau: No. A temporary loop
ileostomy is essential to allow healing of 
the pelvic space without troublesome 
anastomotic leakage in patients who are 
often hypoproteinemic and malnour­
ished.
Dr. Beart: In selected situations we have 
done this but we do not yet recommend 
it as a routine.
Dr. Cohen: We have always used a cover­
ing ileostomy. In Dr. G oldberg’s 
experience in five patients who did not 
have a covering ileostomy, four suffered 
septic complications. Although there are 
complications related to a defunctioning 
loop ileostomy, I do believe it is safer to 
use this rather than to leave the ileoanal 
anastomosis unprotected.
Dr. Morgan: All our reservoirs have been 
protected by an ileostomy. I would be 
unhappy to do the procedure without 
such protection.
Dr. Heppell: No.
Question: Can rectal disease be so severe 
that you would not attempt a pouch 
procedure?
Dr. Heppell: No. The rectum is nearly 
completely resected and a mucosectomy 
performed for a very short distance (2 to 
3 cm) so that only the anal sphincter is 
preserved. In this manner, it is possible 
to perform a mucosectomy even in the 
presence of severe rectal disease.
Dr. Morgan: Most of the patients I see 
with destructive disease of the rectum 
have Crohn’s disease. In general, patients 
with ulcerative colitis have grossly dis­
eased mucosa and submucosa but rarely 
is transmural disease present in the 
anorectal region. We have not rejected 
any patient because of this.
Dr. Cohen: The answer to that is proba­
bly not. In our most recent cases, we 
excised the rectum completely leaving a 
rectal cuff of only 2 cm. With this tech­
nique we have been able to strip away the 
anorectal mucosa in all cases, even though 
in some it has been quite difficult. If you 
are considering leaving a rectal cuff of 8 
to 10 cm, then in some cases it is practi­
cally impossible to be absolutely certain 
that all the diseased mucosa has been 
removed.
Dr. Beart: I have not seen such a case. 
Dr. Goldberg: I suspect that if the rectal 
disease is so severe that the sphincters 
have been destroyed, I certainly would 
not attempt a pouch procedure. But if, 
on anorectal manometry and on clinical 
examination, the sphincters appear to be 
uninvolved, I would not hesitate to do so 
if I was convinced that this was mucosal 
ulcerative colitis and not Crohn’s disease. 
Dr. Belliveau: As long as the diagnosis is 
ulcerative colitis, results are very satisfy­
ing when a strictured rectum is removed 
or the muscle cuff is incised posteriorly 
to allow the reservoir to be pulled through 
satisfactorily.
Question: Do you use systemic antibi­
otics? Which ones? For how long?
Dr. Beart: Yes. A second generation 
cephalosporin for three doses.
Dr. Belliveau: Systemic antibiotics are 
used only in the immediate perioperative 
period and consist of standard oral and 
parenteral agents used in bowel prepa­
ration.
Dr. Morgan: All our prophylactic antibi­
otics have been given orally. We believe 
that the antianaerobic agents are vital and 
the metronidazole group of drugs has 
been shown to be the most effective agent 
in combatting these organisms. We cur­
rently use tinidazole which is totally 
absorbed from the gastrointestinal tract 
and remains within the tissues for a con­
siderable time.
Dr. Goldberg: We used Mefoxin for three 
doses: one preoperatively and two 
postoperatively.
Dr. Cohen: We prepare our patients with 
a gastrointestinal irrigation solution of 
Go-lytely. We also use Flagyl and netil­
micin intravenously on call to the oper­
ating room, intraoperatively and for 48 
hours postoperatively.
Dr. Heppell: I use the same antibiotics I 
use for prophylaxis in colon surgery. 
Question: Is it necessary to preserve the 
ileocolic vessels? Does it make any 
difference?
Dr. Heppell: I usually preserve the ileo­
colic vessels, but if I have difficulty in 
mobilizing the J pouch so that it can reach 
the anus, I would sacrifice vessels in the 
mesentery proximal to the arcades.
Dr. Morgan: We always preserve the ileo­
colic vessels. However, in one patient in 
whom there was an early cancer of the 
hepatic flexure, this vessel was sacrificed; 
luckily, the superior mesenteric was suffi­
ciently long to enable an easy pouch-anal 
canal anastomosis.
Dr. Goldberg: The ileocolic vessels are 
critical to the construction of an ileoanal 
reservoir. We may have to sacrifice one 
arcade in order to straighten out the 
bowel. But we have found that since we 
have gone to the short efferent limb of 
2 to 3 cm, the ileum reaches the anal canal 
with ease.
Dr. Beart: It is not necessary, but a 
general philosophy to preserve as much 
of the blood supply to the distal pouch 
as possible seems reasonable. The ileo­
colic vessels are usually not the limiting 
vessels but we preserve them until the 
limiting vessels are defined.
Dr. Belliveau: It is important to preserve 
the ileocolic vessels when performing the 
colectomy to obtain maximal blood sup­
ply to the terminal ileum and also to use 
its arcades by dividing the vessel close to 
its origin to allow greater mesenteric 
mobilization when constructing the 
reservoir.
Dr. Cohen: I do believe it is important to 
have knowledge of the various types of 
pouches. When one is constructing a J- 
shaped reservoir, one can leave the ileo-
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colic vessels. In order to gain more length, 
one can sacrifice a more proximal portion 
of that vessel. However, in constructing 
an S-shaped pouch, the ileocolic vessels 
must be taken.
Question: How long should the rectal cuff 
be?
Dr. Goldberg: We feel that the rectal cuff 
only has to be about 4 to 5 cm in length, 
just to the top of the anal canal.
Dr. Beart: There is no need to save rectal 
muscle. We transect the rectum just above 
the puborectalis.
Dr. Belliveau: The rectal cuff should be 
relatively short, 4 to 6 cm from the anal 
margin.
Dr. Heppell: No more than 4 cm long. 
Dr. Morgan: We amputate the rectum 
just above the anorectal junction.
Dr. Cohen: In our experience it is not 
necessary to leave a cuff of longer than 
2 cm. In fact, in our early experience, 
leaving a rectal cuff of 8 to 10 cm, we had 
a ninefold increase in the septic compli­
cation rate. Since leaving a short rectal 
cuff there has been no increase in sexual 
complications produced as a result of the 
operation itself. In addition, by leaving 
a short cuff, one can be more certain that 
all the diseased mucosa has been 
removed.
Question: Describe your use of drains in 
or around the pouch. How many do you 
use? Where are they placed and where do 
they exit?
Dr. Morgan: I insert a sump drain from 
the abdomen into the pelvis and usually 
remove it after 36 hours.
Dr. Cohen: We prefer to use short Silas­
tic closed suction drains (Jackson-Pratt 
drains). We use two drains, both placed 
abdominally. From the left lower quad­
rant the drain is placed into the presacral 
space and from the right lower quadrant 
the drain is placed to within 2 cm of the 
anal anastomosis. Our usual routine is to 
remove the right-sided drain close to the 
anastomosis first, followed by the 
presacral drain, but we may leave these 
drains in place for a considerable length 
of time until they have virtually stopped 
draining.
Dr. Heppell: I use two Jackson-Pratt 
drains that are positioned behind the 
pouch and exteriorized in the left iliac 
fossa. These drains are usually left in 
place for 4 to 5 days.
Dr. Belliveau: Drains are used routinely. 
A sump drain of Silastic material and 
fairly large (7 mm) diameter is placed in 
the sacral hollow beside the pouch and 
brought out in the left lower abdomen.
I also place a large (24 F) Foley catheter 
in the pouch, exiting from the anus to 
drain residual bowel contents and blood. 
Drains are generally removed in 3 or 4 
days.
Dr. Beart: I place two round suction 
drains behind the pouch and in front of 
the sacrum bringing them out through
stab wounds in the left lower quadrant. 
Dr. Goldberg: We initially started using 
drains in the way Sir Alan Parks did with 
perineal drains and abdominal drains. 
However, in most of our patients we now 
use a single no. 10 Jackson-Pratt drain 
posterior to the pouch brought out 
through a stab incision. It is usually left 
in for 48 to 72 hours.
Chairman's Conclusions: In the selection 
of the type of operation for the treatment 
of intractable chronic ulcerative colitis, 
the current crest of enthusiasm favours 
the establishment of a pelvic reservoir and 
ileoanal anastomosis with a temporary 
ileostomy to be closed about 3 months 
later. It is unanimously agreed that this 
operation should not be performed on 
patients with Crohn’s disease or those 
with defective sphincter function. Most 
agree that the operation should not be 
performed in the emergency situation, 
but, after their experience gained at the 
University ot Minnesota, Dr. Goldberg 
has stated that his group would not hesi­
tate to construct a pouch after an emer­
gency colectomy. It is not agreed above 
what age the operation should not be 
offered to a patient, but the upper limit 
usually ranges from 50 to 60 years.
All the panelists agree that the rectal 
cuff can and should be short, not more 
than 2 to 4 cm above the levator muscles. 
A shorter cuff will reduce operating time, 
make no difference to the functional 
results, and will reduce the incidence of 
septic complications. Not agreed upon is 
the ideal configuration of the reservoir. 
The most popular configurations are the 
S pouch proposed by the late Sir Alan 
Parks and the J pouch proposed by 
Utsunomiya. Other pouches include the 
lateral ileal pouch described by Fonkals- 
rud and the W pouch of Nicholls.
Each kind of pouch has its proponents 
and detractors, its advantages and disad­
vantages. The original concern with the 
S pouch was the need for catheterization, 
but the modification of constructing a 
short efferent limb of 2 to 3 cm has vir­
tually eliminated the problem as most 
patients with this limb length have spon­
taneous evacuation. The pouch takes 
longer to construct, but it is easier to per­
form the ileoanal anastomosis without 
tension. The J pouch is easier to con­
struct, but difficulties have been encoun­
tered mobilizing the mesentery adequately 
so that the pouch-anal anastomosis can 
be performed without tension. All 
panelists agreed that a covering ileostomy 
is indicated despite the occasional reports 
of patients having a reservoir constructed 
without diversion.
Although the mortality of these proce­
dures has been low there has been con­
siderable morbidity. The most common 
complications have been pelvic sepsis, 
some patients requiring reoperation, and 
small-bowel obstruction, many patients
requiring laparotomy. Anastomotic 
dehiscence and significant stricture occur 
less frequently.
The acid test of any new procedure is 
the functional result. The frequency of 
defecation decreases with time and after 
6 to 12 months averages five to six bowel 
movements per day with about one 
quarter of the patients having to rise at 
night for a bowel movement. As would 
be expected, the frequency of defecation 
is inversely proportional to the reservoir 
capacity. The fact that capacity increases 
with time may explain why the stool fre­
quency decreases with time. Approxi­
mately half the patients require some 
form of antidiarrheal medication. Leak­
age is a frequent problem and many 
patients require an anal pad at night when 
the problem is worse. Manometric studies 
of the anal sphincter after reservoir con­
struction have shown a reduced resting 
pressure but squeeze pressures have been 
maintained. These findings suggest 
impaired internal sphincter function and 
may explain the night leakage, a time 
when the patient cannot rely upon the 
external sphincter.
Bladder and sexual problems have been 
minor with the most common problem 
being retrograde ejaculation.
Inflammation of the pelvic reservoir 
has proven to be an annoying problem. 
Various treatments have been recom­
mended, a popular one being administra­
tion of metronidazole.
There still remain unresolved issues, the 
most prominent being the optimal con­
figuration of the pouch. Although there 
has been and continues to be progress in 
reducing the morbidity of this operation, 
future modifications will undoubtedly 
improve the end results. ■
Canadians all over are 
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Postmastectomy Lymphedema Treated 
With the Wright Linear Pump
Fifteen patients with postmastectomy 
lymphedema of the arm were treated 
with the Wright linear pump, a program­
mable, gradient pressure, sequential, 
intermittent compression pump. The 
group comprised volunteers in whom 
conservative measures had failed. This is 
a phase II trial to determine the efficacy 
of the pump.
All patients had subjective improve­
ment. Objectively, all showed a reduc­
tion in edema, but this was of variable 
degree and depended on the amount of 
pre-existing lymphedema in the arm.
The Wright linear pump is easy to use 
and treatment was well tolerated. IMo 
fluid overload occurred due to treatment 
and no other medical problems were 
encountered.
The Wright linear pump seems more 
effective than other pneumatic intermit­
tent compression pumps available.
Une etude de phase II fut entreprise afin 
de determiner I'efficacite d'une pompe a 
compression sequentielle et intermittente 
(Wright linear pump) dans le traitement 
d'un lymphcedeme du bras secondaire a 
une mastectomie. Quinze patientes, dont 
I'etat demeurait inchange suite a des 
traitements traditionnels, furent selec- 
tionees pour participer a cette etude.
Toutes les patientes ont ressenti une 
amelioration subjective de leur condition. 
De plus, une reduction de I'cedeme fut 
observee chez toutes les participantes.
From the Department o f Radiation Oncol­
ogy, A. Maxwell Evans Clinic o f  the 
Cancer Control Agency o f  British Colum­
bia, Vancouver, BC
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Cependant, cette reduction fut variable, 
dependant de la severite du lymphcedeme 
preexistant. Le traitement fut tres bien 
tolere et aucun probleme medical ne fut 
rencontre, principalement en ce qui, con- 
cerne la surcharge liquidienne.
La Wright linear pump est d'usage tres 
facile et semble etre plus efficace que les 
autres pompes a compression intermit­
tente presentement disponibles.
The incidence of lymphedema after 
mastectomy varies from 6.7% to 
62.5%.' Its cause is due to a combina­
tion of factors, including surgical removal 
of lymphatic channels in the anterior 
axilla, especially along the axillary vein. 
Radiotherapy increases the incidence by 
scarring existing lymphatic channels and 
preventing the formation of new lym­
phatics. Obstruction of the axillary vein 
by scar tissue leads to lymphatic stasis, 
dilatation and valvular insufficiency of 
the lymphatics and increased susceptibil­
ity to infection. The incidence of lym­
phedema rises markedly with underlying 
infection, either superficial or deep.
Conservative management includes 
elevation2 of the affected arm for at least 
30 minutes at a time. Isometric exercises 
of the limb will increase the active mus­
cle pump.3 Diuretics have been used but 
without much success. An elastic sleeve 
interrupts the cycle of edema and prevents 
stretching of tissues and loss of elasticity.
Available surgical procedures are not 
very successful. They include lymphan- 
gioplasty, omental bridging,4 lym- 
phaticovenous shunting,5 Goldsmith’s 
omental transposition,6 superficial to 
deep lymphatic anastomosis,7 lysis of 
axillary vein adhesions8 and in very 
severe cases as a last resort, amputation 
of the affected limb.
Several pneumatic intermittent com­
pression pumps are available. The most 
common one, the Jobst unit,9 is com­
posed of a single cuff that inflates and 
then deflates. The unit fills all at once and 
the pumping milks the limb from distal 
to proximal. The pressure phase forces 
edema fluid up the lymphatic channels 
and the exhaust phase allows them to 
refill.
The Wright linear pump (Pittsburgh, 
Penn.) (Fig. I)10 was developed to over­
come the inherent reverse-flow charac­
teristics of single-cuff pressure devices 
and thereby reduce back flow. Three cells 
enclose the hand and wrist, forearm and 
upper arm. Each cell is provided with a 
hose to receive air from the pump at pre­
set times and pressures. Pressure gra­
dients between cells from distal to prox­
imal are at sequentially lower pressures, 
thus minimizing the tendency for back 
flow. The highest pressure is midway 
between the patient’s systolic and diastolic 
blood pressures. There are three solid- 
state electronic timers. The “ on time”
FIG. 1—Wright linear pump with cuffs for 
arm and leg.
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controls the full time for each cycle (90 cycles (30 seconds). There are two delay 
seconds). The “ off time” controls the timers between the three cells so that the 
time at atmospheric pressure between most distal cell is on for longer than the
FIG. 2—Wright linear pump with three hoses to connect to three pressure devices and three 
solid state electronic timers.
Table 1--Patient Characteristics
Patient
no.
Present 
age, yr Surgery
Date of 
treatment
Nodal
involvement
Radiation 
to axilla
1 70 L mrm August 1983 + Yes
2 70 L seg + nodes July 1981 + Yes
3 51 L seg + nodes May 1980 - Yes
4 60 R seg + nodes July 1983 + Yes
5 69 R mrm January 1980 + Yes
6 63 R mrm December 1982 + Yes
7 81 L radical 1968 + Yes
8 65 R mrm May 1985 + Yes
9 79 R mrm July 1975 + Yes
10 35 L radical December 1973 - No
11 43 R seg + nodes November 1981 - Yes
12 71 L mrm June 1984 + Yes
13 55 R mrm October 1984 + Yes
14 39 R mrm March 1982 - No
15 59 L mrm September 1983 + Yes
mrm = modified radical mastectomy, seg 
tion, radical = radical mastectomy.
+ nodes = segmental resection and axillary node dissec-
middle cell which again is on longer than 
the proximal cell (Fig. 2).
Patients and Methods
Fifteen women with chronic lym­
phedema of the arm were admitted to the 
A. Maxwell Evans Clinic of the Cancer 
Control Agency of British Columbia in 
Vancouver for treatment on the Wright 
linear pump. All had had surgery for car­
cinoma of the breast and 14 had received 
adjuvant radiotherapy. They ranged in 
age from 35 to 81 years (median 67 years). 
Two patients had undergone classic rad­
ical mastectomy, nine modified radical 
mastectomy and four had had segmental 
resection with axillary node dissection. 
Eleven patients had axillary node involve­
ment. Thirteen received adjuvant five- 
field radiotherapy to the internal mam­
mary, supraclavicular and axillary lymph 
nodes and also the chest wall. One woman 
with no cancer in the lymph nodes 
received in ternal m am m ary and 
supraclavicular radiation only for an 
inner quadrant lesion (Table I).
The edema occurred from 1 to 168 
months (mean 30 months) after initial 
therapy.
The patients were self-selected in that 
they requested therapy for the lym­
phedema. In many, conventional conser­
vative measures had failed. None admit­
ted to any psychological difficulty in 
living with a lymphedematous arm. 
Almost all patients complained that the 
arm was cumbersome and heavy, and 
50% experienced some pain in the limb, 
but none had any functional disability. 
Four women had had numerous episodes 
of infection. In another, lymphedema was 
the direct result of trauma.
Six patients had been prescribed 
diuretics, usually furosemide or hydroch­
lorothiazide, but only one reported any
Table II—Duration of Edema and Measurements of Arm Circumference*
Difference
Patient
no.
Time for 
edema to 
occur, mo
Duration,
mo
Circumference 
of normal 
arm, cm
between normal 
and affected 
arms, cm
Circumference of affected arm, cm 
Before treatment After treatment
Reduction in 
edema, cm
Group 1: Edema 2 -  5 cm
2 31 25 24.3 3.7 28.0 26.9 1.1
3 5 65 20.0 4.1 24.1 23.5 0.6
4 12 19 22.8 3.7 26.5 22.6 3.9
5 69 4 23.0 2.0 25.0 24.2 0.8
7 108 108 22.0 2.2 24.2 23.0 1.2
8 1 10 22.7 2.3 25.0 24.0 1.0
10 60 93 25.7 2.3 28.0 26.0 2.0
14 24 26 23.5 3.5 27.0 26.3 0.7
15 18 30 23.0 4.5 27.5 23.8 3.7
Group 2: Edema >  5 cm
1 30 6 19.0 5.4 24.4 22.0 2.4
6 22 15 21.7 6.7 28.4 26.0 2.4
9 12 120 20.7 13.8 34.5 29.0 5.5
11 18 38 20.0 7.0 27.0 22.5 4.5
12 1 19 26.8 6.7 33.5 28.9 4.6
13 96 168 20.0 9.0 29.0 27.8 1.2
'Measured 6 cm below the olecranon.
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improvement. Twelve of the 15 patients 
had previously used a Jobst pneumatic 
intermittent compression pump. Seven 
used it consistently for at least 3 months 
but discontinued its use because of poor 
results. Ten patients had been measured 
for an elastic sleeve but none wore it con­
sistently as they found it too hot in the 
summer. Cosmetically, most patients felt 
that the elastic sleeve attracted more 
attention to the arm than the edema itself.
The women were treated on the Wright 
linear pump according to the protocol 
outlined by Alexander at the DT Watson 
Rehabilitation Hospital, Sewickly, Penn­
sylvania.
The patients were screened for pre­
existing cardiac, respiratory, renal or 
hepatic disease to reduce the risk of 
volume overload. All patients had 
recently undergone chest roentgenogra­
phy, electrocardiography, complete blood 
count, liver function testing, measure­
ment of blood urea nitrogen and creati­
nine levels and serum protein electropho­
resis. Concurrent infection in the arm was 
a contraindication to treatment.
The hospital admission period was 48 
hours. Treatment with the Wright linear 
pump totalled 38 hours, consisting of 
seven sessions of increasing time as fol­
lows: a 2-hour period, two 4-hour 
periods, two 6-hour periods and two 
8-hour periods with 1 hour’s rest between 
each session. Vital signs, including heart 
rate, blood pressure and respiration, were 
checked every 2 hours.
The most distal cell of the pump was 
inflated to the midpoint between the 
patient’s systolic and diastolic pressures. 
The middle-cell pressure was 20 mm Hg 
lower and the proximal cell was in turn 
20 mm Hg lower than that. The distal cell 
was on for 90 seconds. The first delay 
timer was set at 20 seconds so that the 
middle cell was on for 70 seconds. The 
second delay timer was also set for 20 
seconds so that the proximal cell was on 
for 50 seconds. The “ off timer” was set 
at 30 seconds, thus making each cycle a 
total of 120 seconds.
The women were arbitrarily divided 
into two groups (mild and moderate- 
severe edema) to see if there was a rela­
tion between volume of edema and 
response to treatment. Measurements 
were taken 6 cm below the olecranon,
com paring the affected with the 
unaffected arm. Those with a 2- to 5-cm 
difference in circumference fell into group 
1 (nine). A difference greater than 5 cm 
put them into group 2 (six patients). (A 
difference less than 2 cm would have not 
been sufficient to require treatment.)
Results
All patients experienced a subjective 
improvement. Even those who had little 
objective improvement were pleased with 
the results. All said the arm felt lighter 
and pain free, and the skin felt smoother 
and lax. The limb was less tense, and 
some patients were pleased at being able 
to see the elbow and wrist joints and ten­
dons along the back of the hand for the 
first time in years.
Objective improvement was less 
marked (Table II). Eight patients had a 
0.5- to 2-cm reduction, three had a 2- to 
4-cm reduction and three others had a 
4-cm reduction in arm circumference. The 
patient with a 13.8 cm difference between 
the two arms had the most marked reduc­
tion (5.5 cm).
Discussion
The Wright linear pump is extremely 
easy to use and is suitable for home ther­
apy. Subjectively all patients felt 
improved, but objectively the results were 
mixed. In general, patients with more 
edema had more fluid to lose and there­
fore had a better response, although this 
was not consistent (patients 3 and 13, 
Table II). The disability perceived was not 
in direct proportion to the amount of 
edema as the tolerance of each patient 
differed.
No conclusions can be drawn with such 
small patient numbers, but there appears 
to be no relation between prior episodes 
of infection, duration of edema and 
response to treatment (Table III). Under­
lying infection will certainly aggravate 
existing lymphedema as in patients 5, 9 
and 13. In patient 11, the lymphedema 
resulted from infection after a cut from 
a chicken bone; three subsequent episodes 
of infection aggravated the edema.
Some patients complained of stiffness 
at the elbow joint and soreness through­
out the arm but not pain while they were
Table III—Relation of Infection to Duration of Edema and Response
Date of first Difference in Reduction in
Patient infection and arm circumference, edema after
no. no. of episodes cm* treatment, cm*
5 August 1982 4.1 0.8
9 1982 13.8 5.5
1984 6 X
1986
11 1983 4 X 7.0 4.5
13 1972 4 X 9.0 1.2
'Measured 6 cm below the olecranon.
on the machine. A few patients had pre­
existing arthritis which was aggravated by 
the relatively long periods of immobili­
zation.
One problem encountered was dif­
ficulty in fastening the Wright linear 
pump sleeve over the shoulder so that it 
did not slide down. Many patients had 
repeatedly to pull the sleeve up the arm. 
This was a problem at night when they 
were asleep and some had increased 
edema in the axilla as a result.
It was explained to all patients that they 
would require ongoing treatment and 
would probably have to be on the pump 
for several hours a day until a good 
response was obtained. Thereafter the 
time could be reduced to perhaps 1 to 2 
hours a day. However, treatment would 
be for an indefinite period as this treat­
ment was only for symptoms.
The Wright linear pump is efficient and 
has theoretical design advantages. A 
phase III study would now include ran­
domizing patients into two groups — one 
group treated with the Wright linear 
pump and the other with the Jobst inter­
mittent pneumatic compression pump.
A relative disadvantage of the Wright 
linear pump is its high cost, US $4000.00, 
but this may be covered in part by some 
insurance companies.
Patient motivation and compliance are 
absolutely vital in order to obtain good 
results.
We thank Mrs. Evelyn White and Mrs. 
Linda Moore for secretarial assistance.
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Penetrating
From January 1975 to December 1984, 
93 patients with penetrating chest 
wounds were admitted to three hospitals 
in Regina. Sixty-three percent of the 
wounds were caused by knives and 34%  
by firearms. Sixty-three patients were 
treated conservatively, 18 patients had 
thoracotomy and 12 others underwent 
laparotomy. Of the 18 patients, 16 had 
wounds between the nipples; 8 of the 
16 had injuries to the heart or great ves­
sels. Whereas the majority of penetrating 
wounds to the chest may be treated by 
observation or thoracostomy alone, a 
surgical approach is recommended when 
penetrating injuries are thought to have 
traversed the mediastinum, because of 
the high incidence of associated cardiac 
injuries. In doubtful cases the decision 
should favour early thoracotomy.
De janvier 1975 a decembre 1984, 93 
patients avec blessures penetrantes a la 
cage thoracique furent admis aux trois 
hopitaux a Regina. Soixante-trois pour- 
cent des blessures etaient la cause de 
couteaux et 34% causes par arme a feu. 
Soixante-trois patients furent soignes par 
traitement conservateur, 18 patients 
subirent une thoracotomie et 12 patients 
ont recu une laparotomie. Seize des 18 
patients avec thoracotomie avaient des 
blessures entre les mamelons. Huit de 
ces 16 avaient des blessures au coeur 
ou grands vaisseaux. Tandis que la majo­
rity des blessures penetrantes a la poi- 
trine peuvent etre soignees par observa­
tion ou thoracostomie seulement, les cas 
oil on suspecte que les blessures pene­
trantes pourraient avoir traverse le 
mediastinum on recommande ['interven­
tion chirurgicale par cause de I'associa- 
tion au taux eleve des blessures cardia- 
ques. Dans les cas indecis la decision 
devrait etre une thoracotomie des que 
possible.
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Chest Wounds: a 10-Year Review
Although the majority of patients sustain­
ing penetrating chest wounds can be treat­
ed conservatively by closed-tube 
thoracostomy, a number require surgical 
intervention. This study reports our ex­
perience over 10 years and clarifies indi­
cations for management.
Patients
From Jan. 1, 1975 to Dec. 31, 1984, 93 
patients (83 males, 10 females) with 
penetrating chest wounds were admitted 
to one of three hospitals in Regina. The 
patients ranged in age from 6 to 81 years 
(average 26 years); 64% were under 30 
years of age.
In 60 patients (63%) the wounds were 
caused by knives; 37% of these wounds 
were multiple. In 29 patients (34%) fire­
arms (mostly of small calibre) were 
responsible; 10% of the wounds were 
multiple. In the remaining 3%, other 
weapons were involved.
Findings
Location and Cause o f  Wounds
The site of injury was divided into three 
main areas based on the location of the 
entrance wound — the anterior, lateral 
and posterior chest wall (Table I). The 
anterior chest was subdivided into the
Table 1—Location of Chest Wound
Location in No. (%)
chest wall of patients
Anterior
Between nipples 30 (32.2)
Nipple to anterior axillary line 33 (35.4)
Lateral 11 (11.8)
Posterior
> 5  cm from spine 4 (4.3)
< 5  cm from spine 15 (16.1)
area between the nipples and from the 
nipples to the anterior axillary line. The 
lateral chest extended from the anterior 
to the posterior axillary line. The 
posterior chest was subdivided into areas, 
less and more than 5 cm from the spine 
respectively.
There were three treatment regimens. 
In 63 (68%) patients it consisted of obser­
vation or tube thoracostomy, in 18 
patients thoracotomy was performed and 
another 12 underwent laparotomy (Table 
II).
Thoracotomy
All patients who underwent thoracot­
omy had the procedure within 24 hours 
of admission to hospital, usually within 
1 hour. Presenting features included signs 
of cardiac tamponade, as evidenced by 
increased central venous pressure and 
hypotension (four patients), persistent 
hypotension with a systolic blood pressure 
of less than 100 mm Hg, tachycardia 
(more than 100 beats/m in) (seven 
patients) and continuing hemorrhage 
(more than 250 m l/h) from the chest 
tubes after an initial blood loss of more 
than 1000 ml of bright red blood (two 
patients).
Of these 18 patients, 16 had wounds 
between the nipples. Eleven of them were 
operated on because of signs of cardiac 
tamponade, persistent hypotension or 
continuing hemorrhage from chest tubes. 
Five were operated on principally because 
the wound was between the nipples; that 
is, there were no signs of cardiac tam ­
ponade, and no shock or excessive chest 
hemorrhage. There were, however, indi­
cations of underlying injury as suggested 
by indistinct heart sounds, neck-vein dis­
tension and radiologic evidence of 
intrathoracic bleeding. Of the 11 patients
Table II—Treatment Related to Type of Weapon Used
Treatment
No. (%) 
of patients Knife Gun Other
Observation/tube thoracotomy 63 (68) 42 18 3
Thoracotomy 18 (19) 10 7 1
Laparotomy 12 (13) 8 4 0
Totals 93 (100) 60 29 4
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with obvious clinical signs, 5 had suf­
fered injury to the heart or great vessels 
(Tables III and IV) as had 3 of the 
5 operated on principally because the 
wound was between the nipples (Table 
IV). Of the other two patients with 
wounds outside the nipples who under­
went thoracotomy, one was found to have 
injury to a pulmonary artery (Table III).
Laparotomy
The most commonly injured structures 
in the 12 patients who underwent 
laparotomy were the diaphragm and 
spleen. The diaphragm was injured in all 
cases but only in seven were there major 
lacerations (Table V).
Mortality and Morbidity
None of the patients died as a result of 
injury. Atelectasis and consolidation 
occurred in 44% but these complications 
resolved with conservative management. 
Pleural fibrosis developed in one woman, 
who pulled her chest tube out and then 
discharged herself 3 days after treatment 
for a stab wound to the chest. She was 
readmitted 3 weeks later complaining of 
dyspnea, and a decortication for fibrotho- 
rax was required. None of the thoracot­
omy wounds became infected.
T a b le  I l l - T h o r a c o t o m y :  O p e r a t iv e  F in d in g s  in  
1 8  P a t ie n t s *
S tr u c t u r e  in ju re d N o . o f  in ju rie s
V e n t r ic le s 8
A t r ia 1
P e r ic a r d iu m 3
In t e r c o s t a l  a r te r y 3
In t e r n a l  m a m m a ry  a r t e r y 2
D ia p h r a g m 2
P u lm o n a r y  a r te r y 1
C o r o n a r y  a r te r y 1
C o r o n a r y  s inus 1
O th e r 4
* T h e  h e a r t  o r g r e a t  v e s s e ls  
9  p a t ie n t s .
w e r e  in ju re d  in
T a b le  I V - T h o r a c o t o m y :  O p e r a t iv e  F in d in g s  in  
F iv e  P a t ie n t s  O p e r a te d  O n P r in c ip a l ly  B e c a u s e  
t h e  W o u n d s  W e r e  B e tw e e n  th e  N ip p le s
W e a p o n  used S t r u c t u r e  in ju re d
K n ife L e f t  v e n tr ic le ,  p h re n ic  n e rv e
K n ife L in g u la
G u n L e f t  v e n tr ic le ,  lu n g
G u n L in g u la
G u n R ig h t  a t r iu m , r ig h t  v e n tr ic le ,  
c o r o n a r y  s in u s , e s o p h a g u s
T a b le  V - L a p a r o t o m y :  O p e r a t iv e  F in d in g s  in  
1 2  P a t ie n ts
S t r u c t u r e  in ju re d N o . o f  in ju r ie s
D ia p h r a g m 7
S p le e n 5
S to m a c h 3
L iv e r 2
C o lo n 2
S m a ll  b o w e l 2
Discussion
The majority of penetrating chest 
wounds may be treated by observation or 
tube thoracostomy, or both. In this ser­
ies, 64% of patients were treated conser­
vatively, a rate similar to that reported by 
others.
Controversy remains concerning the 
small group of patients requiring early 
thoracotomy. In our series, surgery was 
undertaken in 32% (thoracotomy 19% 
and laparotomy 13%). In most series, the 
proportion of patients requiring thoracot­
omy has ranged from 15% to 21%. 
The reported death rate has ranged from 
10.4% to 17%.5 Our zero mortality is 
attributed to the fact that the patients 
underwent thoracotomy early, usually 
within 1 hour of admission to the emer­
gency room, and the majority of them 
were young. The consequences of a delay 
in the surgical management of penetrat­
ing wounds of the chest have been iden­
tified by McNamara and colleagues;5 the 
operative death rate was reduced from 
29% to 8% in the latter part of their ser­
ies, when the indications for immediate 
thoracotomy became more liberal.
Similarly, Robicsek and colleagues6 
found a lower death rate in those patients 
who underwent early as opposed to late 
thoracotomy. Our experience supports 
the early surgical treatment of penetrat­
ing chest trauma when there is evidence 
of any of the following findings: shock 
unrelieved by aggressive fluid resuscita­
tion, cardiac tamponade as evidenced by 
hypotension and distended neck veins or 
a high central venous pressure, continu­
ing hemorrhage with an initial chest tube 
loss of 1000 ml of bright red blood fol­
lowed by a continuing loss exceeding 250 
ml/h and mediastinal entrance of the 
chest wound or suspicion that the trajec­
tory or line of impalement may traverse 
the mediastinum. Of four patients in 
whom the wound was less than 5 cm from 
the spine, one underwent thoracotomy 
because of shock and one for cardiac tam­
ponade. The first was found to be bleed­
ing from a lacerated lung and the second 
patient had a torn pulmonary artery. 
Cardiac injury must be considered in any 
patient with a mediastinal wound.8 In 
this series, 50% of the patients with medi­
astinal entrance wounds who underwent 
thoracotomy had injuries to the heart or 
great vessels.
Pericardiocentesis does not appear to 
have a place in the treatment of cardiac 
tamponade other than to decompress the 
pericardium in the interval between the 
patient’s admission and arrival in the 
operating room. Pericardiocentesis was 
attempted only once in this series and was 
unsuccessful. The patient underwent 
thoracotomy to relieve his tamponade. 
Pericardiocentesis is associated with a 
false-negative result in 25% of cases.3
In the majority of patients a left 
anterolateral thoracotomy was performed 
and in a few a median sternotomy. The 
benefits of each are debatable. The choice 
of incision may vary from surgeon to 
surgeon.
Ideally, patients with wounds between 
the nipples who may have suffered 
cardiac injury, should be taken to a hospi­
tal where cardiopulmonary bypass is 
available. One of our patients was placed 
on cardiopulmonary bypass while multi­
ple penetrating wounds were repaired. 
There were no complications and he was 
discharged 33 days later. In none of these 
patients did signs or symptoms of cardiac 
decompensation develop. Because of the 
transient nature of this group of patients, 
follow-up was not feasible. Post- 
traumatic cardiac sequelae are relatively 
common.2
Laparotomy, performed in 12 patients, 
was accomplished through separate inci­
sions in all but 1. There were two 
major complications. In one patient, the 
victim of a shotgun wound to the left 
upper abdomen and left lower chest, a 
colocutaneous fistula developed. The 
other suffered a biliary-pleural fistula; he 
had sustained a gunshot wound to the 
right lower thorax and upper abdomen. 
An anterolateral thoracotomy and 
laparotomy were performed, and the 
bullet was removed. Subsequently, bile 
was noted draining through the chest tube 
and a second laparotomy, with suturing 
of the left lobe of the liver and repair of 
the tear in the diaphragm, was necessary. 
His postoperative course was smooth. 
Since the final resting place of a bullet 
penetrating the chest, especially in the 
lower thorax, cannot always be ascer­
tained, abdominal injury and subsequent 
intra-abdominal hemorrhage should be 
considered. Borja and Ransdell4 advo­
cated separate thoracic and abdominal 
incisions for combined injuries, to pre­
vent contamination of the thoracic cavity 
from the abdominal wound, osteomyeli­
tis, osteochondritis and diaphragmatic 
hernia.
Early complications, of which atelec­
tasis was the commonest, developed in 
44% of patients. None were incapacitat­
ing. Delayed thoracotomy was performed 
on a woman who had a retained 
hemothorax, the circumstances being 
previously outlined.
Conclusions
The majority of penetrating chest 
wounds may be treated by observation or 
tube thoracostomy, or both. Early thora­
cotomy is indicated in the following cir­
cumstances: in patients with wounds 
between the nipples, when the injury is 
thought to have traversed the mediasti­
num and when there is any doubt about 
the extent of injury.
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SESAP V Critique
ITEM 105
Hepatitis after transfusion in the United States is due to “ non-A, non-B hepatitis” in at least 80% of properly 
studied patients. Retrospective studies indicate that this has probably always been the dominant form of posttrans­
fusion hepatitis in this country. It is called non-A, non-B hepatitis because hepatitis A and B can now be ruled 
out by serologic testing, and multiple different other agents, presumably viruses, are almost certainly responsible 
for the problem.
Several recent prospective studies have shown that about 7.5% of all patients transfused with blood from volunteer 
donors develop evidence of hepatitis within six months of transfusion. Available data suggest an incidence of 1% 
to 2% after exposure to a single volunteer donor, but exposure to only a single donor is becoming increasingly 
unusual in modern medical practice. These data, along with older studies using hepatitis B as the marker, indicate 
that the risk of hepatitis after transfusion is cumulative and proportional to the number of donors to which the 
patient is exposed. The impression that most of the risk occurs with the first exposure and decreases thereafter is 
potentially dangerous as well as incorrect.
Testing for hepatitis B with currently available tests has not eliminated the transmission of this disease by trans­
fusion. Blood is infective at a concentration of virus far below what can be detected by even these tests, although 
most infective units are in the range of detectability.
Hepatitis A is rarely transmitted by transfusion, because the infective phase of this disease is associated with 
clinical illness in the potential donor. Over 20% of multiply transfused recipients show serologic evidence of exposure 
to cytomegalovirus, however, but this seems to cause clinical illness only in immunosuppressed patients or prema­
ture infants. Apart from the incidence, the most disturbing observation about non-A, non-B hepatitis is its persis­
tence for over a year in nearly half the patients affected, with changes on liver biopsy paralleling the degree of abnor­
mality in liver function tests. Whether this disease behaves as other forms of chronic hepatitis do is now being studied. 
Even when all available practical methods of screening for transmitted diseases are used, including some, such as 
measuring alanine aminotransferase, not in general use, blood from commercial sources remains over twice as likely 
to transmit hepatitis as blood from volunteer sources.
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Lower Extremity Amputations: 
a 5-Year Review and Comparative Study
In order to review major lower extremity 
amputations at the Toronto East General 
and Orthopaedic Hospital Inc. between 
1979 and 1984, 60 patients with 42 
below-knee, 17 mid-thigh and 20 Cal­
lander through-knee amputations were 
studied retrospectively.
The three amputation groups demon­
strated comparable rates of stump heal­
ing. A previous history of vascular sur­
gery on the extremity increased the risk 
for both delayed healing and failure to 
heal. The Callander through-knee ampu­
tees were rehabilitated earlier and more 
easily than were the mid-thigh amputees, 
and once rehabilitated they were more 
likely to continue using their prostheses.
The authors recommend that, when 
possible, the chosen site of amputation 
for the majority of patients should be 
below the knee, but when this is not 
practical a through-knee amputation 
should be done in preference to a mid­
thigh amputation.
Dans le but de comparer les principales 
formes d'amputations de membres 
inferieurs qui ont ete pratiquees au 
Toronto East General and Orthopaedic 
Hospital Inc. entre 1979 et 1984, 42 
amputations sous le genou, 17 amputa­
tions a mi-cuisse et 20 amputations
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selon la methode de Callander a travers 
le genou ont ete etudiees retrospective- 
ment sur 60 patients.
Les trois genres d'amputations ont 
montre un taux de guerison equivalent. 
On a aussi observe que dans les cas 
d'antecedant de chirurgie vasculaire sur 
la meme jambe, on court le risque d'une 
guerison prolongee et d'un echec. ou les 
deux. D'autre part, les amputes selon la 
methode de Callander a travers le genou 
ont ete retablis plus rapidement et avec 
plus de facilite que les amputes a mi- 
cuisse, et une fois retablis, ils ont eu 
plus de tendance a se servir de leur pro- 
these.
Les auteurs recommandent d'opter de 
preference pour I'amputation au-dessous 
du genou pour la majorite des patients, 
mais si ce choix n'est pas possible on 
donnera la priorite a I'amputation a 
travers le genou plutot qu'a I'amputation 
a mi-cuisse.
The through-knee amputation, despite a 
long history of use in Europe, remains an 
unpopular and infrequently performed 
procedure in North America.1,2 In 1935,3 
and again in 1938,1 Callander reported 
on his modification of the through-knee 
amputation. Apart from two notable ser­
ies,2,4 the Callander amputation has 
fallen out of favour in North America. 
Objections raised to the performance of 
this procedure include difficulty with 
prosthetic fitting, poor cosmesis and 
wound healing problems. A recent liter­
ature review, however, confirms that 
through-knee amputation remains popu­
lar in Europe.5-11
The advantages of this amputation over 
the above-knee one include the following: 
it provides an excellent end-bearing stump 
that, combined with lateral and ischial 
bearing, facilitates ambulation with a 
prosthesis and increases stability; because 
the amputation cuts across tendons and 
not muscles, it is technically a less bloody 
procedure with less potential for infec­
tion; the rate of prosthetic use is higher
than after other types of amputation; 
and, finally, a longer lever arm provides 
greater seating stability, especially for 
patients with bilateral amputations.
The objectives of this study were to 
compare below-knee, through-knee and 
above-knee amputations with respect to 
wound healing, level of amputation, dis­
ease process, the presence or absence of 
antecedent vascular surgery, revision 
rates, mortality and the ultimate level 
of rehabilitation achieved.
Methods
A retrospective study was conducted 
at the Toronto East General and 
Orthopaedic Hospital Inc. on all ampu­
tations performed by two staff surgeons 
(I.J.H . and J.M.W.) between 1979 and 
1984, inclusive. The in-hospital and out­
patient charts of 60 patients (39 men, 21 
women) were reviewed. Information on 
rehabilitation and prosthetic function was 
obtained by clinical review at recall 
whenever possible. Patients living out 
of town were followed up by telephone 
interview; if the patient had died, the 
relatives were questioned. The records 
of the prosthetic supply company were 
consulted for each patient.
All amputations were standard and 
performed according to established prin­
ciples. The majority of below-knee ampu­
tations utilized the long posterior 
myocutaneous flap. All above-knee 
amputations employed the standard fish- 
mouth incision with equal anterior and 
posterior flaps. All through-knee ampu­
tations were done by one surgeon 
(J.M.W.), using a modification of the 
Callander technique.
The Callander amputation embodies a 
long, anterior, full-thickness flap, extend­
ing medially from the adductor tubercle 
down to and including almost the total 
patellar tendon at its insertion into the 
tibia and laterally to the superior margin 
of the lateral condyle at its junction with 
the femoral shaft. The flap should be 
elongated and spatulate. Great care is 
necessary in coring the patella from the
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patellar tendon as the residual raw area 
is positioned over the severed end of the 
femur during the final reconstruction.
A relatively short flap, no more than 
7.5 cm long, with a gentle curve, should 
be made posteriorly. This is a departure 
from the technique of Callander, who 
made a much longer flap. These soft tis­
sues are severed and allowed to retract. 
The femur is carefully transected 
perpendicular to its long axis, just 
above the adductor tubercle. Hemostasis 
is assured and the flaps are approximated 
and sutured with the material of the sur­
geon’s choice. Hemovac drainage of the 
amputation site is always used and 
removed after 24 hours. The choice of 
dressing is again at the discretion of the 
operating surgeon.
The level of amputation was deter­
mined solely by clinical judgement — 
by assessing skin temperature and colour, 
and the presence or absence of pulses 
preoperatively, and whether the patient 
would be able to walk with a prothesis. 
Below-knee amputation was the preferred 
choice of both surgeons, as preservation 
of the knee joint provides easier rehabi­
litation and virtually guarantees successful
prosthetic wear. Below-knee amputees 
have a more stable gait with a prosthesis 
than either Callander or above-knee 
amputees.
A Callander procedure was chosen over 
the mid-thigh amputation whenever the 
operating surgeon (J.M.W.) thought the 
patient was likely to walk postoperatively. 
The final decision on the level of ampu­
tation, however, was made at the time of 
operation and depended on the vascular­
ity of the tissues. Ancillary tests such as 
fluorOcine dye studies, assessment of oxy­
gen tension, Doppler studies and angiog­
raphy were not used to determine the level 
of amputation. Angiography was per­
formed on 22 patients to determine their 
suitability for vascular reconstruction.
The only real variability noted in the 
study was the postoperative management 
of below-knee amputations; one surgeon 
(J.M.W.) favoured soft dressings and 
delayed weight-bearing, the other (l.J.H .) 
favoured an immediate application of a 
cast with an early ambulation on a 
pylon.12
Vascular surgery had been performed, 
in the majority of cases, at our institution. 
Included were a variety of arterial bypass
graft procedures with either synthetic 
materials (Gore-Tex) or vein, embolecto- 
mies or sympathectomies, which could be 
either surgical or chemical. An amputa­
tion was said to have healed primarily if 
it did so within 3 weeks from operation. 
Delayed healing was present when an 
amputation required 6 weeks or more to 
heal, or if formal debridement or local 
revision was required to achieve healing. 
Failure was defined by the necessity to 
revise the amputation to a higher level or 
when the amputation had not healed at 
the time of death (when this exceeded 6 
weeks from operation).
Findings
The age of the 60 patients at the time 
of amputation ranged from 37 to 84 years 
(average 66.4 years). Forty-two below- 
knee amputations were done in 37 
patients, 20 Callander amputations (20 
patients) and 17 above-knee amputations 
in 14 patients.
The indications for amputation are set 
forth in Table I and the results in Table 
II. In both the below-knee and through- 
knee groups, 75% of amputations with 
delayed healing and 100% of stumps that 
failed to heal and required revision were 
associated with previous vascular surgery 
on the extremity (Table III). In the above­
knee group, all amputations with delayed 
healing and 50% of those that failed to 
heal were associated with previous vascu­
lar surgery.
Twenty-eight (76%) of the 37 below- 
knee amputees were rehabilitated and 25 
of them used their prostheses regularly. 
Eleven (55%) of the 20 through-knee 
amputees were rehabilitated and all used 
their prostheses; 8 (57%) of the 14 above­
knee amputees were successfully rehabili­
tated and, of these, 7 used their prostheses 
regularly.
Table -Indication for Major Lower Extremity Amputations
Level of amputation No.
Peripheral 
vascular disease Diabetes Other
Below-knee 42 15 26 1
Through-knee 20 13 7 —
Above-knee 17 13 4 -
Table I I - Results
Level of 
amputation No.
Primary healing, 
no. (%)
Delayed healing, 
no. (%)
Failure, 
no. (%)
Hospital 
death,* no. (%)
Below-knee 42 29 (69) 8 (19) 3 (7) 2 (5.4)
Through-knee 20 13 (65) 4 (20) 2 (101 1 15)
Above-knee 17 12 (71) 2 (12) 2 (12) 1 (6)
* < 3 0  d.
Table Ill-Antecedent Vascular Surgery
Study group _______ Primary healing_______  Delayed healing Failure
Level of 
amputation No.
Previous vascular 
surgery, no. (%)
No.
(%)
Previous vascular 
surgery, no. (%)
No.
(%)
Previous vascular 
surgery, no. (%)
No.
(%)
Previous vascular 
surgery, no. (%)
Below-knee 42 20 (47.6)* 29 (69.0) 11 (37.9) 8 (19.0) 6 (75.0) 3 (7.1) 3 (100.0)
Through-knee 20 15 (75.0) 13 (65.0) 8 (61.5) 4 (20.0) 3 (75.0) 2 (10.0) 2 (100.0)
Above-knee 17 10 (58.8) 12 (70.6) 6 (50.0) 2 (11.8) 2 (100.0) 2 (11.8) 1 (50.0)
"Chemical sympathectomies.
Table IV—Rehabilitation
Amputation No.
Wearing
prosthesis
Time to
prosthesis wear 
from operation
Never
fitted Wheelchair
Walker Prosthesis 
with cane
Community 
ambulator 
without assistsNo prosthesis Prosthesis
Above-knee 14 7 3 mo 2 1 __ __ 5 2
Through-knee 20 11 6 wk 3 — — 2 6 3
Below-knee 37 25
Unilateral 20 4 wk 2 1 2 1 6 13
Bilateral 5 — _ — 1 2 2
Bilateral 10 - 3 5 — — 2 —
(excluding
below-knee)
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Discussion
The level of amputation did not signifi­
cantly alter the likelihood of achieving 
primary wound healing. The only iden­
tifiable factor adversely influencing 
wound healing was a history of vascular 
surgery and was uniform in all groups 
(Table III). This has been documented in 
other studies.13,14 The rate of wound 
infection and breakdown was approxi­
mately the same at all levels, reflecting the 
inaccuracy of determining level of ampu­
tation by clinical judgement rather than 
by the real status of the blood supply to 
the tissues.
Although postoperative synovial 
fistulas have been a distressing problem 
in some series of through-knee amputa­
tions,11’15 we did not encounter any case 
in our study. Finally, contrary to the 
experience in earlier series,3 and fortun­
ately for our patients, we did not record 
one case of gas gangrene. Routine admi­
nistration of antibiotics preoperatively 
and continued postoperatively may 
explain this.
The near-universal unpopularity of the 
Callander through-knee amputation 
appears to be based on criticisms that can 
no longer be substantiated. Newer light­
weight materials facilitate fitting and con­
tribute to a lighter end product (6 to 9 lbs) 
that is minimally heavier than an above­
knee (5 to 8 lbs) prosthesis. Newer inter­
nal knee mechanisms, including hydraulic 
and pneumatic swing phase control units, 
provide a more cosmetically acceptable 
prosthesis. Costs for through-knee pros- 
theses are the same as those for above­
knee units ($2753.00).
Functionally, the through-knee ampu­
tation provides an excellent end-bearing 
stump which, when combined with lateral 
and ischial bearing in the prosthesis, con­
tributes to an increased stability while 
walking. It has been our impression that 
through-knee amputees are rehabilitated 
earlier and more easily than above-knee 
amputees (Table IV), and this has been 
the case in other studies.9 Furthermore, 
once rehabilitated, it appears that 
through-knee amputees are more likely to 
continue using their prostheses than 
above-knee amputees (Table IV). It 
should be noted, however, that attempts 
to determine frequency of prosthetic use 
are notoriously inaccurate. Many patients 
are seen after a long follow-up wearing 
prostheses that are as new as the day they 
were purchased and yet on direct ques­
tioning they admit to daily use. In reality 
there appears to be no easy way to recon­
cile the conflicting evidence.
In our study, the below-knee amputees 
ultimately achieved the best rehabilitation 
with their prostheses. This was related to 
their younger age (mean 64 years versus 
71 and 67 for Callander and above-knee 
respectively) and to the fact that their
knee joints were preserved, thus making 
them more likely to use their prostheses. 
Those below-knee amputees who were 
unable to use their prostheses still found 
the knee joint advantageous for seating 
and transfers. For patients with above­
knee and Callander amputations, their 
seating stability was purely a function of 
the length of their prostheses and there­
fore the Callander group did better.
In general, bilateral amputees with any 
combination other than bilateral below- 
knee amputations were not rehabilitated 
well. Factors militating against rehabili­
tation in such cases were loss of the knee 
joint, advanced age, poor cardiovascular 
status and high postoperative death rate.
Conclusions
We identified no statistically significant 
difference in the rates of primary healing 
amongst the three amputation groups 
studied. Previous vascular surgery on the 
extremity increased the risk for both 
delayed healing and failure of healing.
Thirty-day in-hospital death rates were 
comparable for all three amputation 
groups studied.
The Callander amputation heals well 
and provides an excellent end-bearing 
stump for ultimate rehabilitation. Most 
criticisms of the Callander through-knee 
amputation seem no longer justified.
Below-knee amputation should be the 
site of choice in the majority of patients. 
If this is not possible, then the Callander 
procedure should be performed in prefer­
ence to a formal mid-thigh amputation.
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ANTIBIOTIC
ACTION
In vitro studies demonstrate that the bacteri­
cidal action of cefoxitin, a cephamycin derived 
from cephamycin C, results from the inhibition 
of bacterial cell wall synthesis. Evidence 
suggests that the methoxy group in the 
7a position is responsible for the resistance of 
cefoxitin to degradation by bacterial beta- 
lactamases.
INDICATIONS AND CLINICAL USES 
TREATMENT
The treatment of the following infections when 
due to susceptible organisms:
1 - In tra-abdom inal in fections such as
peritonitis and intra-abdominal abscess
2 - G yneco log ica l in fe c tio ns  such as
endometritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia marcescens and 
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and jo in t infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections
Appropriate culture and susceptibility studies 
should be performed to determine the sus­
ceptibility of the causative organism(s) to 
MEFOXIN* Therapy may be started while 
awaiting the results of these tests, however, 
modification of the treatment may be required 
once these results become available. 
O rganism s p a rticu la rly  appropria te fo r 
therapy with MEFOXIN* are:
Gram positive
Staphylococci, penicillinase producing and 
non-producing
Streptococci excluding enterococci 
Gram negative (beta-lactamase producing 
and non-producing strains)
E. coli
Klebsiella species (including K. pneumoniae) 
Proteus, indole positive and negative 
Haemophilus influenzae 
Providencia species 
Anaerobes 
Bacteroides fragilis
MEFOXIN* may also be appropriate for the 
treatment of infections involving susceptible 
strains of both aerobic and anaerobic bacteria.
Clinical experience has demonstrated that 
MEFOXIN* can be administered to patients 
w ho are also rece iv ing  c a rb e n ic illin , 
gentamicin, tobramycin, or amikacin (see 
PRECAUTIONS and ADMINISTRATION).
intravenous Administration
The intravenous route is preferable for 
patients with bacteremia, bacterial septicemia, 
or other severe or life-threatening infections, 
or for patients who may be poor risks because 
of lowered resistance resulting from such 
deb ilita tin g  cond itions as m alnutrition , 
trauma, surgery, diabetes, heart failure, or 
malignancy, particularly if shock is present or 
impending.
PROPHYLACTIC USE
MEFOXIN* may be administered periopera- 
tively (preoperatively, intraoperatively and 
postoperatively) to patients undergoing 
vaginal or abdominal hysterectomy and ab­
dominal surgery when there is a significant 
risk of postoperative infection or where the 
occurrence of postoperative infection is 
considered to be especially serious.
In patients undergoing cesarean section, intra­
operative (after clamping the umbilical cord) 
and postoperative use of MEFOXIN* may 
reduce the incidence of surgery related post­
operative infections.
Effective prophylactic use depends on the 
time of administration. MEFOXIN* usually 
should be given one-half to one hour before376
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the operation. Prophylactic administration 
should usually be stopped within 12 hours. It 
has been generally reported that continuing 
adm inistration of any an tib io tic  beyond 
24 hours fo llow ing surgery increases the 
possibility of adverse reactions but, in the 
majority of surgical procedures, does not 
reduce the incidence of subsequent infection.
If signs of postsurgical infection should 
appear, specimens for culture should be 
obtained for identification of the causative 
organism(s) so that appropriate therapy may 
be instituted.
CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who 
have shown hypersensitivity to cefoxitin or to 
the cephalosporin group of antibiotics.
WARNINGS
Before therapy with MEFOXIN' is instituted, 
careful inquiry should be made to determine 
whether the patient has had previous hyper­
sensitivity reactions to MEFOXIN*, cephalo­
sporins, penicillins or other drugs. MEFOXIN" 
should be given with caution to penicillin- 
sensitive patients.
There is some clinical and laboratory evidence 
of pa rtia l c ro s s -a lle rg e n ic ity  between 
cephamycins and the other beta-lactam anti­
b io tics, pen ic illins and cephalosporins. 
Severe reactions (including anaphylaxis) have 
been reported  w ith  m ost beta-lactam  
antibiotics.
Pseudomembranous colitis has been reported 
with virtually all antibiotics. This colitis can 
range from mild to life threatening in severity. 
Antibiotics should therefore be prescribed 
with caution in individuals with a history of 
gastrointestinal disease, particularly colitis. It 
is important to consider a diagnosis of pseudo­
membranous colitis in patients who develop 
diarrhea in association with antibiotic use. 
While studies indicate that a toxin produced 
by Clostridium difficile is one primary cause of 
antibiotic-associated colitis, other causes 
should also be considered.
Any patient who has demonstrated some form 
of allergy, particularlytodrugs,should receive 
antibiotics including MEFOXIN* with caution. 
If an allergic reaction to MEFOXIN* occurs, 
administration of the drug should be discon­
tinued. Serious hypersensitivity reactions may 
require treatment with epinephrine and other 
emergency measures.
PRECAUTIONS
The total daily dosage should be reduced 
when MEFOXIN* is administered to patients 
with transient or persistent reduction of 
urinary output due to renal insufficiency (see 
DOSAGE AND ADMINISTRATION) because 
high and prolonged serum antibiotic con­
centrations can occur from usual doses.
In patients treated with MEFOXIN* a false­
positive reaction to glucose in the urine may 
occur with Benedict’s or Fehling's solutions 
but not with the use of specific glucose 
oxidase methods.
Using the Jaffe Method, falsely high creatinine 
values in serum may occur if serum concen­
trations of cefoxitin exceed 100#/g/mL. Serum 
samples from patients treated with MEFOXIN* 
should not be analyzed for creatinine if with­
drawn within two hours of drug administration.
Increased nephrotoxicity has been reported 
fo llow ing concom itant administration of 
cephalosporins and aminoglycoside antibiotics. 
The safety of MEFOXIN* in the treatment of 
infections during pregnancy has not been 
es ta b lish ed . If the a d m in is tra tio n  of 
MEFOXIN* to pregnant patients is considered 
necessary, its use requires thattheanticipated 
benefits be weighed against possible hazards 
to the fetus. Reproductive and teratogenic 
studies have been performed in mice and rats 
and have revealed no evidence of impaired 
fertility or harm to the fetus due to MEFOXIN*. 
Cefoxitin has been observed in the milk of 
nursing mothers receiving the drug. 
Prolonged use of MEFOXIN* may result in the 
overgrowth of non-susceptible organisms. 
Repeated evaluation of the patient's condition 
is essential and if superinfection occurs 
during therapy, appropriate measures should 
be taken. Should an organism become 
resistant during antibiotic therapy, another 
antibiotic should be substituted.
In children 3 months of age or older, higher 
doses of MEFOXIN* (100 m g/kg/day and 
above) have been associated w ith  an 
increased incidence of eosinophilia and 
elevated SGOT.
ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse 
reactions rare ly requ ired cessation of 
treatment and usually have been mild and 
transient.
Local Reactions
Thrombophlebitis has occurred with intra­
venous administration. Some degree of pain 
and tenderness is usually experienced after 
in tra m u scu la r in je c tio n s  using water. 
Induration has occasionally been reported.
Allergic
M aculopapular rash, urticaria , pruritus, 
eosinophilia, fever and other allergic reactions 
have been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can 
appear during or after antibiotic treatment. 
Nausea and vomiting have been reported 
rarely.
Blood
Transient eosinophilia, leukopenia, neutropenia, 
hemolytic anemia, and thrombocytopenia 
have been reported. Some individuals, particu­
larly those w ith azotemia, may develop 
positive direct Coombs tests during therapy 
with MEFOXIN*.
Liver Function
Transient elevations in SGOT, SGPT, serum 
LDH, and serum alkaline phosphatase have 
been reported.
Kidney
Elevations in serum creatinine and/or blood 
urea nitrogen levels have been observed. As 
with the cephalosporins, acute renal failure 
has been reported rarely. The role of 
MEFOXIN* in changes in renal function tests 
is d iff icu lt to  assess, since factors pre­
disposing to prerenal azotemia or to impaired 
renal function have often been present.
TREATMENT OF OVERDOSE
Other than general supportive treatment, no 
specific antidote is known. MEFOXIN* can be 
eliminated by dialysis in patients with renal 
insufficiency.
Adults with Impaired Renal Function
MEFOXIN* may be used in patients with 
reduced renal function but a reduced dosage 
should be employed and it is advisable to 
monitor serum levels in patients with severe 
impairment.
In adults with renal insufficiency, an initial 
loading dose of 1 g to 2 g should be given. 
After a loading dose, the following recommen­
dations for maintenance dosage may be used 
as a guide:
R E N A L C R E A T IN IN E
F U N C T IO N C L E A R A N C E D O S E F R E Q U E N C Y
m L /m in
M ild>
im p a irm e n t
M o d era te
50-30 1-2 g e ve ry  8 -1 2  h
im p a irm e n t
Severe
29-10 1 -2  g eve ry  12-24 h
im p a irm e n t 9-5 0.5-1 g eve ry  12-24 h
E sse n tia lly  
no  fu n c t io n < 5 0.5-1 g eve ry  24-48  h
In the patient undergoing hemodialysis, the 
loading dose of 1 - 2g should be given after 
each hemodialysis, and the maintenance dose 
should be given as indicated in the Table 
above.
Neonates (Including Premature Infants), 
Infants and Children (See WARNINGS for 
Neonates under ADMINISTRATION in the 
complete monograph.)
P re m a tu re  In fa n ts  
w ith  B o d y  W e ig h ts  
A b o v e  1 5 0 0  g 20-40  m g /k g  eve ry  12 h I.V.
N e o n a te s
0 -  1 w e ek  o f age
1- 4  w e e k s  o f  age
20-40  m g /k g  every  12 h I.V. 
20-40  m g /k g  every  8  h I.V.
In fa n ts
1 m o n th  to  2 years  
o f age
2 0-40  m g /k g  eve ry  6 h o r  
eve ry  8 h I.M . o r  I.V.
C h ild re n 20-40  m g /k g  eve ry  6  h o r 
e ve ry  8  h I.M . o r  I.V.
In severe infections, the total daily dosage in 
infants and children may be increased to 
200 mg/kg, but not to exceed 12 g per day. 
MEFOXIN* is not recommended fo r the
therapy of meningitis. If meningitis is sus­
pected, an appropriate antibiotic should be 
used.
DOSAGE AND ADMINISTRATION
MEFOXIN* may be administered intravenously 
or in tram uscu larly  when required. (See 
complete monograph on ADMINISTRATION 
and RECONSTITUTION.)
TREATMENT DOSAGE 
Adults
The usual adult dosage is 1 g or 2 g of 
MEFOXIN* every 6 to 8 hours. Dosage and 
route of administration should be determined 
by severity of infection, susceptibility of the 
causative organisms, and condition of the 
patient. The usual adult dosages are shown in 
the Table below.
Usual Adult Dosage
T y p e  o f 
in fe c t io n
D a ily
D o s a g e
F re q u e n c y  
a n d  R o u te
U n c o m p lic a te d  
fo rm s * o f in ­
fe c tio n s  su ch  as 
pne um on ia , 
u r in a ry  tra c t 
in fe c tio n , so ft 
tissu e  in fe c tio n
3-4  g 1 g e ve ry  6 -8  h 
I.V. o r  I.M.
M o d era te ly  
severe o r severe 
in fe c tio n s
6-8  g 1 g e v e ry  4  h 
o r
2 g e v e ry  6 -8  h I.V.
In fe c tio n s  
c o m m o n ly  
n ee d ing  a n t i­
b io t ic s  in h ig h e r 
d osa ge  (e .g. gas 
g an gren e )
1 2 9 2 g eve ry  4 h
o r
3 g eve ry  6  h I.V.
' I n c l u d in g  p a t ie n t s  in  w h o r r  
a b s e n t  o r  u n l i k e ly
i b a c t e r e m ia  is
Therapy may be started while awaiting the 
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic 
streptococcal infectionsshould be maintained 
for at least 10 days to guard against the risk of 
rheumatic fever or glomerulonephritis. In 
staphylococcal and other infections involving 
a collection of pus, surgical drainage should 
be carried out where indicated.
At present there is in su ffic ie n t data to 
recommend a specific dosage for children 
with impaired renal function. However, if the 
administration of MEFOXIN* is deemed to be 
essential the dosage should be modified 
consistent with the recommendations for 
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of 
MEFOXIN* is recommended as follows: 
Vaginal or abdominal hysterectomy and 
abdominal surgery
2 g administered intramuscularly or intra­
venously just prior to surgery (approximately 
one-half to one hour before initial incision).
The second and third 2 g doses should be 
administered at 2-6hour intervals after the 
Initial dose.
Cesarean Section
The first dose of 2g should be administered 
intravenously as soon as the umbilical cord 
has been clamped. The second and third 
2 g doses should be given intravenously or 
intramuscularly four hours and eight hours 
after the first dose.
AVAILABILITY
MEFOXIN* is supplied as sterile powder in 
boxes of 10 vials:
3356 Ca - 1 g cefoxitin as sodium salt
3357 Ca - 2 g cefoxitin as sodium salt
Storage
MEFOXIN* in the dry state should be stored 
below 30° C.
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Silastic Catheter Separation Due to Subcutaneous Suture
The development of large-bore, double­
lumen Silastic catheters for introduction 
into the superior vena cava has made it 
possible for patients with renal failure to 
receive immediate dialysis while awaiting 
maturation of an arteriovenous fistula. 
Although Infections and thrombotic com­
plications have been well documented, 
separation of Silastic cannulas has sel­
dom been described and is poorly 
explained. The authors report two such 
cases. In one the catheter was clearly 
sheared off due to snaring by a sub­
cutaneous suture. In the second case, 
awareness of the possibility of such a 
complication allowed the authors to 
explore the catheter at the level of the 
venotomy. By dividing the suture under 
direct vision, they were able to remove 
the snared catheter before it became 
transected.
La mise au point de catheters de Silastic 
de calibre important, a double paroi, pour 
insertion dans la veine cave superieure, a 
rendu possible la dialyse immediate des 
patients souffrant d'insuffisance renale 
en attendant la maturation d'une fistule 
arterioveineuse. Alors que les infections 
et les complications thrombotiques sont 
bien connues, la separation de la canule 
de Silastic a rarement ete decrite et elle 
s'explique mal. Les auteurs en signalent 
deux cas. Dans un cas, le catheter s'est 
carrement detache a cause d'une defail- 
lance d'une suture sous-cutanee. Dans le 
second cas, les auteurs ayant a I'esprit 
cette possibility, il leur fut possible 
d explorer le catheter au niveau de la vei- 
notomie. En divisant la suture sous ins­
pection directe ils purent retirer le cathe­
ter avant qu'il ne se sectionne.
From the Division o f General Surgery, 
Queen’s University, Kingston, Ont.
*Medical student.
Accepted fo r  publication Feb. 3, 1987
Reprint requests to: Dr. R.F. Pace, Divi­
sion o f General Surgery, Queen’s Univer­
sity, Kingston General Hospital, Kingston, 
Ont. K7L 2V7
The use of central venous access lines is 
now well established in the treatment of 
patients requiring vascular access for the 
delivery of drugs, blood products or 
parenteral nutrition. Large-bore, double­
lumen Silastic catheters have recently 
been developed to allow temporary, 
immediate hemodialysis for patients while 
they await maturation of an arteriovenous 
fistula.1 Although infectious and throm­
botic complications of Silastic cannulas 
are well documented,2’3 only a few cases 
of mechanical failure have been pub­
lished.4'10 We report two cases which 
suggest that catheter separation may 
result from the scissorlike action of a sub­
cutaneous suture.
Case Reports
Case 1
A 25-year-old man with renal failure due to 
insulin-dependent diabetes required vascular 
access for hemodialysis while awaiting matu­
ration of an arteriovenous fistula. A double­
lumen HemoCath dialysis catheter (Quinton 
Inc., Seattle, Wash.) was inserted by cutdown 
through a venotomy in the right internal jugu­
lar vein because the large size of the catheter 
precluded percutaneous insertion. A purses­
tring suture of 5-0 Prolene controlled bleeding 
at the venotomy site and, to prevent sharp 
angulation, the catheter was secured in place 
with a subcutaneous suture of 5-0 Prolene. A 
postoperative chest x-ray film showed proper 
placement above the right atrium and dialysis 
proceeded without incident.
Maturation of a right Brescia-Cimino arteri­
ovenous fistula allowed removal of the catheter 
29 days after insertion. In the operating room, 
the Dacron cuff was dissected free from the 
surrounding tissue and the catheter was 
removed using steady traction. However, the 
catheter separated 4.2 cm distal to the cuff, 
leaving a long segment in situ. An immediate 
chest x-ray film demonstrated the catheter seg­
ment in the internal jugular vein (Fig. 1). On 
exploration of the neck, the end of the catheter 
fragment was found at the entrance site to the 
internal jugular vein, adjacent to the Prolene 
retaining suture. This 14.8-cm segment was 
withdrawn without incident (Fig. 2). It 
exhibited a sharply cut edge, evidently where 
it had been sheared off by the Prolene retain­
ing suture.
Case 2
A 47-year-old woman with renal failure from
polycystic kidney disease underwent right 
nephrectomy prior to a proposed renal trans­
plant . Postoperatively her arteriovenous fistula 
thrombosed and she required venous access for 
hemodialysis until a permanent site could be 
established. A HemoCath dialysis catheter was 
inserted into the right internal jugular vein by 
the cutdown technique and a pursestring of 5-0 
Prolene was used to control bleeding at the 
venotomy site. A subcutaneous retaining suture 
was not placed in this patient. The catheter 
functioned satisfactorily for 1 month, then 
removal was indicated because peritoneal dial­
ysis was satisfactory. The Dacron cuff was dis­
sected free from the subcutaneous tissue by 
sharp dissection, and the catheter was with­
drawn approximately 3 to 4 cm before there 
was increased resistance. After several unsuc­
cessful attempts to remove the catheter, the old 
incision was explored and the catheter exposed 
down to its insertion into the internal jugular 
vein. The pursestring suture at the site of the 
venotomy had snared the catheter and only 
after the suture was divided under direct vision
FIG. 1—Case 1. Chest x-ray film demon­
strating fragment of distal catheter lying in 
superior vena cava without evidence of migra­
tion. Site of separation (arrow) corresponds to 
position of subcutaneous retaining suture.
FIG. 2—Case 1. Two sections of Silastic 
catheter after removal of distal fragment.
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could the catheter be removed. The catheter 
had an indentation at the site of the pursestring 
suture and it was clear that vigorous attempts 
at withdrawal might have resulted in tran­
section.
D iscussion
Separation of a central venous catheter 
is a serious complication, especially when 
there is distal embolization which requires 
complicated retrieval techniques and has 
serious medicolegal implications.
Catheters inserted by the percutaneous 
subclavian route such as the Hickman or 
Broviac Silastic catheters are subject to 
compression between clavicle and first 
rib. Reports of separation after weeks or 
months of catheter use have demon­
strated this problem by virtue of compres­
sion of the catheter at the separation 
site.4,9 With other insertion techniques 
separation has been reported5,8 but the 
cause not clearly demonstrated. Because
of the findings in our two patients we 
believe that a pursestring suture at the site 
of the venotomy or a subcutaneous 
retaining suture may snare the catheter 
upon removal, leading to transection with 
possible distal embolization. With the 
experience gained from the first case, we 
were aware of possible catheter transec­
tion in the second case, and appropriate 
steps were taken to divide the suture.
In case 1, the catheter was undoubtedly 
sheared off at the level of the subcutane­
ous retaining suture by its scissorlike 
action when removal was attempted. We 
now avoid using subcutaneous sutures to 
stabilize the catheters, apart from those 
needed to control bleeding at the venot­
omy site. Because case 2 demonstrates 
that even the pursestring suture may snare 
the catheter, we advocate its removal in 
the operating room with facilities availa­
ble to perform an immediate cutdown 
should there be resistance to catheter 
withdrawal.
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QUICK REFERENCE TO SURGICAL 
EMERGENCIES. 2nd ed. Edited by Ber­
nard Gardner and Gerald W. Shaftan. 743 
pp. Illust. J.B. Lippincott Company, 
Philadelphia, 1986. $39.50 (US), paper- 
hound. ISBN 0-397-50702-X.
The objective of this book is to provide the 
physician on the “ firing line” with a guide and 
quick reference for the recognition and treat­
ment of acute surgical emergencies. This text 
is directed primarily to emergency physicians 
and residents training in trauma surgery.
The advanced trauma life support course 
(ATLS) deals with the “ first hour” of manage­
ment of critically injured patients. This edition 
covers full management and protocols to the 
present. Management includes prehospital tri­
age, organization of trauma services and emer­
gency departments, planning for and handling 
disaster situations, the initial and ongoing 
management of the trauma patient. The major 
revision and additions to this second edition 
are in this field. A reference work of this nature 
has been sorely needed. Although detailed 
knowledge of each problem is beyond the scope 
of this work, as a thumb-nail summary and ini­
tial guide to management of trauma and acute 
surgical emergencies, this text achieves its goal 
as an emergency reference.
One criticism of the format is that the phy­
sician must make an initial correct diagnosis, 
and in order to derive full benefit from the 
book have first studied the subject. It is not 
primarily organized as a problem-solving text. 
However, an initial understanding of the broad 
scope of the contents provides the basis on 
which to recognize the problem and use the text 
as a quick reference guide. It was not intended 
to, nor does it, replace detailed dissertations 
in each specialty field.
The text consists of contributions from 48 
recognized authorities. The first four chapters
deal with the evaluation, monitoring and resus­
citation of the patient. The next four give 
guidance in radiologic investigations, anesthe­
sia, ventilation and infection management. The 
body of the text, 26 concise chapters, contains 
a comprehensive review of surgical emergen­
cies in each body system. A 150-page section 
deals with emergencies in the pediatric patient. 
The final chapter is devoted to appropriate 
planning for surgical emergencies. The physi­
cal characteristics of the emergency depart­
ment, personnel organization, treatment pro­
tocols, disaster planning and organization of 
trauma services are outlined. The index is 
detailed providing rapid direction to specific 
problem areas.
I would recommend this text as required 
reading for all emergency physicians, trauma 
service personnel and those exposed to caring 
for acute surgical emergencies.
C .M . Bu r n s , m d , frcsc
Director of Trauma Services,
GF419 General Centre,
Health Sciences Centre,
700 William Ave.,
Winnipeg, Man.
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VASCULAR SURGERY. A Comprehensive 
Review. 2nd ed. Edited by Wesley S. 
Moore. 994 pp. Illust. Grune & Stratton, 
Inc., Orlando, Fla.; Academic Press 
Canada, Don Mills, Ont., 1986. $166.75. 
ISBN 0-12-792979-7.
This multiauthored text under the editorial 
guidance of W.S. Moore was developed to 
accompany the postgraduate review course in 
general vascular surgery held at the University 
of California at Los Angeles. It was designed 
to help the vascular trainee and surgeon pre­
pare for the examination to grant “ certifica­
tion of special competence in general vascular 
surgery” .
Based on these goals, experts in the field of 
vascular surgery have authored a textbook that 
provides a strong flavour of basic science as 
it pertains to vascular surgery and expert 
reviews of day-to-day vascular topics.
Of particular excellence and importance are 
the chapters on the pathogenesis of atheros­
clerosis, hemodynamics and the surgeon and 
the noninvasive vascular laboratory. However, 
certain chapters were obviously written close 
to a deadline and detract from the book. An 
example of this is the chapter on preoperative 
evaluation of the vascular patient, which res­
tricts itself to the cardiac system and ignores 
renal, pulmonary, carotid and infectious 
assessment. A further negative feature is the 
poor quality o f the angiograms that are so 
important in exemplifying certain points. One 
angiogram is even printed upside down, 
indicating that editorial review was often brief.
Outstanding reviews are offered by Dean 
(renovascular hypertension), Moore (extra­
cranial cerebrovascular disease) and Perry (vas­
cular trauma). Their chapters give all levels of 
vascular surgeons up-to-date and exact infor­
mation in dealing with these important and 
exciting areas o f vascular surgery.
Despite the variability in the style and depth 
of the writing, this book is comprehensive yet 
easily readable. The review questions at the end 
of each chapter add further to the goal of the 
book in aiding the trainee to prepare for board 
examinations. It is a must for all vascular resi­
dents and fellows in preparation for their 
examination in vascular surgery. It should also 
be a welcome and important addition to the 
library of all vascular surgeons for ease of 
review of a number of topics.
A .M . G r a h a m , m d , frcsc
Division of Cardiovascular and
Thoracic Surgery,
McGill University,
687 Pine Ave. W,
Montreal, PQ 
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Aorta-Right Atrial Fistula:
an Unusual Complication of Ascending Aortic Dissection
V
I
Ik
AV
Ascending aortic dissection complicated 
by aorta-right atrial fistula is a very rare 
occurrence. The patient may present 
with atypical clinical findings such as a 
continuous murmur or atrioventricular 
block, making the diagnosis difficult. 
Surgical repair is straightforward unless 
the correct diagnosis is missed, in which 
case there may be difficulties during the 
initial period of cardiopulmonary bypass. 
This report deals with the successful 
management of a 67-year-old man with 
this condition.
On rencontre rarement une dissection de 
I'aorte ascendante compliquee d’une fis- 
tule entre I'aorte et I'oreillette droite. Le 
patient peut presenter des signes clini- 
ques atypiques tels qu'un souffle continu 
ou un bloc auriculoventriculaire, ce qui 
rend le diagnostic difficile. La reparation 
chirurgicale est simple a moins de rater 
le diagnostic; en I'occurrence, des diffi- 
cultes peuvent survenir pendant la 
periode initiate de circulation extracorpo- 
relle. Cet article commente la reussite du 
traitement chez un homme de 67 ans 
souffrant de cette affection.
Aorta-right atrial fistula has been well 
described in patients with aneurysms of 
the sinus of Valsalva, following trauma, 
cardiac catheterization and acquired aor­
tic aneurysms.1-3 A fistula arising from 
rupture of the false channel of ascending 
aortic dissection into the right atrium is 
extremely rare. In Hirst’s exhaustive 
review of dissecting aneurysms, this com­
plication was not reported.4 To our 
knowledge, the patient whose case we 
describe here represents the third success-
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ful repair of an aorta-right atrial fistula 
secondary to ascending aortic dissection.
Case Report
A 67-year-old man was admitted to hospi­
tal with a diagnosis of possible ascending aor­
tic dissection. Fifteen months previously he had 
undergone aortic valve replacement with a no. 
27 Ionescu-Shiley prosthesis for aortic insuffi­
ciency. The cause of his disease was unclear, 
and preoperative angiography revealed dilata­
tion of the entire thoracic aorta. This was con­
firmed at surgery, but it was thought that graft 
replacement was not warranted. Biopsy of the 
aortic wall later revealed mild intimal hyper­
plasia. His postoperative course was compli­
cated by sternal dehiscence. Otherwise recov­
ery was smooth.
Five days before this admission (15 months 
after the original operation) he was seen in the 
emergency department with vague chest dis­
comfort, diaphoresis and shock (blood pres­
sure 80 mm Hg, pulse rate 140 beats/min). 
There was no evidence of a new murmur and 
the neck veins were not distended. He was 
admitted to the coronary care unit where his 
vital signs stabilized with volume replacement. 
There were no changes in the electrocardiogram 
or enzyme levels. The patient was discharged 
home after 72 hours of observation. Two days 
later he returned complaining of vague chest 
discomfort. He was diaphorectic and hypoten­
sive (blood pressure 70/50 mm Hg). A diastolic 
murmur was now heard. The patient was 
referred to our hospital with the provisional 
diagnosis of ascending aortic dissection with 
aortic insufficiency. On arrival, he was still 
hypotensive. A 2-D echocardiogram revealed 
an intimal flap in the ascending aorta. In view 
of his deteriorating clinical condition, aortog­
raphy was not done before operation.
Cardiopulmonary bypass was instituted 
through the femoral artery and a two-stage 
right atrial cannula. During cardioplegic infu­
sion into the coronary ostia, the venous can­
nula filled with air and cardiopulmonary 
bypass had to be discontinued. The aortic 
lumen was inspected and a tear found in the 
lateral wall communicating with the right 
atrium. The defect measured approximately 2 
x 2 cm. The intimal tear was 2 cm above the 
left coronary ostium and 5 cm long. Cardiopul­
monary bypass was restarted with two caval 
cannulas and the fistula was closed with 
sutures. The bioprosthetic valve appeared satis­
factory and the coronary ostia retained their 
usual spatial relationship with the aortic annu­
lus. A woven Dacron tube graft was interposed
above the coronary ostia to the ascending aorta 
below the innominate artery. An aortic wall 
biopsy revealed intimal thickening with focal 
atherosclerosis. The patient recovered without 
complication and was well at follow-up 9 
months later.
Subsequently, a large false aneurysm of the 
distal anastomosis of the Dacron graft deve­
loped, with a large hematoma extending into 
the right chest and compressing the right 
atrium, superior vena cava and lung. Under cir­
culatory arrest this was repaired. A bleeding 
duodenal ulcer then developed, requiring a 
vagotomy apd pyloroplasty. Unfortunately, the 
patient suffered severe sepsis with wound infec­
tion (Escherichia colij and subsequent infec­
tion of the ascending aorta Dacron graft. This 
initially was drained by a small right anterior 
thoracotomy, but despite this and the admi­
nistration of antibiotics, the sepsis continued. 
The Dacron graft was removed under deep 
hypothermia and an aortic homograft was used 
to reconstruct the aorta. He did well postope- 
ratively, but bled profusely from the distal 
anastomosis on postoperative day 10 and requi­
red emergency re-sternotomy, repair of the 
small dehiscence and placement of a right pec- 
toralis muscle flap to cover a large space 
around the homograft. At present, he appears 
to be recovering satisfactorily.
Discussion
Kuipers and Schatz5 in 1963 were the 
first to report aorta-right atrial fistula fol­
lowing ascending aortic dissection. 
Dulake and Ashfield6 reported a patient 
with an ascending aortic dissection and 
a continuous murmur who presented in 
congestive failure. The patient improved 
with medical therapy but died 3 months 
later of congestive heart failure. The 
antemortem diagnosis was aortic dissec­
tion with aortic insufficiency. At autopsy, 
an aorta-right atrial fistula was found. 
Since then, four other patients with this 
condition have been reported.7-10
Yacoub and associates" have 
described the pathogenesis of this lesion. 
The aortoatrial space is bounded by the 
aortic media, aortic annulus and right 
atrial wall. The medial layer of the aorta 
is continuous with the aortic annulus 
except in the region of the commissures. 
In ascending aortic dissections, the false 
lumen ruptures into this space then
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traverses the membranous septum into 
the right atrium, creating a fistula.
These patients may present with the 
usual features of aortic dissection. Addi­
tionally, there may be atypical findings 
suggesting the presence of an aorta-right 
atrial fistula. Jugular venous distension 
and other signs of acute right heart 
failure, associated with a continuous mur­
mur over the right sternal border, will 
differentiate this complication from 
ascending aortic dissection with aortic 
insufficiency. The electrocardiogram may 
indicate an atrioventricular block11 and 
the chest x-ray film may reflect increased 
pulmonary blood flow. Echocardiogra­
phy and cardiac catheterization, with or 
without oximetry, are also useful in estab­
lishing the diagnosis.8
The size of the aorta-right atrial fistula 
and the pulmonary vascular resistance 
will dictate the magnitude of the left-to- 
right shunt and hence determine the 
patient’s hemodynamic status. The first 
successful repair was described by Tem­
ple and colleagues7 in 1966, and Page 
and colleagues9 in 1973 also reported 
their success. Repair of the fistula is 
achieved using cardiopulmonary bypass 
with cannulation and snaring of the venae 
cavae and femoral artery. The left heart 
is usually vented. With cardioplegic 
arrest, the ascending aortic dissection is 
repaired by graft interposition and closure 
of the fistula. If the diagnosis is not sus­
pected preoperatively, air will be siphoned 
into the venous circuit via the fistula once 
the aorta is opened. Either immediate 
repair of the atrial defect or snared 
bicaval cannulation will solve the 
problem.
Our patient was unusual in that the 
fistula occurred 15 months after aortic 
valve replacement. The six previously 
reported patients had no history of 
cardiac surgery. Since our patient 
presented with a dilated aorta and aortic 
insufficiency, one must question the 
histologic integrity of the aorta and 
whether the initial procedure was the cor­
rect one. The aortic biopsy specimens did 
not reveal evidence of cystic medial necro­
sis. The proximal aortic contour was not 
consistent with that described for 
annuloaortic ectasia. Most likely, the 
patient’s aortic dissection was caused by 
systemic hypertension superimposed on 
a dilated, diseased aorta.
We acknowledge the assistance of Dr. A. 
Hess the cardiologist who initially referred this 
patient to us and who subsequently managed 
and diagnosed acute dissection.
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Diagnostic Ultrasound
A series of continuing education seminars 
providing hands-on instruction in diag­
nostic ultrasound are scheduled for the 
fall, in Dallas and Nashville. Course 
titles include: “ Cardiac 2-D/M-Mode 
Imaging” , “ Cardiac Doppler” , “ Abdo­
minal Imaging Techniques” , “ Ob/Gyn 
Imaging Techniques” and “ Lower/ 
Upper Extremity Applications of Duplex 
Technology” . For course dates, locations 
and further information contact: Ms. 
Barbara Bhatt, Keith Mauney and Asso­
ciates, Inc., 1230 Riverbend Drive, 
Suite 100, Dallas, Texas 75247; tele­
phone; (214) 630-4288.
Hand Surgery
The American Association for Hand Sur­
gery will be holding its 17th annual meet­
ing in San Juan, Puerto Rico, Nov. 4-8, 
1987. Instructional courses, panels and 
scientific papers will highlight the meet­
ing. Information can be obtained by writ­
ing to: American Association for Hand 
Surgery, 2934 Fish Hatchery Road, Suite 
218, Madison, WI 53713 or calling: (608) 
273-8940.
NOTICE OF CHANGE OF ADDRESS /
AVIS DE CHANGEMENT D’ADRESSE
To ensure that you continue to receive the Canadian Journal o f  Surgery without 
interruption, please fill in this form before you move.
Avant de demenager, assurez-vous de recevoir sans interruption le Journal cana- 
dien de chirurgie en completant le formulaire suivant.
Please print /  en lettres moulees, svp
Name /  nom ............................................................................................................
Royal College member number /  numero d’identite .......................................
Old address /  ancienne adresse ............................................................................
New address /  nouvelle adresse
Postal code /  code postal .....................................................................................
Date ...........................................................................................................................
Royal College fellows please mail to: Royal College of Physicians and Sur­
geons of Canada, 74 Stanley, Ottawa, Ont. KIM 1P4.
Membres du College royal, veuillez expedier a: College royal des medecins et 
chirurgiens du Canada, 74 Stanley, Ottawa, Ont. KIM 1P4.
Subscribers please mail to: Information Systems, Canadian Medical Associa­
tion, PO Box 8650, Ottawa, Ont. K1G 0G8.
Abonnes, veuillez expedier a: Systeme de diffusion d ’informations, l’Associa- 
tion medicale canadienne, CP 8650, Ottawa, Ont. K1G 0G8.
VOLUME 30, NO. 5, SEPTEMBER 1987 /  THE CANADIAN JOURNAL OF SURGERY 381
BOOKS RECEIVED CLASSIFIED ADVERTISING
4
As a further service to its readers the Canadian Journal o f  Surgery is pleased to accept 
suitable classified advertisements. The deadline is 1 month before issue date. Regular 
classified rates (for each insertion): $40.00 for the first 40 words or less, additional 
words 50C each (additional $16.00 for frame). Special Display under 75 words, 2 'A" 
x  2" $100.00. $6.00 charge (first insertion only) for CJS box numbers. Display rates 
available on request.
Copy should be mailed to the Canadian Journal o f  Surgery, PO Box 8650, Ottawa, 
Ontario K1G 0G8.
This list is an acknowledgement of 
books received. It does not preclude 
review at a later date.
Adas of Advanced Surgery. Edited by Martin 
S. Litwin. 198 pp. Must. Yorke Medical 
Books, New York, 1986. Price not stated. 
ISBN 0-914316-50-8.
Hypertension Mechanisms. Irvine H. Page. 
1102 pp. Grune & Stratton, Inc., Orlando, 
Fla.; Academic Press Canada, Don Mills, 
Ont., 1987. $102.95. ISBN 0-12-793228-3.
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Jeffrey Street. 306 pp. Lester & Orpen 
Dennys Limited, Toronto, 1987. $22.85. 
ISBN 0-88619-103-3.
The Silent Epidemic. A Comprehensive Guide 
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Becton Dickinson Canada Inc.
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GENERAL SURGEON: MB — Prospective partner 
required to  replace retiring surgeon. The group 
services a productive economically stable region 
of 180 000, located in a university city of 42 000. 
Excellent schools, recreational and cultural facili­
ties. The clinic having a modern laboratory, x-ray 
and other diagnostic services is located adjacent 
to a 220-bed acute care hospital. Interest in chest 
or vascular surgery an asset but not essential. 
Canadian fellowship is required. Contact: Mr. A.J. 
Lockhart, Administrator, Box 280, Brandon, MB 
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CARDIO THORACIC SURGEON: US -  Northear 
stern, busy non-cardiac thoracic surgical group 
w ith university affiliation has position leading to 
early partnership available now or July 1988. 
Please reply to: Box S115 CJS. -S 8 7 -5 8
GENERAL SURGEON: ON — required for a modern 
medical clinic attached to a 45-bed hospital. Five 
general practitioners. Located 120 miles from Ot­
tawa in an unopposed catchment area of 8000 
residents. An opportunity exists to develop an ex­
cellent surgical practice. Good schools in a lovely 
community. All the amenities of a major center. 
Situated in the picturesque Ottawa Valley. For in­
formation call collect: Mr. G.C. Mahon, Adminis­
trator, Deep River & District Hospital, tel: 
(613) 584-3333. S87-57
GENERAL SURGEON: BC — required to move to 
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Calgary District Hospital Group
Trauma Surgeon — 
Director of Trauma Care
The Rockyview General Hospital, a 450 bed active 
treatment hospital serving Calgary and Southern Alberta, is 
seeking an individual to become Director of our Level 2 
Trauma Unit. This hospital is a progressive, ultramodern 
facility which already participates in existing air and ground 
prehospital transport. Responsibilities: to coordinate clinical 
activities of our Trauma Unit and assist in the development of 
a regional trauma system, to organize and be responsible for 
ongoing clinical teaching programs in trauma and clinical 
research, to play an active role in the Department of Surgery 
and head the Division of Trauma Surgery.
Requirements: Board certified General or Thoracic Surgeon 
with special expertise and training in trauma surgery.
Replies should be directed to:
The Director of Surgery 
c/o Rockyview General Hospital 
7007 -14 Street Southwest 
Calgary, Alberta T2V 1P9
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